| 1 |
Ngo HV, Oster H, Andreou C, Obleser J. Circadian rhythms in auditory hallucinations and psychosis. Acta Physiol (Oxf) 2023;237:e13944. [PMID: 36744985 DOI: 10.1111/apha.13944] [Reference Citation Analysis]
|
| 2 |
Schamiloglu S, Lewis E, Keeshen CM, Hergarden AC, Bender KJ, Whistler JL. Arrestin-3 agonism at D3 dopamine receptors defines a subclass of second generation antipsychotics that promotes drug tolerance. Biol Psychiatry 2023:S0006-3223(23)01092-2. [PMID: 36931452 DOI: 10.1016/j.biopsych.2023.03.006] [Reference Citation Analysis]
|
| 3 |
Iasevoli F, Avagliano C, D’ambrosio L, Barone A, Ciccarelli M, De Simone G, Mazza B, Vellucci L, de Bartolomeis A. Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal. Biomedicines 2023;11:895. [DOI: 10.3390/biomedicines11030895] [Reference Citation Analysis]
|
| 4 |
Percie du Sert O, Unrau J, Gauthier CJ, Chakravarty M, Malla A, Lepage M, Raucher-Chéné D. Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies. Prog Neuropsychopharmacol Biol Psychiatry 2023;121:110669. [PMID: 36341843 DOI: 10.1016/j.pnpbp.2022.110669] [Reference Citation Analysis]
|
| 5 |
Coutts F, Koutsouleris N, McGuire P. Psychotic disorders as a framework for precision psychiatry. Nat Rev Neurol 2023. [PMID: 36879033 DOI: 10.1038/s41582-023-00779-1] [Reference Citation Analysis]
|
| 6 |
Astill Wright L, McElroy E, Barawi K, Roberts NP, Simon N, Zammit S, Bisson JI. Associations among psychosis, mood, anxiety, and posttraumatic stress symptoms: A network analysis. J Trauma Stress 2023. [PMID: 36862599 DOI: 10.1002/jts.22916] [Reference Citation Analysis]
|
| 7 |
Kassim FM, Mark Lim JH, Albrecht MA, Martin-Iverson MT. Dexamphetamine influences funneling illusion based on psychometric score. Hum Psychopharmacol 2023;38:e2862. [PMID: 36799101 DOI: 10.1002/hup.2862] [Reference Citation Analysis]
|
| 8 |
Dang X, Liu J, Zhang Z, Luo XJ. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Identifies Novel Risk Genes for Schizophrenia. Mol Neurobiol 2023;60:1537-46. [PMID: 36517655 DOI: 10.1007/s12035-022-03160-3] [Reference Citation Analysis]
|
| 9 |
Stępnicki P, Targowska-duda KM, Martínez AL, Zięba A, Wronikowska-denysiuk O, Wróbel MZ, Bartyzel A, Trzpil A, Wróbel TM, Chodkowski A, Mirecka K, Karcz T, Szczepańska K, Loza MI, Budzyńska B, Turło J, Handzlik J, Fornal E, Poleszak E, Castro M, Kaczor AA. Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling. European Journal of Medicinal Chemistry 2023. [DOI: 10.1016/j.ejmech.2023.115285] [Reference Citation Analysis]
|
| 10 |
van Hooijdonk CFM, van der Pluijm M, Bosch I, van Amelsvoort TAMJ, Booij J, de Haan L, Selten JP, Giessen EV. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings. Eur Neuropsychopharmacol 2023;68:57-77. [PMID: 36640734 DOI: 10.1016/j.euroneuro.2022.12.008] [Reference Citation Analysis]
|
| 11 |
Zhang HC, Du Y, Chen L, Yuan ZQ, Cheng Y. MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets. Neurosci Biobehav Rev 2023;146:105064. [PMID: 36707012 DOI: 10.1016/j.neubiorev.2023.105064] [Reference Citation Analysis]
|
| 12 |
Walsh MJM, Gibson K, Hynd M, Eisenlohr-Moul TA, Walsh EC, Schiff L, Jarskog F, Lalush D, Dichter GS, Schiller CE. Perimenopausal Effects of Estradiol on Anhedonia and Psychosis Study (PEEPs): study protocol for a neural and molecular mechanistic clinical trial. Trials 2023;24:150. [PMID: 36855177 DOI: 10.1186/s13063-023-07166-7] [Reference Citation Analysis]
|
| 13 |
Mastwal S, Li X, Stowell R, Manion M, Zhang W, Kim NS, Yoon KJ, Song H, Ming GL, Wang KH. Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function. bioRxiv 2023:2023. [PMID: 36778456 DOI: 10.1101/2023.02.03.526987] [Reference Citation Analysis]
|
| 14 |
Di Bartolomeo M, Stark T, Di Martino S, Iannotti FA, Ruda-Kucerova J, Romano GL, Kuchar M, Laudani S, Palivec P, Piscitelli F, Wotjak CT, Bucolo C, Drago F, Di Marzo V, D'Addario C, Micale V. The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology. Int J Mol Sci 2023;24. [PMID: 36835313 DOI: 10.3390/ijms24043907] [Reference Citation Analysis]
|
| 15 |
Faron-Górecka A, Latocha K, Pabian P, Kolasa M, Sobczyk-Krupiarz I, Dziedzicka-Wasylewska M. The Involvement of Prolactin in Stress-Related Disorders. Int J Environ Res Public Health 2023;20. [PMID: 36833950 DOI: 10.3390/ijerph20043257] [Reference Citation Analysis]
|
| 16 |
Panula JM, Lindgren M, Kieseppä T, Suvisaari J, Raij TT. Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study. Schizophr Res 2023;254:27-34. [PMID: 36774695 DOI: 10.1016/j.schres.2023.02.001] [Reference Citation Analysis]
|
| 17 |
Frau R, Melis M. Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone. J Neuroendocrinol 2023;:e13240. [PMID: 36810840 DOI: 10.1111/jne.13240] [Reference Citation Analysis]
|
| 18 |
Brown NK, Roche JK, Farmer CB, Roberts RC. Evidence for upregulation of excitatory synaptic transmission in the substantia nigra in Schizophrenia: a postmortem ultrastructural study. J Neural Transm (Vienna) 2023. [PMID: 36735096 DOI: 10.1007/s00702-023-02593-x] [Reference Citation Analysis]
|
| 19 |
Ogyu K, Matsushita K, Honda S, Wada M, Tamura S, Takenouchi K, Tobari Y, Kusudo K, Kato H, Koizumi T, Arai N, Koreki A, Matsui M, Uchida H, Fujii S, Onaya M, Hirano Y, Mimura M, Nakajima S, Noda Y. Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia. Schizophr Res 2023;252:129-37. [PMID: 36641960 DOI: 10.1016/j.schres.2023.01.011] [Reference Citation Analysis]
|
| 20 |
Zhang Y, Xiang Q, Huang CC, Zhao J, Liu Y, Lin CP, Liu D, Lo CZ. Short-term Medication Effects on Brain Functional Activity and Network Architecture in First-Episode psychosis: a longitudinal fMRI study. Brain Imaging Behav 2023. [PMID: 36646973 DOI: 10.1007/s11682-022-00704-y] [Reference Citation Analysis]
|
| 21 |
Walsh MJ, Gibson K, Hynd M, Eisenlohr-moul TA, Walsh EC, Schiff L, Jarskog F, Lalush D, Dichter GS, Schiller CE. Perimenopausal Effects of Estradiol on Anhedonia and Psychosis Study (PEEPs): Study Protocol for a Neural and Molecular Mechanistic Clinical Trial {1}.. [DOI: 10.21203/rs.3.rs-2364268/v1] [Reference Citation Analysis]
|
| 22 |
Fišar Z. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2023;120:110626. [PMID: 36055561 DOI: 10.1016/j.pnpbp.2022.110626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Juza R, Musilek K, Mezeiova E, Soukup O, Korabecny J. Recent advances in dopamine D(2) receptor ligands in the treatment of neuropsychiatric disorders. Med Res Rev 2023;43:55-211. [PMID: 36111795 DOI: 10.1002/med.21923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Moritz S, Krieger EC, Bohn F, Elmers J, Veckenstedt R. Schizophrenie. MKT+ 2023. [DOI: 10.1007/978-3-662-64467-6_2] [Reference Citation Analysis]
|
| 25 |
Wirgenes KV, Smeland OB, Andreassen OA. Genetics of psychotic disorders with focus on early-onset psychosis. Adolescent Psychosis 2023. [DOI: 10.1016/b978-0-323-89832-4.00005-6] [Reference Citation Analysis]
|
| 26 |
Arcadepani FB, Gadelha A, Margolis RL. Mutation of GPR143 Associated With Ocular Albinism Type 1, Intellectual Disability, and Schizophrenia: The Complex Biological and Social Interactions Between Genetic Syndromes and Mental Illness. J Psychiatr Pract 2023;29:77-81. [PMID: 36649556 DOI: 10.1097/PRA.0000000000000685] [Reference Citation Analysis]
|
| 27 |
Sekiguchi H, Pavey G, Dean B. Altered levels of dopamine transporter in the frontal pole and the striatum in mood disorders: A postmortem study. J Affect Disord 2023;320:313-8. [PMID: 36162690 DOI: 10.1016/j.jad.2022.09.065] [Reference Citation Analysis]
|
| 28 |
Schlagenhauf F, Sterzer P. Psychotic Disorders (“Schizophrenia”). Psychoneuroscience 2023. [DOI: 10.1007/978-3-662-65774-4_11] [Reference Citation Analysis]
|
| 29 |
Konopaske GT, Coyle JT. The neurobiology of schizophrenia. Neurobiology of Brain Disorders 2023. [DOI: 10.1016/b978-0-323-85654-6.00056-3] [Reference Citation Analysis]
|
| 30 |
Zeller SL, Wilson MP, Pacciardi B. Assessment and Management of Agitation. Tasman’s Psychiatry 2023. [DOI: 10.1007/978-3-030-42825-9_5-1] [Reference Citation Analysis]
|
| 31 |
Panayi MC, Boerner T, Jahans-Price T, Huber A, Sprengel R, Gilmour G, Sanderson DJ, Harrison PJ, Walton ME, Bannerman DM. Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience. Mol Psychiatry 2023;28:579-87. [PMID: 36460723 DOI: 10.1038/s41380-022-01861-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ. Dopamine, Immunity, and Disease. Pharmacol Rev 2023;75:62-158. [PMID: 36757901 DOI: 10.1124/pharmrev.122.000618] [Reference Citation Analysis]
|
| 33 |
Bhatt S, Dhar AK, Samanta MK, Suttee A. Effects of Current Psychotropic Drugs on Inflammation and Immune System. Adv Exp Med Biol 2023;1411:407-34. [PMID: 36949320 DOI: 10.1007/978-981-19-7376-5_18] [Reference Citation Analysis]
|
| 34 |
Kanniah G, Kumar R. A selective literature review exploring the role of the nicotinic system in schizophrenia. Gen Psychiatr 2023;36:e100756. [PMID: 36937093 DOI: 10.1136/gpsych-2022-100756] [Reference Citation Analysis]
|
| 35 |
Sone M, Koshiyama D, Zhu Y, Maikusa N, Okada N, Abe O, Yamasue H, Kasai K, Koike S. Structural brain abnormalities in schizophrenia patients with a history and presence of auditory verbal hallucination. Transl Psychiatry 2022;12:511. [PMID: 36543775 DOI: 10.1038/s41398-022-02282-5] [Reference Citation Analysis]
|
| 36 |
Krystal JH, Kane JM, Correll CU, Walling DP, Leoni M, Duvvuri S, Patel S, Chang I, Iredale P, Frohlich L, Versavel S, Perry P, Sanchez R, Renger J. Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial. Lancet 2022;400:2210-20. [PMID: 36528376 DOI: 10.1016/S0140-6736(22)01990-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 37 |
Yang C, Zhang W, Liu J, Yao L, Bishop JR, Lencer R, Gong Q, Yang Z, Lui S. Disrupted subcortical functional connectome gradient in drug-naïve first-episode schizophrenia and the normalization effects after antipsychotic treatment. Neuropsychopharmacology 2022. [PMID: 36496508 DOI: 10.1038/s41386-022-01512-0] [Reference Citation Analysis]
|
| 38 |
Sapienza J, Spangaro M, Guillemin GJ, Comai S, Bosia M. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 36460745 DOI: 10.1007/s00406-022-01519-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 39 |
Liu H, Liu C, Hsieh MH, Chien Y, Hsu Y, Lai W. Dysregulated affective arousal regulates reward-based decision making in patients with schizophrenia: an integrated study. Schizophr 2022;8:26. [DOI: 10.1038/s41537-022-00234-y] [Reference Citation Analysis]
|
| 40 |
Rodrigues-Neves AC, Ambrósio AF, Gomes CA. Microglia sequelae: brain signature of innate immunity in schizophrenia. Transl Psychiatry 2022;12:493. [PMID: 36443303 DOI: 10.1038/s41398-022-02197-1] [Reference Citation Analysis]
|
| 41 |
Smucny J, Vlasova RM, Lesh TA, Rowland DJ, Wang G, Chaudhari AJ, Chen S, Iosif AM, Hogrefe CE, Bennett JL, Shumann CM, Van de Water JA, Maddock RJ, Styner MA, Geschwind DH, McAllister AK, Bauman MD, Carter CS. Increased Striatal Presynaptic Dopamine in a Nonhuman Primate Model of Maternal Immune Activation: A Longitudinal Neurodevelopmental Positron Emission Tomography Study With Implications for Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging 2022:S2451-9022(22)00277-4. [PMID: 36805246 DOI: 10.1016/j.bpsc.2022.10.012] [Reference Citation Analysis]
|
| 42 |
Chang X, Zhao W, Kang J, Xiang S, Xie C, Corona-hernández H, Palaniyappan L, Feng J. Language abnormalities in schizophrenia: binding core symptoms through contemporary empirical evidence. Schizophr 2022;8:95. [DOI: 10.1038/s41537-022-00308-x] [Reference Citation Analysis]
|
| 43 |
Kang Y, Zhang Y, Huang K, Wang Z. Effects of dopamine-based genetic risk score on dynamic low-frequency fluctuations in patients with first-episode drug-naïve schizophrenia.. [DOI: 10.21203/rs.3.rs-2237212/v1] [Reference Citation Analysis]
|
| 44 |
Xu H, Yang F. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry 2022;12:464. [PMID: 36344514 DOI: 10.1038/s41398-022-02233-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Roberts RC, McCollum LA, Schoonover KE, Mabry SJ, Roche JK, Lahti AC. Ultrastructural evidence for glutamatergic dysregulation in schizophrenia. Schizophr Res 2022;249:4-15. [PMID: 32014360 DOI: 10.1016/j.schres.2020.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 46 |
Ravanfar P, Syeda WT, Jayaram M, Rushmore RJ, Moffat B, Lin AP, Lyall AE, Merritt AH, Yaghmaie N, Laskaris L, Luza S, Opazo CM, Liberg B, Chakravarty MM, Devenyi GA, Desmond P, Cropley VL, Makris N, Shenton ME, Bush AI, Velakoulis D, Pantelis C. In Vivo 7-Tesla MRI Investigation of Brain Iron and Its Metabolic Correlates in Chronic Schizophrenia. Schizophrenia (Heidelb) 2022;8:86. [PMID: 36289238 DOI: 10.1038/s41537-022-00293-1] [Reference Citation Analysis]
|
| 47 |
He B, Wang Y, Li H, Huang Y. The role of integrin beta in schizophrenia: a preliminary exploration. CNS Spectr 2022;:1-10. [PMID: 36274632 DOI: 10.1017/S1092852922001080] [Reference Citation Analysis]
|
| 48 |
Panula JM, Alho J, Lindgren M, Kieseppä T, Suvisaari J, Raij TT. State-like changes in the salience network correlate with delusion severity in first-episode psychosis patients. Neuroimage Clin 2022;36:103234. [PMID: 36270161 DOI: 10.1016/j.nicl.2022.103234] [Reference Citation Analysis]
|
| 49 |
Ye J, Sun H, Gao S, Dadashkarimi J, Rosenblatt M, Rodriguez RX, Mehta S, Jiang R, Noble S, Westwater ML, Scheinost D. Altered brain dynamics across bipolar disorder and schizophrenia revealed by overlapping brain states.. [DOI: 10.1101/2022.10.07.22280835] [Reference Citation Analysis]
|
| 50 |
Dourron HM, Strauss C, Hendricks PS, Barker E. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Pharmacol Rev 2022;74:982-1027. [DOI: 10.1124/pharmrev.121.000514] [Reference Citation Analysis]
|
| 51 |
Yang G, Zhang S, Zhou Y, Song Y, Hu W, Peng Y, Shi H, Zhang Y. Increased resting-state interhemispheric functional connectivity of striatum in first-episode drug-naive adolescent-onset schizophrenia. Asian J Psychiatr 2022;76:103134. [PMID: 35551877 DOI: 10.1016/j.ajp.2022.103134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 52 |
Cuesta MJ, Ballesteros A, Sánchez-Torres AM, Amoretti S, López-Ilundain JM, Merchán-Naranjo J, González-Ortega I, Salgado P, Rodriguez-Jimenez R, Roldán-Bejarano A, Sarró S, Ibáñez Á, Usall J, Escartí MJ, Moreno-Izco L, Mezquida G, Parellada M, González-Pinto A, Berrocoso E, Bernardo M; 2EPs group. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden. Schizophr Res 2022;248:331-40. [PMID: 36155307 DOI: 10.1016/j.schres.2022.09.014] [Reference Citation Analysis]
|
| 53 |
Chen KC, Yang YK, Howes OD, Lee IH, Yeh TL, Chiu NT, Chen PS, David AS, Bramon E. Striatal dopamine D(2/3) receptors in medication-naïve schizophrenia: an [(123)I] IBZM SPECT study. Psychol Med 2022;52:3251-9. [PMID: 33682657 DOI: 10.1017/S0033291720005413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 54 |
Zhu Y, Owens SJ, Murphy CE, Ajulu K, Rothmond D, Purves-Tyson T, Middleton F, Webster MJ, Weickert CS. Inflammation-related transcripts define "high" and "low" subgroups of individuals with schizophrenia and bipolar disorder in the midbrain. Brain Behav Immun 2022;105:149-59. [PMID: 35764269 DOI: 10.1016/j.bbi.2022.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 55 |
Ariza-salamanca DF, Corrales-hernández MG, Pachón-londoño MJ, Hernández-duarte I. Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence. Front Mol Neurosci 2022;15:993671. [DOI: 10.3389/fnmol.2022.993671] [Reference Citation Analysis]
|
| 56 |
Park BY, Kebets V, Larivière S, Hettwer MD, Paquola C, van Rooij D, Buitelaar J, Franke B, Hoogman M, Schmaal L, Veltman DJ, van den Heuvel OA, Stein DJ, Andreassen OA, Ching CRK, Turner JA, van Erp TGM, Evans AC, Dagher A, Thomopoulos SI, Thompson PM, Valk SL, Kirschner M, Bernhardt BC. Multiscale neural gradients reflect transdiagnostic effects of major psychiatric conditions on cortical morphology. Commun Biol 2022;5:1024. [PMID: 36168040 DOI: 10.1038/s42003-022-03963-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Dokhoyan AY, Glushchenko MV, Orlov YL. RECONSTRUCTION OF SCHIZOPHRENIA GENE NETWORK IN SEARCH FOR TARGET GENES. Ulyanovsk Medico-biological Journal 2022. [DOI: 10.34014/2227-1848-2022-3-6-22] [Reference Citation Analysis]
|
| 58 |
El Hayek SA, Shatila MA, Adnan JA, Geagea LE, Kobeissy F, Talih FR. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia? Expert Review of Neurotherapeutics. [DOI: 10.1080/14737175.2022.2124369] [Reference Citation Analysis]
|
| 59 |
Vanes LD, Murray RM, Nosarti C. Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis. Schizophr Res 2022;247:41-54. [PMID: 34006427 DOI: 10.1016/j.schres.2021.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 60 |
Huang Y, Zhang X, Zhou N. The Interrelation between Interleukin-2 and Schizophrenia. Brain Sciences 2022;12:1154. [DOI: 10.3390/brainsci12091154] [Reference Citation Analysis]
|
| 61 |
Gordillo D, da Cruz JR, Chkonia E, Lin WH, Favrod O, Brand A, Figueiredo P, Roinishvili M, Herzog MH. The EEG multiverse of schizophrenia. Cereb Cortex 2022:bhac309. [PMID: 36030389 DOI: 10.1093/cercor/bhac309] [Reference Citation Analysis]
|
| 62 |
Takase S, Liao J, Liu Y, Tanaka R, Miyagawa Y, Sawahata M, Sobue A, Mizoguchi H, Nagai T, Kaibuchi K, Ozaki N, Yamada K. Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia. Eur J Pharmacol 2022;931:175207. [PMID: 35987254 DOI: 10.1016/j.ejphar.2022.175207] [Reference Citation Analysis]
|
| 63 |
Schamiloglu S, Lewis E, Hergarden AC, Bender KJ, Whistler JL. Arrestin-3 agonism at D3 dopamine receptors defines a subclass of second generation antipsychotics that promotes drug tolerance.. [DOI: 10.1101/2022.08.17.504324] [Reference Citation Analysis]
|
| 64 |
Brown JS. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer. Neurosci Biobehav Rev 2022;141:104809. [PMID: 35970416 DOI: 10.1016/j.neubiorev.2022.104809] [Reference Citation Analysis]
|
| 65 |
Ferranti AS, Foster DJ. Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits. Front Neurosci 2022;16:925792. [DOI: 10.3389/fnins.2022.925792] [Reference Citation Analysis]
|
| 66 |
Zeng J, Zhang W, Wu G, Wang X, Shah C, Li S, Xiao Y, Yao L, Cao H, Li Z, Sweeney JA, Lui S, Gong Q. Effects of Antipsychotic Medications and Illness Duration on Brain Features That Distinguish Schizophrenia Patients. Schizophr Bull 2022;48:1354-62. [PMID: 35925035 DOI: 10.1093/schbul/sbac094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Schiwy LC, Forlim CG, Fischer DJ, Kühn S, Becker M, Gallinat J. Aberrant functional connectivity within the salience network is related to cognitive deficits and disorganization in psychosis. Schizophr Res 2022;246:103-11. [PMID: 35753120 DOI: 10.1016/j.schres.2022.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 68 |
de Bartolomeis A, Vellucci L, Barone A, Manchia M, De Luca V, Iasevoli F, Correll CU. Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacol Ther 2022;236:108236. [PMID: 35764175 DOI: 10.1016/j.pharmthera.2022.108236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Mørkved N, Johnsen E, Kroken RA, Winje D, Larsen TK, Thimm JC, Rettenbacher MA, Johannesen CAB, Løberg EM. Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial. Schizophr Res 2022;246:49-59. [PMID: 35709647 DOI: 10.1016/j.schres.2022.05.022] [Reference Citation Analysis]
|
| 70 |
Hunter J. SEEKING God’s Presence. JCSR 2022;8. [DOI: 10.1558/jcsr.22411] [Reference Citation Analysis]
|
| 71 |
Barnby JM, Mehta MA, Moutoussis M. The computational relationship between reinforcement learning, social inference, and paranoia. PLoS Comput Biol 2022;18:e1010326. [DOI: 10.1371/journal.pcbi.1010326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 72 |
Hui M, Beier KT. Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain. Front Mol Neurosci 2022;15:971349. [DOI: 10.3389/fnmol.2022.971349] [Reference Citation Analysis]
|
| 73 |
Castagnola E, Robbins EM, Wu B, Pwint MY, Garg R, Cohen-Karni T, Cui XT. Flexible Glassy Carbon Multielectrode Array for In Vivo Multisite Detection of Tonic and Phasic Dopamine Concentrations. Biosensors (Basel) 2022;12. [PMID: 35884343 DOI: 10.3390/bios12070540] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Kállai J, Páll T, Herold R, Tényi T, Zsidó AN. Ambiguous handedness and visuospatial pseudoneglect in schizotypy in physical and computer-generated virtual environments. Sci Rep 2022;12:12169. [PMID: 35842454 DOI: 10.1038/s41598-022-16454-2] [Reference Citation Analysis]
|
| 75 |
Schonfeld L, Jaehne EJ, Ogden AR, Spiers JG, Hogarth S, van den Buuse M. Differential effects of chronic adolescent glucocorticoid or methamphetamine on drug-induced locomotor hyperactivity and disruption of prepulse inhibition in adulthood in mice. Prog Neuropsychopharmacol Biol Psychiatry 2022;117:110552. [PMID: 35337859 DOI: 10.1016/j.pnpbp.2022.110552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Morris EL, Taylor SF, Kang J. On predictability of individual functional connectivity networks from clinical characteristics. Hum Brain Mapp 2022;43:5250-65. [PMID: 35811395 DOI: 10.1002/hbm.26000] [Reference Citation Analysis]
|
| 77 |
Adams RA, Vincent P, Benrimoh D, Friston KJ, Parr T. Everything is connected: Inference and attractors in delusions. Schizophr Res 2022;245:5-22. [PMID: 34384664 DOI: 10.1016/j.schres.2021.07.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 78 |
Harrison PJ, Mould A, Tunbridge EM. New drug targets in psychiatry: neurobiological considerations in the genomics era. Neurosci Biobehav Rev 2022;:104763. [PMID: 35787892 DOI: 10.1016/j.neubiorev.2022.104763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Croft J, Teufel C, Heron J, Fletcher PC, David AS, Lewis G, Moutoussis M, FitzGerald THB, Linden DEJ, Thompson A, Jones PB, Cannon M, Holmans P, Adams RA, Zammit S. A Computational Analysis of Abnormal Belief Updating Processes and Their Association With Psychotic Experiences and Childhood Trauma in a UK Birth Cohort. Biol Psychiatry Cogn Neurosci Neuroimaging 2022;7:725-34. [PMID: 34954139 DOI: 10.1016/j.bpsc.2021.12.007] [Reference Citation Analysis]
|
| 80 |
Terevnikov V, Joffe G. Mirtazapine in schizophrenia - an undeservedly overlooked option? Int Clin Psychopharmacol 2022;37:131-42. [PMID: 35357339 DOI: 10.1097/YIC.0000000000000404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Korann V, Jacob A, Lu B, Devi P, Thonse U, Nagendra B, Maria Chacko D, Dey A, Padmanabha A, Shivakumar V, Dawn Bharath R, Kumar V, Varambally S, Venkatasubramanian G, Deshpande G, Rao NP. Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia. Schizophr Bull 2022;48:1115-24. [PMID: 35759349 DOI: 10.1093/schbul/sbac066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Hamzehpour L, Bohn T, Jaspers L, Grimm O. Seed-based connectivity of ventral tegmental area correlates with decreased physical fitness in schizophrenia.. [DOI: 10.1101/2022.06.27.22276810] [Reference Citation Analysis]
|
| 83 |
Rovira P, Gutiérrez B, Sorlózano-Puerto A, Gutiérrez-Fernández J, Molina E, Rivera M, Martínez-Leal R, Ibanez-Casas I, Martín-Laguna MV, Rosa A, Torres-González F, Cervilla JA. Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia. Genes (Basel) 2022;13. [PMID: 35741850 DOI: 10.3390/genes13061088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 84 |
Pearson D, Watson P, Albertella L, Le Pelley ME. Attentional economics links value-modulated attentional capture and decision-making. Nat Rev Psychol 2022;1:320-33. [DOI: 10.1038/s44159-022-00053-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 85 |
Sanwald S, Montag C, Kiefer M. Cumulative Genetic Score of DRD2 Polymorphisms Is Associated with Impulsivity and Masked Semantic Priming. J Mol Neurosci. [DOI: 10.1007/s12031-022-02019-5] [Reference Citation Analysis]
|
| 86 |
Białoń M, Wąsik A. Advantages and Limitations of Animal Schizophrenia Models. Int J Mol Sci 2022;23:5968. [PMID: 35682647 DOI: 10.3390/ijms23115968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Chen S, Lian J, Su Y, Deng C. Effects of Risperidone and Prenatal Poly I:C Exposure on GABAA Receptors and AKT-GSK3β Pathway in the Ventral Tegmental Area of Female Juvenile Rats. Biomolecules 2022;12:732. [PMID: 35625659 DOI: 10.3390/biom12050732] [Reference Citation Analysis]
|
| 88 |
Wu G, Zhang N, Matarasso A, Heck I, Li H, Lu W, Phaup JG, Schneider MJ, Wu Y, Weng Z, Sun H, Gao Z, Zhang X, Sandberg SG, Parvin D, Seaholm E, Islam SK, Wang X, Phillips PEM, Castro DC, Ding S, Li DP, Bruchas MR, Zhang Y. Implantable Aptamer-Graphene Microtransistors for Real-Time Monitoring of Neurochemical Release in Vivo. Nano Lett 2022;22:3668-77. [PMID: 35439419 DOI: 10.1021/acs.nanolett.2c00289] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 89 |
Zong X, He C, Huang X, Xiao J, Li L, Li M, Yao T, Hu M, Liu Z, Duan X, Zheng J. Predictive Biomarkers for Antipsychotic Treatment Response in Early Phase of Schizophrenia: Multi-Omic Measures Linking Subcortical Covariant Network, Transcriptomic Signatures, and Peripheral Epigenetics. Front Neurosci 2022;16:853186. [DOI: 10.3389/fnins.2022.853186] [Reference Citation Analysis]
|
| 90 |
Myken AN, Ebdrup BH, Sørensen ME, Broberg BV, Skjerbæk MW, Glenthøj BY, Lykkesfeldt J, Nielsen MØ. Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis. Int J Neuropsychopharmacol 2022;25:613-8. [PMID: 35532335 DOI: 10.1093/ijnp/pyac029] [Reference Citation Analysis]
|
| 91 |
Colizzi M, Bortoletto R, Costa R, Bhattacharyya S, Balestrieri M. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. Int J Environ Res Public Health 2022;19. [PMID: 35565034 DOI: 10.3390/ijerph19095616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 92 |
Adam Yaple Z, Tolomeo S, Yu R. Spatial and chronic differences in neural activity in medicated and unmedicated schizophrenia patients. Neuroimage Clin 2022;35:103029. [PMID: 35569228 DOI: 10.1016/j.nicl.2022.103029] [Reference Citation Analysis]
|
| 93 |
de Bartolomeis A, Barone A, Buonaguro EF, Tomasetti C, Vellucci L, Iasevoli F. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. Neurosci Biobehav Rev 2022;136:104596. [PMID: 35248676 DOI: 10.1016/j.neubiorev.2022.104596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 94 |
Zhang Y, Peng Y, Song Y, Zhou Y, Zhang S, Yang G, Yang Y, Li W, Yue W, Lv L, Zhang D. Abnormal functional connectivity of the striatum in first-episode drug-naive early-onset Schizophrenia. Brain Behav 2022;12:e2535. [PMID: 35384392 DOI: 10.1002/brb3.2535] [Reference Citation Analysis]
|
| 95 |
Sigvard AK, Bojesen KB, Ambrosen KS, Nielsen MØ, Gjedde A, Tangmose K, Kumakura Y, Edden R, Fuglø D, Jensen LT, Rostrup E, Ebdrup BH, Glenthøj BY. Dopamine synthesis capacity and gamma-aminobutyric acid - and glutamate levels separate antipsychotic-naïve patients with first-episode psychosis from healthy control subjects in a multimodal prediction model. Biological Psychiatry Global Open Science 2022. [DOI: 10.1016/j.bpsgos.2022.05.004] [Reference Citation Analysis]
|
| 96 |
Avram M, Müller F, Rogg H, Korda A, Andreou C, Holze F, Vizeli P, Ley L, Liechti ME, Borgwardt S. Characterizing thalamocortical (dys)connectivity following d-amphetamine, LSD, and MDMA administration. Biol Psychiatry Cogn Neurosci Neuroimaging 2022:S2451-9022(22)00096-9. [PMID: 35500840 DOI: 10.1016/j.bpsc.2022.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 97 |
Li Y, Zhu Z, Sun L, Xiang Z, Chang C, Fan C. Physicochemical Insights on Terahertz Wave Diminished Side Effects of Drugs from Slow Dissociation. ACS Nano 2022. [PMID: 35438483 DOI: 10.1021/acsnano.2c02952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 98 |
de Oliveira Figueiredo EC, Bondiolotti BM, Laugeray A, Bezzi P. Synaptic Plasticity Dysfunctions in the Pathophysiology of 22q11 Deletion Syndrome: Is There a Role for Astrocytes? Int J Mol Sci 2022;23:4412. [PMID: 35457231 DOI: 10.3390/ijms23084412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Nordio G, Easmin R, Giacomel A, Dipasquale O, Martins D, Williams S, Turkheimer F, Howes O, Veronese M. Digital data repository and automatic analysis framework for FDOPA PET neuroimaging.. [DOI: 10.1101/2022.04.14.488129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 100 |
Almey A, Milner TA, Brake WG. Estrogen receptors observed at extranuclear neuronal sites and in glia in the nucleus accumbens core and shell of the female rat: Evidence for localization to catecholaminergic and GABAergic neurons. J Comp Neurol 2022. [PMID: 35397175 DOI: 10.1002/cne.25320] [Reference Citation Analysis]
|
| 101 |
Feng A, Luo N, Zhao W, Calhoun VD, Jiang R, Zhi D, Shi W, Jiang T, Yu S, Xu Y, Liu S, Sui J. Multimodal brain deficits shared in early-onset and adult-onset schizophrenia predict positive symptoms regardless of illness stage. Hum Brain Mapp 2022. [PMID: 35388581 DOI: 10.1002/hbm.25862] [Reference Citation Analysis]
|
| 102 |
Bonnavion P, Varin C, Fakhfouri G, De Groote A, Cornil A, Isingrini E, Rainer Q, Xu K, Tzavara E, Vigneault E, Dumas S, de Kerchove d’Exaerde A, Giros B. Unexpected inhibition of motor function by dopamine activation of D1/D2 co-expressing striatal neurons.. [DOI: 10.1101/2022.04.05.487163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 103 |
Spark DL, Fornito A, Langmead CJ, Stewart GD. Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics. Transl Psychiatry 2022;12:147. [PMID: 35393394 DOI: 10.1038/s41398-022-01904-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 104 |
Ceccarini MR, Fittipaldi S, Ciccacci C, Granese E, Centofanti F, Dalla Ragione L, Bertelli M, Beccari T, Botta A. Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population. Front Nutr 2022;9:838177. [PMID: 35369087 DOI: 10.3389/fnut.2022.838177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Rodríguez-toscano E, Martínez K, Fraguas D, Janssen J, Pina-camacho L, Arias B, Vieta E, Mezquida G, Amoretti S, Bernardo M, Castro-fornieles J, Cuesta-zorita MJ, Lobo A, González-pinto A, Collado IC, Mané A, Arango C, Parellada M. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis. Revista de Psiquiatría y Salud Mental (English Edition) 2022;15:74-87. [DOI: 10.1016/j.rpsmen.2022.07.001] [Reference Citation Analysis]
|
| 106 |
Panov GP. Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug. Diagnostics 2022;12:803. [DOI: 10.3390/diagnostics12040803] [Reference Citation Analysis]
|
| 107 |
Gunasekaran S, Jacob RS, Omkumar RV. Differential expression of miR-148b, miR-129-2 and miR-296 in animal models of schizophrenia-Relevance to NMDA receptor hypofunction. Neuropharmacology 2022;:109024. [PMID: 35276119 DOI: 10.1016/j.neuropharm.2022.109024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 108 |
Gogos A, van den Buuse M. Sex Differences in Psychosis: Focus on Animal Models. Curr Top Behav Neurosci 2023;62:133-63. [PMID: 35243605 DOI: 10.1007/7854_2022_305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
van Hooijdonk CF, Drukker M, van de Giessen E, Booij J, Selten J, van Amelsvoort TA. Dopaminergic alterations in populations at increased risk for psychosis: a systematic review of imaging findings. Progress in Neurobiology 2022. [DOI: 10.1016/j.pneurobio.2022.102265] [Reference Citation Analysis]
|
| 110 |
Moussiopoulou J, Schmitt A, Falkai P. Diagnose und Differenzialdiagnose der Schizophrenie. PSYCH up2date 2022;16:145-163. [DOI: 10.1055/a-1469-4845] [Reference Citation Analysis]
|
| 111 |
van Rensburg D, Lindeque Z, Harvey BH, Steyn SF. Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research. Mitochondrion 2022. [DOI: 10.1016/j.mito.2022.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 112 |
Tsai CW, Tsai SJ, Pan YJ, Lin HM, Pan TY, Yang FY. Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia. Neurotherapeutics 2022;19:649-59. [PMID: 35229268 DOI: 10.1007/s13311-022-01195-x] [Reference Citation Analysis]
|
| 113 |
Li XJ, Yu JH, Wu X, Zhu XM, Lv P, Du Z, Lu Y, Wu X, Yao J. Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model. Neurotoxicol Teratol 2022;:107079. [PMID: 35202796 DOI: 10.1016/j.ntt.2022.107079] [Reference Citation Analysis]
|
| 114 |
Ballerini A, Tortorelli M, Marino P, Appignanesi C, Baschirotto C, Mallardo L, Tofani T, Pietrini F, D'Anna G, Rossi A, Ricca V, Santella M. Aberrant salience relationship with first rank symptoms. Ann Gen Psychiatry 2022;21:8. [PMID: 35172844 DOI: 10.1186/s12991-022-00383-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 115 |
Ioanas HI, Saab BJ, Rudin M. Whole-brain opto-fMRI map of mouse VTA dopaminergic activation reflects structural projections with small but significant deviations. Transl Psychiatry 2022;12:60. [PMID: 35165257 DOI: 10.1038/s41398-022-01812-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 116 |
Yin K, Xu C, Zhao G, Xie H. Epigenetic Manipulation of Psychiatric Behavioral Disorders Induced by Toxoplasma gondii. Front Cell Infect Microbiol 2022;12:803502. [DOI: 10.3389/fcimb.2022.803502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 117 |
Li ML, Peng Y, An Y, Li GY, Lan Y. LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia. Brain Behav 2022;12:e2466. [PMID: 35025141 DOI: 10.1002/brb3.2466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 118 |
Juza R, Vojtechova I, Stefkova-mazochova K, Dehaen W, Petrasek T, Prchal L, Kobrlova T, Janousek J, Vlcek P, Mezeiova E, Svozil D, Karasova JZ, Pejchal J, Stark H, Satala G, Bojarski AJ, Kubacka M, Mogilski S, Randakova A, Musilek K, Soukup O, Korabecny J. Novel D2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 119 |
Gu M, Xiao H, Wei S, Chen Z, Cao L. A portable and sensitive dopamine sensor based on AuNPs functionalized ZnO-rGO nanocomposites modified screen-printed electrode. Journal of Electroanalytical Chemistry 2022. [DOI: 10.1016/j.jelechem.2022.116117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 120 |
Millard SJ, Bearden CE, Karlsgodt KH, Sharpe MJ. The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. Neuropsychopharmacology 2022;47:628-40. [PMID: 34588607 DOI: 10.1038/s41386-021-01188-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 121 |
Osugo M, Whitehurst T, Shatalina E, Townsend L, O’brien O, Mak TLA, Mccutcheon R, Howes O. Dopamine partial agonists and prodopaminergic drugs for schizophrenia: systematic review and meta-analysis of randomized controlled trials. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 122 |
Sabaroedin K, Razi A, Chopra S, Tran N, Pozaruk A, Chen Z, Finlay A, Nelson B, Allott K, Alvarez-Jimenez M, Graham J, Yuen HP, Harrigan S, Cropley V, Sharma S, Saluja B, Williams R, Pantelis C, Wood SJ, O'Donoghue B, Francey S, McGorry P, Aquino K, Fornito A. Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum. Brain 2023;146:372-86. [PMID: 35094052 DOI: 10.1093/brain/awac018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 123 |
Pasquini S, Contri C, Merighi S, Gessi S, Borea PA, Varani K, Vincenzi F. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets. Int J Mol Sci 2022;23:1219. [PMID: 35163142 DOI: 10.3390/ijms23031219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 124 |
Sigvard AK, Nielsen MØ, Gjedde A, Bojesen KB, Fuglø D, Tangmose K, Kumakura Y, Heltø K, Ebdrup BH, Jensen LT, Rostrup E, Glenthøj BY. Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D(2) Receptor Agonist Treatment: Association With Psychotic Symptoms and Treatment Response. Biol Psychiatry 2022;91:236-45. [PMID: 34743917 DOI: 10.1016/j.biopsych.2021.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 125 |
Yan Q, Wu X, Zhou P, Zhou Y, Li X, Liu Z, Tan H, Yao W, Xia Y, Zhu F. HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk. Viruses 2022;14:145. [PMID: 35062349 DOI: 10.3390/v14010145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 126 |
Corripio I, Roldán A, McKenna P, Sarró S, Alonso-Solís A, Salgado L, Álvarez E, Molet J, Pomarol-Clotet E, Portella M. Target selection for deep brain stimulation in treatment resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2022;112:110436. [PMID: 34517055 DOI: 10.1016/j.pnpbp.2021.110436] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 127 |
Đorđević V, Pešić S, Živković J, Nikolić GM, Veselinović AM. Development of novel antipsychotic agents by inhibiting dopamine transporter – in silico approach. New J Chem 2022;46:2687-96. [DOI: 10.1039/d1nj04759k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 128 |
Liebenow B, Jones R, DiMarco E, Trattner JD, Humphries J, Sands LP, Spry KP, Johnson CK, Farkas EB, Jiang A, Kishida KT. Computational reinforcement learning, reward (and punishment), and dopamine in psychiatric disorders. Front Psychiatry 2022;13:886297. [PMID: 36339844 DOI: 10.3389/fpsyt.2022.886297] [Reference Citation Analysis]
|
| 129 |
Mould AW, Al-Juffali N, von Delft A, Brennan PE, Tunbridge EM. Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia. CNS Drugs 2022;36:1-16. [PMID: 34928485 DOI: 10.1007/s40263-021-00884-z] [Reference Citation Analysis]
|
| 130 |
An Y, Song Y, Kang UG. A Conceptual Review on ADHD and Adult ADHD (2): Psychopathology, Diagnostic and Therapeutic Implications of ADHD. J Korean Neuropsychiatr Assoc 2022;61:45. [DOI: 10.4306/jknpa.2022.61.2.45] [Reference Citation Analysis]
|
| 131 |
Smucny J, Dienel SJ, Lewis DA, Carter CS. Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia. Neuropsychopharmacology 2022;47:292-308. [PMID: 34285373 DOI: 10.1038/s41386-021-01089-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 33.0] [Reference Citation Analysis]
|
| 132 |
Öztürk ME, Yirün A, Erdemli-köse SB, Balcı-özyurt A, Çakır DA, Oral D, Erkekoğlu P. Evaluation of the toxic effects of thimerosal and/or aluminum hydroxide in SH-SY5Y cell line. Hum Exp Toxicol 2022;41:096032712211362. [DOI: 10.1177/09603271221136206] [Reference Citation Analysis]
|
| 133 |
Zhang Q, Wan Y, Du X, Gao Y, Wang X, Wu K, Zheng X, Wang Y, Zhao C, Li L, Guo X, Li X, Liu S, Xu Y. Association between neuropeptide Y gene polymorphism and antipsychotics effect. Front Psychiatry 2022;13:1014952. [PMID: 36339882 DOI: 10.3389/fpsyt.2022.1014952] [Reference Citation Analysis]
|
| 134 |
Bastiampillai T, Chan SKW, Allison S, Copolov D, Looi JC. Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis? Aust N Z J Psychiatry 2022;56:97. [PMID: 33971747 DOI: 10.1177/00048674211011243] [Reference Citation Analysis]
|
| 135 |
Huang J, Zhang P, Zhou Y, Tong J, Cui Y, Tan S, Wang Z, Yang F, Kochunov P, Tian B, Tian L, Hong LE, Tan Y. Serum kynurenine metabolites might not be associated with risk factors of treatment-resistant schizophrenia. J Psychiatr Res 2022;145:339-46. [PMID: 34776248 DOI: 10.1016/j.jpsychires.2021.11.002] [Reference Citation Analysis]
|
| 136 |
Dong D. COMT, DRD1, DRD2, DRD4: Genetic evidence for the dopamine hypothesis in schizophrenia. 7TH INTERNATIONAL CONFERENCE ON MATHEMATICS: PURE, APPLIED AND COMPUTATION: Mathematics of Quantum Computing 2022. [DOI: 10.1063/5.0112965] [Reference Citation Analysis]
|
| 137 |
Davies C, Appiah-Kusi E, Wilson R, Blest-Hopley G, Bossong MG, Valmaggia L, Brammer M, Perez J, Allen P, Murray RM, McGuire P, Bhattacharyya S. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. Eur Arch Psychiatry Clin Neurosci 2022;272:461-75. [PMID: 34480630 DOI: 10.1007/s00406-021-01318-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 138 |
Hanssen E, van Buuren M, Van Atteveldt N, Lemmers-Jansen IL, Fett AJ. Neural, behavioural and real-life correlates of social context sensitivity and social reward learning during interpersonal interactions in the schizophrenia spectrum. Aust N Z J Psychiatry 2022;56:59-70. [PMID: 34006142 DOI: 10.1177/00048674211010327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 139 |
Mansour HM. Nutrition and Psychiatric Disorders: Focus on Schizophrenia. Nutritional Neurosciences 2022. [DOI: 10.1007/978-981-19-5021-6_15] [Reference Citation Analysis]
|
| 140 |
Gao WJ, Yang SS, Mack NR, Chamberlin LA. Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction. Mol Psychiatry 2022;27:731-43. [PMID: 34163013 DOI: 10.1038/s41380-021-01196-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 141 |
Casado-Sainz A, Gudmundsen F, Baerentzen SL, Lange D, Ringsted A, Martinez-Tejada I, Medina S, Lee H, Svarer C, Keller SH, Schain M, Kjaerby C, Fisher PM, Cumming P, Palner M. Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats. Neuropsychopharmacology 2022;47:454-64. [PMID: 34725486 DOI: 10.1038/s41386-021-01207-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 142 |
Fisher VL, Ortiz LS, Powers AR 3rd. A computational lens on menopause-associated psychosis. Front Psychiatry 2022;13:906796. [PMID: 35990063 DOI: 10.3389/fpsyt.2022.906796] [Reference Citation Analysis]
|
| 143 |
Schulz J, Zimmermann J, Sorg C, Menegaux A, Brandl F. Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review. Front Psychiatry 2022;13:925476. [PMID: 36203848 DOI: 10.3389/fpsyt.2022.925476] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 144 |
Li H, Chen W, Gou M, Li W, Tong J, Zhou Y, Xie T, Yu T, Feng W, Li Y, Chen S, Tian B, Tan S, Wang Z, Pan S, Li N, Luo X, Zhang P, Huang J, Tian L, Li CR, Tan Y. The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia. Front Psychiatry 2022;13:966657. [PMID: 36051545 DOI: 10.3389/fpsyt.2022.966657] [Reference Citation Analysis]
|
| 145 |
Valli I, Verdolini N. Imaging in Psychiatry: A Reappraisal of Preventative Potential. Prevention in Mental Health 2022. [DOI: 10.1007/978-3-030-97906-5_14] [Reference Citation Analysis]
|
| 146 |
Xiao X, Zhang CY, Zhang Z, Hu Z, Li M, Li T. Revisiting tandem repeats in psychiatric disorders from perspectives of genetics, physiology, and brain evolution. Mol Psychiatry 2022;27:466-75. [PMID: 34650204 DOI: 10.1038/s41380-021-01329-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 147 |
Ouyang L, Li D, Li Z, Ma X, Yuan L, Fan L, Yang Z, Zhang Z, Li C, He Y, Chen X. IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals. Front Psychiatry 2022;13:1072380. [PMID: 36590607 DOI: 10.3389/fpsyt.2022.1072380] [Reference Citation Analysis]
|
| 148 |
Stuke H. Markers of muscarinic deficit for individualized treatment in schizophrenia. Front Psychiatry 2022;13:1100030. [PMID: 36699495 DOI: 10.3389/fpsyt.2022.1100030] [Reference Citation Analysis]
|
| 149 |
Frau R, Melis M. Effects of prenatal THC exposure on the mesolimbic dopamine system: Unveiling an endophenotype of sensory information processing deficits. Cannabis and the Developing Brain 2022. [DOI: 10.1016/b978-0-12-823490-7.00012-5] [Reference Citation Analysis]
|
| 150 |
Bernardin F, Schwitzer T, Schwan R, Angioi-Duprez K, Ligier F, Bourion-Bedes S, Jansen C, Giersch A, Laprevote V. Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia. Schizophr Res 2022;239:134-41. [PMID: 34891077 DOI: 10.1016/j.schres.2021.11.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 151 |
Mallet J, Le Strat Y, Dubertret C, Gorwood P. Recovery-Oriented Psychopharmacological Interventions in Schizophrenia. Recovery and Major Mental Disorders 2022. [DOI: 10.1007/978-3-030-98301-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 152 |
McGuinness AJ, Davis JA, Dawson SL, Loughman A, Collier F, O'Hely M, Simpson CA, Green J, Marx W, Hair C, Guest G, Mohebbi M, Berk M, Stupart D, Watters D, Jacka FN. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry 2022;27:1920-35. [PMID: 35194166 DOI: 10.1038/s41380-022-01456-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 54.0] [Reference Citation Analysis]
|
| 153 |
Muguruza C, Callado LF. Glutamate, Glutamatergic Drugs and Schizophrenia. Glutamate and Neuropsychiatric Disorders 2022. [DOI: 10.1007/978-3-030-87480-3_17] [Reference Citation Analysis]
|
| 154 |
Smith BJ, Carregari VC. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-97182-3_6] [Reference Citation Analysis]
|
| 155 |
Sukiasyan SH. TRADITIONAL CONCEPTS AND APPROACHES IN PSYCHIATRY AS PRECONDITIONS FOR PSYCHOSOMATIC CONCEPT: THE NEUROBIOLOGICAL ASPECT. AJMH 2022. [DOI: 10.55436/1829202x-12.2021.14-24] [Reference Citation Analysis]
|
| 156 |
Nishioka M. The Current Progress of Psychiatric Genomics. Juntendo Medical Journal 2022;68:2-11. [DOI: 10.14789/jmj.jmj21-0038-r] [Reference Citation Analysis]
|
| 157 |
Mehta TR, Murala S, Siddiqui J. Dopamine. Neurochemistry in Clinical Practice 2022. [DOI: 10.1007/978-3-031-07897-2_1] [Reference Citation Analysis]
|
| 158 |
Harju-seppänen J, Irizar H, Bramon E, Blakemore S, Mason L, Bell V. Reward Processing in Children With Psychotic-Like Experiences. Schizophrenia Bulletin Open 2022;3. [DOI: 10.1093/schizbullopen/sgab054] [Reference Citation Analysis]
|
| 159 |
Mätlik K, Garton DR, Montaño-Rodríguez AR, Olfat S, Eren F, Casserly L, Damdimopoulos A, Panhelainen A, Porokuokka LL, Kopra JJ, Turconi G, Schweizer N, Bereczki E, Piehl F, Engberg G, Cervenka S, Piepponen TP, Zhang FP, Sipilä P, Jakobsson J, Sellgren CM, Erhardt S, Andressoo JO. Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. Mol Psychiatry 2022;27:3247-61. [PMID: 35618883 DOI: 10.1038/s41380-022-01554-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 160 |
Kelly RE, Ahmed AO, Hoptman MJ, Alix AF, Alexopoulos GS. The Quest for Psychiatric Advancement through Theory, beyond Serendipity. Brain Sciences 2022;12:72. [DOI: 10.3390/brainsci12010072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 161 |
Frydecka D, Hamza EA, Helal A, Moustafa AA. Childhood traumatic events and the dopaminergic theory of psychosis: A mini-review of studies investigating gene – environment interactions. Curr Psychol. [DOI: 10.1007/s12144-021-02650-2] [Reference Citation Analysis]
|
| 162 |
Frydecka D, Misiak B, Piotrowski P, Bielawski T, Pawlak E, Kłosińska E, Krefft M, Al Noaimy K, Rymaszewska J, Moustafa AA, Drapała J. The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders. Brain Sciences 2021;12:7. [DOI: 10.3390/brainsci12010007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 163 |
Tepper Á, Cuiza A, Alliende LM, Mena C, Ramirez-Mahaluf JP, Iruretagoyena B, Ornstein C, Fritsch R, Nachar R, González-Valderrama A, Undurraga J, Cruz JP, Tejos C, Fornito A, Repetto G, Crossley N. Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome. Schizophr Bull 2022;48:485-94. [PMID: 34931688 DOI: 10.1093/schbul/sbab139] [Reference Citation Analysis]
|
| 164 |
Whitehurst T, Howes O. The role of mitochondria in the pathophysiology of schizophrenia: A critical review of the evidence focusing on mitochondrial complex one. Neurosci Biobehav Rev 2021;132:449-64. [PMID: 34864002 DOI: 10.1016/j.neubiorev.2021.11.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 165 |
Garg R, Roman DS, Wang Y, Cohen-Karni D, Cohen-Karni T. Graphene nanostructures for input-output bioelectronics. Biophys Rev (Melville) 2021;2:041304. [PMID: 35005709 DOI: 10.1063/5.0073870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 166 |
Xiao MF, Roh SE, Zhou J, Chien CC, Lucey BP, Craig MT, Hayes LN, Coughlin JM, Leweke FM, Jia M, Xu D, Zhou W, Conover Talbot C Jr, Arnold DB, Staley M, Jiang C, Reti IM, Sawa A, Pelkey KA, McBain CJ, Savonenko A, Worley PF. A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function. Sci Adv 2021;7:eabf6935. [PMID: 34818031 DOI: 10.1126/sciadv.abf6935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 167 |
Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? Postgrad Med 2021;:1-13. [PMID: 34766870 DOI: 10.1080/00325481.2021.2006514] [Reference Citation Analysis]
|
| 168 |
Sukiasyan SH. TRADITIONAL CONCEPTS AND APPROACHES IN PSYCHIATRY AS PRECONDITIONS FOR PSYCHOSOMATIC CONCEPT: THE NEUROBIOLOGICAL ASPECT. AJMH 2021. [DOI: 10.55436/1829202x-1.2022.14-24] [Reference Citation Analysis]
|
| 169 |
Ng B, Casazza W, Kim NH, Wang C, Farhadi F, Tasaki S, Bennett DA, De Jager PL, Gaiteri C, Mostafavi S. Cascading epigenomic analysis for identifying disease genes from the regulatory landscape of GWAS variants. PLoS Genet 2021;17:e1009918. [PMID: 34807913 DOI: 10.1371/journal.pgen.1009918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 170 |
Pieters LE, Nadesalingam N, Walther S, van Harten PN. A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis. Neurosci Biobehav Rev 2021:S0149-7634(21)00520-0. [PMID: 34813828 DOI: 10.1016/j.neubiorev.2021.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 171 |
Allen P, Hird EJ, Orlov N, Modinos G, Bossong M, Antoniades M, Sampson C, Azis M, Howes O, Stone J, Perez J, Broome M, Grace AA, McGuire P. Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function. Transl Psychiatry 2021;11:579. [PMID: 34759289 DOI: 10.1038/s41398-021-01705-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Rodríguez-toscano E, Martínez K, Fraguas D, Janssen J, Pina-camacho L, Arias B, Vieta E, Mezquida G, Amoretti S, Bernardo M, Castro-fornieles J, Cuesta-zorita MJ, Lobo A, González-pinto A, Collado IC, Mané A, Arango C, Parellada M. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis. Revista de Psiquiatría y Salud Mental 2021. [DOI: 10.1016/j.rpsm.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 173 |
Monfared RV, Alhassen W, Truong TM, Gonzales MAM, Vachirakorntong V, Chen S, Baldi P, Civelli O, Alachkar A. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions. Cells 2021;10:2967. [PMID: 34831190 DOI: 10.3390/cells10112967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 174 |
Ueno F, Iwata Y, Nakajima S, Caravaggio F, Rubio JM, Horga G, Cassidy CM, Torres-Carmona E, de Luca V, Tsugawa S, Honda S, Moriguchi S, Noda Y, Gerretsen P, Graff-Guerrero A. Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021:S0149-7634(21)00468-1. [PMID: 34718049 DOI: 10.1016/j.neubiorev.2021.10.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 175 |
Speers LJ, Bilkey DK. Disorganization of Oscillatory Activity in Animal Models of Schizophrenia. Front Neural Circuits 2021;15:741767. [PMID: 34675780 DOI: 10.3389/fncir.2021.741767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 176 |
Qi S, Schumann G, Bustillo J, Turner JA, Jiang R, Zhi D, Fu Z, Mayer AR, Vergara VM, Silva RF, Iraji A, Chen J, Damaraju E, Ma X, Yang X, Stevens M, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, Potkin SG, Preda A, Zhuo C, Xu Y, Chu C, Banaschewski T, Barker GJ, Bokde ALW, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Fröhner JH, Smolka MN, Walter H, Whelan R, Calhoun VD, Sui J; IMAGEN Consortium. Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. Biol Psychiatry 2021;90:529-39. [PMID: 33875230 DOI: 10.1016/j.biopsych.2021.01.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 177 |
Sul JR. Delusional mood and affection. Philosophical Psychology. [DOI: 10.1080/09515089.2021.1988546] [Reference Citation Analysis]
|
| 178 |
Onaolapo OJ, Onaolapo AY. Nutrition, nutritional deficiencies, and schizophrenia: An association worthy of constant reassessment. World J Clin Cases 2021; 9(28): 8295-8311 [PMID: 34754840 DOI: 10.12998/wjcc.v9.i28.8295] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 179 |
Joe P, Clemente JC, Piras E, Wallach DS, Robinson-Papp J, Boka E, Remsen B, Bonner M, Kimhy D, Goetz D, Hoffman K, Lee J, Ruby E, Fendrich S, Gonen O, Malaspina D. An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth. Schizophr Res 2022;247:101-15. [PMID: 34625336 DOI: 10.1016/j.schres.2021.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 180 |
Gunasekaran S, Jacob RS, Omkumar RV. Novel microRNAs targeting NMDA receptor subunits in animal models of schizophrenia.. [DOI: 10.1101/2021.10.04.463021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 181 |
Venta A, Hart JR. Schizophrenia. Developmental Psychopathology 2021. [DOI: 10.1002/9781118686089.ch12] [Reference Citation Analysis]
|
| 182 |
Okita K, Kato K, Shigemoto Y, Sato N, Matsumoto T, Matsuda H. Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography. Front Neurosci 2021;15:729153. [PMID: 34588952 DOI: 10.3389/fnins.2021.729153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 183 |
Penedo MA, Rivera-Baltanás T, Pérez-Rodríguez D, Allen J, Borrajo A, Alonso-Crespo D, Fernández-Pereira C, Nieto-Araujo M, Ramos-García S, Barreiro-Villar C, Caruncho HJ, Olivares JM, Agís-Balboa RC. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain Behav Immun Health 2021;12:100199. [PMID: 34589732 DOI: 10.1016/j.bbih.2021.100199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 184 |
Poltavskaya EG, Fedorenko OY, Kornetova EG, Loonen AJM, Kornetov AN, Bokhan NA, Ivanova SA. Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms. Life (Basel) 2021;11:997. [PMID: 34685369 DOI: 10.3390/life11100997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 185 |
Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 186 |
Kowalski J, Aleksandrowicz A, Dąbkowska M, Gawęda Ł. Neural Correlates of Aberrant Salience and Source Monitoring in Schizophrenia and At-Risk Mental States-A Systematic Review of fMRI Studies. J Clin Med 2021;10:4126. [PMID: 34575237 DOI: 10.3390/jcm10184126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 187 |
Strelets VB, Rodionov GI, Nurbekov MK, Ushakov VL, Arkhipov AY. Analysis of Paradoxical Neurophysiological Reactions at Different Stages of the Perception of Negative Emotional Stimuli in Schizophrenia Patients. Neurosci Behav Physi 2021;51:985-992. [DOI: 10.1007/s11055-021-01156-5] [Reference Citation Analysis]
|
| 188 |
Chopra S, Francey SM, O'Donoghue B, Sabaroedin K, Arnatkeviciute A, Cropley V, Nelson B, Graham J, Baldwin L, Tahtalian S, Yuen HP, Allott K, Alvarez-Jimenez M, Harrigan S, Pantelis C, Wood SJ, McGorry P, Fornito A. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry 2021;78:994-1004. [PMID: 34160595 DOI: 10.1001/jamapsychiatry.2021.1422] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 189 |
Eleni P, Georgia P, Constantine P, Efstratios K, Georgios V, Nikolaos K, Christoph K, Nikolaos S. Functional brain imaging of speeded decision processing in Parkinson's disease and comparison with Schizophrenia. Psychiatry Res Neuroimaging 2021;314:111312. [PMID: 34111721 DOI: 10.1016/j.pscychresns.2021.111312] [Reference Citation Analysis]
|
| 190 |
Hayat TTA, Sami MB. Early magnetic resonance imaging biomarkers of schizophrenia spectrum disorders: Toward a fetal imaging perspective. Dev Psychopathol 2021;33:899-913. [PMID: 32489161 DOI: 10.1017/S0954579420000218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 191 |
Naysmith LF, Kumari V, Williams SCR. Neural mapping of prepulse-induced startle reflex modulation as indices of sensory information processing in healthy and clinical populations: A systematic review. Hum Brain Mapp 2021;42:5495-518. [PMID: 34414633 DOI: 10.1002/hbm.25631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 192 |
Horvath G, Kis G, Kekesi G, Büki A, Adlan LG, Szűcs E, Heni HE, Benyhe S. Interaction of clozapine with metformin in a schizophrenia rat model. Sci Rep 2021;11:16862. [PMID: 34413440 DOI: 10.1038/s41598-021-96478-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 193 |
Nakazawa T. Modeling schizophrenia with iPS cell technology and disease mouse models. Neurosci Res 2021:S0168-0102(21)00187-5. [PMID: 34411680 DOI: 10.1016/j.neures.2021.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 194 |
Nassar MR, Waltz JA, Albrecht MA, Gold JM, Frank MJ. All or nothing belief updating in patients with schizophrenia reduces precision and flexibility of beliefs. Brain 2021;144:1013-29. [PMID: 33434284 DOI: 10.1093/brain/awaa453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 195 |
Mirza MB, Cullen M, Parr T, Shergill S, Moran RJ. Contextual perception under active inference. Sci Rep 2021;11:16223. [PMID: 34376705 DOI: 10.1038/s41598-021-95510-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 196 |
Abashkin DA, Kurishev AO, Karpov DS, Golimbet VE. Cellular Models in Schizophrenia Research. Int J Mol Sci 2021;22:8518. [PMID: 34445221 DOI: 10.3390/ijms22168518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 197 |
Remington G, Hahn MK, Agarwal SM, Chintoh A, Agid O. Schizophrenia: Antipsychotics and drug development. Behav Brain Res 2021;414:113507. [PMID: 34352293 DOI: 10.1016/j.bbr.2021.113507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 198 |
Seo S, Sizemore RJ, Reader KL, Smither RA, Wicky HE, Hughes SM, Bilkey DK, Parr-Brownlie LC, Oorschot DE. A schizophrenia risk factor induces marked anatomical deficits at GABAergic-dopaminergic synapses in the rat ventral tegmental area: Essential evidence for new targeted therapies. J Comp Neurol 2021. [PMID: 34338311 DOI: 10.1002/cne.25225] [Reference Citation Analysis]
|
| 199 |
Mittal VA, Bernard JA, Walther S. Cerebellar-thalamic circuits play a critical role in psychomotor function. Mol Psychiatry 2021;26:3666-8. [PMID: 33203993 DOI: 10.1038/s41380-020-00935-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 200 |
Minwalla HD, Wrzesinski P, Desforges A, Caskey J, Wagner B, Ingraffia P, Patterson JC 2nd, Edinoff AN, Kaye AM, Kaye AD, Viswanath O, Urits I. Paliperidone to Treat Psychotic Disorders. Neurol Int 2021;13:343-58. [PMID: 34449689 DOI: 10.3390/neurolint13030035] [Reference Citation Analysis]
|
| 201 |
Panayi MC, Boerner T, Jahans-price T, Huber A, Sprengel R, Gilmour G, Sanderson DJ, Harrison PJ, Walton ME, Bannerman DM. Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience.. [DOI: 10.1101/2021.07.23.453593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 202 |
Inaba H, Namba H, Kida S, Nawa H. The dopamine D2 agonist quinpirole impairs frontal mismatch responses to sound frequency deviations in freely moving rats. Neuropsychopharmacol Rep 2021;41:405-15. [PMID: 34296531 DOI: 10.1002/npr2.12199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 203 |
Ľupták M, Michaličková D, Fišar Z, Kitzlerová E, Hroudová J. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World J Psychiatr 2021; 11(7): 277-296 [PMID: 34327122 DOI: 10.5498/wjp.v11.i7.277] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 204 |
Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatr 2021; 11(7): 355-364 [PMID: 34327128 DOI: 10.5498/wjp.v11.i7.355] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 205 |
le Sommer J, Low AM, Møllegaard Jepsen JR, Fagerlund B, Vangkilde S, Habekost T, Glenthøj B, Oranje B. Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients. Psychol Med 2021;:1-9. [PMID: 34218835 DOI: 10.1017/S0033291721002373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 206 |
Jongsma HE, Gayer-Anderson C, Tarricone I, Velthorst E, van der Ven E, Quattrone D, di Forti M, Menezes PR, Del-Ben CM, Arango C, Lasalvia A, Berardi D, La Cascia C, Bobes J, Bernardo M, Sanjuán J, Santos JL, Arrojo M, de Haan L, Tortelli A, Szöke A, Murray RM, Rutten BP, van Os J, Morgan C, Jones PB, Kirkbride JB; EU-GEI WP2 Group. Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study. Psychol Med 2021;51:1536-48. [PMID: 32122439 DOI: 10.1017/S003329172000029X] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 207 |
Chopra S, Fornito A, Francey SM, O'Donoghue B, Cropley V, Nelson B, Graham J, Baldwin L, Tahtalian S, Yuen HP, Allott K, Alvarez-Jimenez M, Harrigan S, Sabaroedin K, Pantelis C, Wood SJ, McGorry P. Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study. Neuropsychopharmacology 2021;46:1494-501. [PMID: 33637835 DOI: 10.1038/s41386-021-00980-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 208 |
Wenzel J, Haas SS, Dwyer DB, Ruef A, Oeztuerk OF, Antonucci LA, von Saldern S, Bonivento C, Garzitto M, Ferro A, Paolini M, Blautzik J, Borgwardt S, Brambilla P, Meisenzahl E, Salokangas RKR, Upthegrove R, Wood SJ, Kambeitz J, Koutsouleris N, Kambeitz-Ilankovic L; PRONIA consortium. Cognitive subtypes in recent onset psychosis: distinct neurobiological fingerprints? Neuropsychopharmacology 2021;46:1475-83. [PMID: 33723384 DOI: 10.1038/s41386-021-00963-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 209 |
Gregory MD, Eisenberg DP, Hamborg M, Kippenhan JS, Kohn P, Kolachana B, Dickinson D, Berman KF. Neanderthal-derived genetic variation in living humans relates to schizophrenia diagnosis, to psychotic symptom severity, and to dopamine synthesis. Am J Med Genet B Neuropsychiatr Genet 2021;186:329-38. [PMID: 34487600 DOI: 10.1002/ajmg.b.32872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 210 |
Nour MM, Liu Y, Arumuham A, Kurth-Nelson Z, Dolan RJ. Impaired neural replay of inferred relationships in schizophrenia. Cell 2021;184:4315-4328.e17. [PMID: 34197734 DOI: 10.1016/j.cell.2021.06.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 211 |
Anda L, Johnsen E, Kroken RA, Joa I, Rettenbacher M, Løberg EM. Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT. Schizophr Res Cogn 2021;26:100204. [PMID: 34258237 DOI: 10.1016/j.scog.2021.100204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 212 |
Purves-Tyson TD, Brown AM, Weissleder C, Rothmond DA, Shannon Weickert C. Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia. Mol Brain 2021;14:96. [PMID: 34174930 DOI: 10.1186/s13041-021-00805-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 213 |
Xu M, Guo Y, Cheng J, Xue K, Yang M, Song X, Feng Y, Cheng J. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping. Neuroimage Clin 2021;31:102736. [PMID: 34186296 DOI: 10.1016/j.nicl.2021.102736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 214 |
Castagnola E, Garg R, Rastogi SK, Cohen-Karni T, Cui XT. 3D fuzzy graphene microelectrode array for dopamine sensing at sub-cellular spatial resolution. Biosens Bioelectron 2021;191:113440. [PMID: 34171734 DOI: 10.1016/j.bios.2021.113440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 215 |
Kogure M, Kanahara N, Miyazawa A, Oishi K, Nakata Y, Oda Y, Iyo M. Interacting Roles of COMT and GAD1 Genes in Patients with Treatment-Resistant Schizophrenia: a Genetic Association Study of Schizophrenia Patients and Healthy Controls. J Mol Neurosci 2021. [PMID: 34125398 DOI: 10.1007/s12031-021-01866-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 216 |
Plataki ME, Diskos K, Sougklakos C, Velissariou M, Georgilis A, Stavroulaki V, Sidiropoulou K. Effect of Neonatal Treatment With the NMDA Receptor Antagonist, MK-801, During Different Temporal Windows of Postnatal Period in Adult Prefrontal Cortical and Hippocampal Function. Front Behav Neurosci 2021;15:689193. [PMID: 34177484 DOI: 10.3389/fnbeh.2021.689193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 217 |
van Zessen R, Flores-Dourojeanni JP, Eekel T, van den Reijen S, Lodder B, Omrani A, Smidt MP, Ramakers GMJ, van der Plasse G, Stuber GD, Adan RAH. Cue and Reward Evoked Dopamine Activity Is Necessary for Maintaining Learned Pavlovian Associations. J Neurosci 2021;41:5004-14. [PMID: 33888609 DOI: 10.1523/JNEUROSCI.2744-20.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 218 |
Braun U, Harneit A, Pergola G, Menara T, Schäfer A, Betzel RF, Zang Z, Schweiger JI, Zhang X, Schwarz K, Chen J, Blasi G, Bertolino A, Durstewitz D, Pasqualetti F, Schwarz E, Meyer-Lindenberg A, Bassett DS, Tost H. Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat Commun 2021;12:3478. [PMID: 34108456 DOI: 10.1038/s41467-021-23694-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 219 |
Cruz G, Grent-'t-Jong T, Krishnadas R, Palva JM, Palva S, Uhlhaas PJ. Long range temporal correlations (LRTCs) in MEG-data during emerging psychosis: Relationship to symptoms, medication-status and clinical trajectory. Neuroimage Clin 2021;31:102722. [PMID: 34130193 DOI: 10.1016/j.nicl.2021.102722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 220 |
Lech MA, Leśkiewicz M, Kamińska K, Rogóż Z, Lorenc-Koci E. Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague-Dawley Rats. Int J Mol Sci 2021;22:6171. [PMID: 34201038 DOI: 10.3390/ijms22126171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 221 |
Hirai S. Development of a Novel Mouse Model of Psychiatric Disorders with Decreased Glucose Logistics and Related Findings. The Brain & Neural Networks 2021;28:93-101. [DOI: 10.3902/jnns.28.93] [Reference Citation Analysis]
|
| 222 |
Moon SY, Kim M, Lho SK, Oh S, Kim SH, Kwon JS. Systematic Review of the Neural Effect of Electroconvulsive Therapy in Patients with Schizophrenia: Hippocampus and Insula as the Key Regions of Modulation. Psychiatry Investig 2021;18:486-99. [PMID: 34218638 DOI: 10.30773/pi.2020.0438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 223 |
Harju-seppänen J, Irizar H, Bramon E, Blakemore S, Mason L, Bell V. Reward Processing in Children with Psychotic-like Experiences.. [DOI: 10.1101/2021.06.01.21257966] [Reference Citation Analysis]
|
| 224 |
Terravecchia C, Mostile G, Rascunà C, Arabia G, Barone P, Marconi R, Morgante L, Quattrone A, Nicoletti A, Zappia M. Does an association between cigarette smoking and Parkinson's Disease-related psychosis exist? Insights from a large non-demented cohort. J Neurol Sci 2021;427:117509. [PMID: 34082149 DOI: 10.1016/j.jns.2021.117509] [Reference Citation Analysis]
|
| 225 |
Al-Nema MY, Gaurav A. Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia. Curr Top Med Chem. 2020;20:2404-2421. [PMID: 32533817 DOI: 10.2174/1568026620666200613202641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 226 |
Tripathi A, Sato SS, Medini P. Cortico-cortical connectivity behind acoustic information transfer to mouse orbitofrontal cortex is sensitive to neuromodulation and displays local sensory gating: relevance in disorders with auditory hallucinations? J Psychiatry Neurosci 2021;46:E371-87. [PMID: 34043305 DOI: 10.1503/jpn.200131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 227 |
Peterson RE, Bigdeli TB, Ripke S, Bacanu SA, Gejman PV, Levinson DF, Li QS, Rujescu D, Rietschel M, Weinberger DR, Straub RE, Walters JTR, Owen MJ, O'Donovan MC, Mowry BJ, Ophoff RA, Andreassen OA, Esko T, Petryshen TL, Kendler KS, Fanous AH; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium. J Psychiatr Res 2021;137:215-24. [PMID: 33691233 DOI: 10.1016/j.jpsychires.2021.02.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 228 |
Schöbi D, Homberg F, Frässle S, Endepols H, Moran RJ, Friston KJ, Tittgemeyer M, Heinzle J, Stephan KE. Model-based prediction of muscarinic receptor function from auditory mismatch negativity responses. Neuroimage 2021;237:118096. [PMID: 33940149 DOI: 10.1016/j.neuroimage.2021.118096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 229 |
Shayganfard M. Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives. Biol Trace Elem Res 2021. [PMID: 33904124 DOI: 10.1007/s12011-021-02733-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 230 |
Gandolfi D, Boiani GM, Bigiani A, Mapelli J. Modeling Neurotransmission: Computational Tools to Investigate Neurological Disorders. Int J Mol Sci 2021;22:4565. [PMID: 33925434 DOI: 10.3390/ijms22094565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 231 |
Gomes FV, Grace AA. Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention. Int J Mol Sci 2021;22:4467. [PMID: 33922888 DOI: 10.3390/ijms22094467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 232 |
Post MR, Sulzer D. The chemical tools for imaging dopamine release. Cell Chem Biol 2021;28:748-64. [PMID: 33894160 DOI: 10.1016/j.chembiol.2021.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 233 |
Sotoyama H, Namba H, Kobayashi Y, Hasegawa T, Watanabe D, Nakatsukasa E, Sakimura K, Furuyashiki T, Nawa H. Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia. Transl Psychiatry 2021;11:236. [PMID: 33888687 DOI: 10.1038/s41398-021-01346-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 234 |
Smigielski L, Wotruba D, Treyer V, Rössler J, Papiol S, Falkai P, Grünblatt E, Walitza S, Rössler W. The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study. Schizophr Bull 2021;47:1495-508. [PMID: 33876249 DOI: 10.1093/schbul/sbab034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 235 |
Geana A, Barch DM, Gold JM, Carter CS, MacDonald AW 3rd, Ragland JD, Silverstein SM, Frank MJ. Using Computational Modeling to Capture Schizophrenia-Specific Reinforcement Learning Differences and Their Implications on Patient Classification. Biol Psychiatry Cogn Neurosci Neuroimaging 2021:S2451-9022(21)00115-4. [PMID: 33878489 DOI: 10.1016/j.bpsc.2021.03.017] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 236 |
Chopra S, Francey SM, O’donoghue B, Sabaroedin K, Arnatkeviciute A, Cropley V, Nelson B, Graham J, Baldwin L, Tahtalian S, Yuen HP, Allott K, Alvarez-jimenez M, Harrigan S, Pantelis C, Wood SJ, Mcgorry P, Fornito A. Longitudinal Changes in Functional Connectivity in Antipsychotic-treated and Antipsychotic-naive Patients with First Episode Psychosis.. [DOI: 10.1101/2021.04.13.21255375] [Reference Citation Analysis]
|
| 237 |
Begni V, Sanson A, Luoni A, Sensini F, Grayson B, Munni S, Neill JC, Riva MA. Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856. Int J Mol Sci 2021;22:4119. [PMID: 33923479 DOI: 10.3390/ijms22084119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 238 |
Ferdinand JM, Peters KZ, Yavas E, Young AMJ. Modulation of stimulated dopamine release in rat nucleus accumbens shell by GABA in vitro: Effect of sub-chronic phencyclidine pretreatment. J Neurosci Res 2021;99:1885-901. [PMID: 33848365 DOI: 10.1002/jnr.24843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 239 |
Jones DN, Raghanti MA. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J Chem Neuroanat 2021;114:101957. [PMID: 33836221 DOI: 10.1016/j.jchemneu.2021.101957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 240 |
Liu X, Eickhoff SB, Caspers S, Wu J, Genon S, Hoffstaedter F, Mars RB, Sommer IE, Eickhoff CR, Chen J, Jardri R, Reetz K, Dogan I, Aleman A, Kogler L, Gruber O, Caspers J, Mathys C, Patil KR. Functional parcellation of human and macaque striatum reveals human-specific connectivity in the dorsal caudate. Neuroimage 2021;235:118006. [PMID: 33819611 DOI: 10.1016/j.neuroimage.2021.118006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 241 |
Turner A, Baker A, Dean OM, Walker AJ, Dodd S, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Brown E, McGrath JJ, Berk M. Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo. Can J Psychiatry 2021;66:354-66. [PMID: 33355478 DOI: 10.1177/0706743720982437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 242 |
Brouwer A, Carhart-Harris RL. Pivotal mental states. J Psychopharmacol 2021;35:319-52. [PMID: 33174492 DOI: 10.1177/0269881120959637] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 243 |
Allen P, Hird EJ, Orlov N, Modinos G, Bossong M, Antoniades M, Sampson C, Azis M, Howes O, Stone J, Perez J, Broome M, Grace AA, Mcguire P. Adverse clinical outcomes in people at clinical high-risk for psychosis related to activity and glutamate function in the hippocampus.. [DOI: 10.1101/2021.03.19.21253942] [Reference Citation Analysis]
|
| 244 |
Gee TA, Weintraub NC, Lu D, Phelps CE, Navratilova E, Heien ML, Porreca F. A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens. Pain 2020;161:2376-84. [PMID: 32453137 DOI: 10.1097/j.pain.0000000000001925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 245 |
Horne CM, Vanes LD, Verneuil T, Mouchlianitis E, Szentgyorgyi T, Averbeck B, Leech R, Moran RJ, Shergill SS. Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia. Neuroimage Clin 2021;30:102631. [PMID: 33799270 DOI: 10.1016/j.nicl.2021.102631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 246 |
Perju-Dumbrava L, Kempster P. Movement disorders in psychiatric patients. BMJ Neurol Open 2020;2:e000057. [PMID: 33681793 DOI: 10.1136/bmjno-2020-000057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 247 |
Ney LJ, Akhurst J, Bruno R, Laing PAF, Matthews A, Felmingham KL. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110118. [PMID: 32991952 DOI: 10.1016/j.pnpbp.2020.110118] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 248 |
Cupaioli FA, Zucca FA, Caporale C, Lesch KP, Passamonti L, Zecca L. The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110059. [PMID: 32822763 DOI: 10.1016/j.pnpbp.2020.110059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 249 |
Croft J, Martin D, Madley-Dowd P, Strelchuk D, Davies J, Heron J, Teufel C, Zammit S. Childhood trauma and cognitive biases associated with psychosis: A systematic review and meta-analysis. PLoS One 2021;16:e0246948. [PMID: 33630859 DOI: 10.1371/journal.pone.0246948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 250 |
Foster DJ, Bryant ZK, Conn PJ. Targeting muscarinic receptors to treat schizophrenia. Behav Brain Res 2021;405:113201. [PMID: 33647377 DOI: 10.1016/j.bbr.2021.113201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 251 |
Fang H, Wu M, Ji W, Wang L, Chen Y, Chen D, Yang N, Wu Q, Yu C, Liu J, Liu J, Bai H, Peng B, Huang X, Yu HD, Li L. Simultaneously Detecting Monoamine Oxidase A and B in Disease Cell/Tissue Samples Using Paper-Based Devices. ACS Appl Bio Mater 2021;4:1395-402. [PMID: 35014490 DOI: 10.1021/acsabm.0c01288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 252 |
Casado-sainz A, Gudmundsen F, Baerentzen SL, Lange D, Ringsted A, Martinez-tajada I, Medina S, Lee H, Svarer C, Keller SH, Schain M, Kjaerby C, Fisher PM, Cumming P, Palner M. Dorsal striatal dopamine induces fronto-cortical hypoactivity and implies reduced anxiety and compulsive behaviors in rats.. [DOI: 10.1101/2021.02.11.430770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 253 |
Bianciardi B, Uhlhaas PJ. Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective. Neurosci Biobehav Rev 2021;124:308-23. [PMID: 33581223 DOI: 10.1016/j.neubiorev.2021.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 254 |
Chen J, Müller VI, Dukart J, Hoffstaedter F, Baker JT, Holmes AJ, Vatansever D, Nickl-Jockschat T, Liu X, Derntl B, Kogler L, Jardri R, Gruber O, Aleman A, Sommer IE, Eickhoff SB, Patil KR. Intrinsic Connectivity Patterns of Task-Defined Brain Networks Allow Individual Prediction of Cognitive Symptom Dimension of Schizophrenia and Are Linked to Molecular Architecture. Biol Psychiatry 2021;89:308-19. [PMID: 33357631 DOI: 10.1016/j.biopsych.2020.09.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 255 |
Zhang T, Song J, Chen C, Li R, Li Y, Sun Y, Fang T, Xu W, Tian H, Zhuo C. Brain features of nearly drug-naïve female monozygotic twins with first-episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study. Brain Behav 2021;11:e01992. [PMID: 33295156 DOI: 10.1002/brb3.1992] [Reference Citation Analysis]
|
| 256 |
Smeland OB, Shadrin A, Bahrami S, Broce I, Tesli M, Frei O, Wirgenes KV, O'Connell KS, Krull F, Bettella F, Steen NE, Sugrue L, Wang Y, Svenningsson P, Sharma M, Pihlstrøm L, Toft M, O'Donovan M, Djurovic S, Desikan R, Dale AM, Andreassen OA. Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci. Biol Psychiatry 2021;89:227-35. [PMID: 32201043 DOI: 10.1016/j.biopsych.2020.01.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 257 |
Howes OD, Whitehurst T, Shatalina E, Townsend L, Onwordi EC, Mak TLA, Arumuham A, O'Brien O, Lobo M, Vano L, Zahid U, Butler E, Osugo M. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry 2021;20:75-95. [PMID: 33432766 DOI: 10.1002/wps.20822] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 258 |
Warren N, O'Gorman C, McKeon G, Swayne A, Blum S, Siskind D. Psychiatric management of anti-NMDAR encephalitis: a cohort analysis. Psychol Med 2021;51:435-40. [PMID: 31739809 DOI: 10.1017/S0033291719003283] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 259 |
Debrey SM, Goldsmith DR. Tardive Dyskinesia: Spotlight on Current Approaches to Treatment. Focus (Am Psychiatr Publ) 2021;19:14-23. [PMID: 34483762 DOI: 10.1176/appi.focus.20200038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 260 |
Vargas-Cáceres S, Cera N, Nobre P, Ramos-Quiroga JA. The Impact of Psychosis on Sexual Functioning: A Systematic Review. J Sex Med 2021;18:457-66. [PMID: 33504468 DOI: 10.1016/j.jsxm.2020.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 261 |
Imburgio MJ, Ballard HK, Cornwall AC, Worthy DA, Bernard JA, Orr JM. Preliminary effects of prefrontal tDCS on dopamine-mediated behavior and psychophysiology. Behav Brain Res 2021;402:113091. [PMID: 33359843 DOI: 10.1016/j.bbr.2020.113091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 262 |
Amin HS, Parikh PK, Ghate MD. Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress. Eur J Med Chem 2021;214:113155. [PMID: 33581555 DOI: 10.1016/j.ejmech.2021.113155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 263 |
Cupo L, McIlwaine SV, Daneault JG, Malla AK, Iyer SN, Joober R, Shah JL. Timing, Distribution, and Relationship Between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis. Schizophr Bull 2021;47:604-14. [PMID: 33410487 DOI: 10.1093/schbul/sbaa183] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 264 |
Kuusimäki T, Al‐abdulrasul H, Kurki S, Hietala J, Hartikainen S, Koponen M, Tolppanen A, Kaasinen V. Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders. Mov Disord 2021;36:1353-61. [DOI: 10.1002/mds.28484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 265 |
Karson A, Balcı F. Timing behavior in genetic murine models of neurological and psychiatric diseases. Exp Brain Res 2021;239:699-717. [PMID: 33404792 DOI: 10.1007/s00221-020-06021-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 266 |
Larijani B, Parhizkar Roudsari P, Hadavandkhani M, Alavi-Moghadam S, Rezaei-Tavirani M, Goodarzi P, Sayahpour FA, Mohamadi-Jahani F, Arjmand B. Stem cell-based models and therapies: a key approach into schizophrenia treatment. Cell Tissue Bank 2021;22:207-23. [PMID: 33387152 DOI: 10.1007/s10561-020-09888-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 267 |
Yang C, Tang J, Liu N, Yao L, Xu M, Sun H, Tao B, Gong Q, Cao H, Zhang W, Lui S. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies. Front Psychiatry 2021;12:593703. [PMID: 34248691 DOI: 10.3389/fpsyt.2021.593703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 268 |
Booij J, van Wieringen J, van de Giessen E, Knol RJJ, Finnema SJ. PET and SPECT Imaging of the Central Dopamine System in Humans. PET and SPECT of Neurobiological Systems 2021. [DOI: 10.1007/978-3-030-53176-8_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 269 |
Crowley SK. Pathophysiology, associations, and consequences of circadian rhythm sleep wake disorders. Reference Module in Neuroscience and Biobehavioral Psychology 2021. [DOI: 10.1016/b978-0-12-822963-7.00162-6] [Reference Citation Analysis]
|
| 270 |
Evermann U, Schmitt S, Meller T, Pfarr JK, Grezellschak S, Nenadić I. Distress severity in perceptual anomalies moderates the relationship between prefrontal brain structure and psychosis proneness in nonclinical individuals. Eur Arch Psychiatry Clin Neurosci 2021;271:1111-22. [PMID: 33532868 DOI: 10.1007/s00406-020-01229-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 271 |
Kim Y. Implications of Adult Neural Stem Cell Abnormalities in the Pathophysiological Mechanism of Schizophrenia. J Korean Neuropsychiatr Assoc 2021;60:28. [DOI: 10.4306/jknpa.2021.60.1.28] [Reference Citation Analysis]
|
| 272 |
Kindler J, Resch F. Psychosen im Kindes- und Jugendalter. Psychiatrie und Psychotherapie des Kindes- und Jugendalters 2021. [DOI: 10.1007/978-3-662-49289-5_100-1] [Reference Citation Analysis]
|
| 273 |
Purves-Tyson TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, Labouesse MA, Polesel M, Robinson K, Shannon Weickert C, Meyer U. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation. Mol Psychiatry 2021;26:849-63. [PMID: 31168068 DOI: 10.1038/s41380-019-0434-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 274 |
Dawes C, Bickerdike A, O'Neill C, Carneiro Pereira S, Waddington JL, Moran PM, O'Tuathaigh CMP. Cannabis Use, Schizotypy and Kamin Blocking Performance. Front Psychiatry 2021;12:633476. [PMID: 34887781 DOI: 10.3389/fpsyt.2021.633476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 275 |
Bacil RP, de O. Marcondes Filho EA, de A. Dias K, Portes MC, de Araujo WR, Oliveira-silva D, dos Santos AA, Serrano SH. The chemical interaction between the neurotransmitter dopamine and the antipsychotic drugs olanzapine and quetiapine. Journal of Electroanalytical Chemistry 2021;881:114946. [DOI: 10.1016/j.jelechem.2020.114946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 276 |
Colombo M. (Mis)computation in Computational Psychiatry. Neural Mechanisms 2021. [DOI: 10.1007/978-3-030-54092-0_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 277 |
Muzaffar A, Ullah S, Subhan F, Nazar Z, Hussain SM, Khuda F, Khan A, Khusro A, Sahibzada MUK, Albogami S, El-Shehawi AM, Emran TB, Javed B, Ali J. Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population. Front Psychiatry 2021;12:730388. [PMID: 34925083 DOI: 10.3389/fpsyt.2021.730388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 278 |
de Filippis R, Gaetano R, Schoretsanitis G, Verde G, Oliveti CA, Kane JM, Segura-Garcia C, De Fazio P. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. Neuropsychiatr Dis Treat 2021;17:2141-50. [PMID: 34234440 DOI: 10.2147/NDT.S312095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 279 |
Limongi R, Mackinley M, Dempster K, Khan AR, Gati JS, Palaniyappan L. Frontal-striatal connectivity and positive symptoms of schizophrenia: implications for the mechanistic basis of prefrontal rTMS. Eur Arch Psychiatry Clin Neurosci 2021;271:3-15. [PMID: 32683527 DOI: 10.1007/s00406-020-01163-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 280 |
Ntephe CU, Demjaha A. Dopamine and Response to Antipsychotic Medication. PET and SPECT in Psychiatry 2021. [DOI: 10.1007/978-3-030-57231-0_14] [Reference Citation Analysis]
|
| 281 |
Wieland L, Fromm S, Hetzer S, Schlagenhauf F, Kaminski J. Neuromelanin-Sensitive Magnetic Resonance Imaging in Schizophrenia: A Meta-Analysis of Case-Control Studies. Front Psychiatry 2021;12:770282. [PMID: 34777070 DOI: 10.3389/fpsyt.2021.770282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 282 |
Collins N. Low Prevalence Psychiatric Disorders in Rural and Remote Settings. Handbook of Rural, Remote, and very Remote Mental Health 2021. [DOI: 10.1007/978-981-15-6631-8_35] [Reference Citation Analysis]
|
| 283 |
Li S, Li X, Liu J, Huo Y, Li L, Wang J, Luo XJ. Functional variants fine-mapping and gene function characterization provide insights into the role of ZNF323 in schizophrenia pathogenesis. Am J Med Genet B Neuropsychiatr Genet 2021;186:28-39. [PMID: 33522098 DOI: 10.1002/ajmg.b.32835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 284 |
Báthori N, Moustafa AA, Polner B. Sleep and psychosis. Cognitive and Behavioral Dysfunction in Schizophrenia 2021. [DOI: 10.1016/b978-0-12-820005-6.00010-4] [Reference Citation Analysis]
|
| 285 |
Thomas M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, Barry EF, Patel K, Wong K, Joyce D, Shergill S. Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms? Psychiatry Res 2021;295:113607. [PMID: 33285345 DOI: 10.1016/j.psychres.2020.113607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 286 |
Williams M. The Basal Ganglia. The Neuropathology of Schizophrenia 2021. [DOI: 10.1007/978-3-030-68308-5_9] [Reference Citation Analysis]
|
| 287 |
Iliopoulou SM, Tsartsalis S, Kaiser S, Millet P, Tournier BB. Dopamine and Neuroinflammation in Schizophrenia - Interpreting the Findings from Translocator Protein (18kDa) PET Imaging. Neuropsychiatr Dis Treat 2021;17:3345-57. [PMID: 34819729 DOI: 10.2147/NDT.S334027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 288 |
Im D, Inoue A, Fujiwara T, Nakane T, Yamanaka Y, Uemura T, Mori C, Shiimura Y, Kimura KT, Asada H, Nomura N, Tanaka T, Yamashita A, Nango E, Tono K, Kadji FMN, Aoki J, Iwata S, Shimamura T. Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone. Nat Commun 2020;11:6442. [PMID: 33353947 DOI: 10.1038/s41467-020-20221-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 289 |
Gordillo D, Ramos da Cruz J, Chkonia E, Lin W, Favrod O, Brand A, Figueiredo P, Roinishvili M, Herzog MH. The EEG multiverse of schizophrenia.. [DOI: 10.1101/2020.12.21.20248665] [Reference Citation Analysis]
|
| 290 |
Baj J, Forma A, Sitarz E, Karakuła K, Flieger W, Sitarz M, Grochowski C, Maciejewski R, Karakula-Juchnowicz H. Beyond the Mind-Serum Trace Element Levels in Schizophrenic Patients: A Systematic Review. Int J Mol Sci 2020;21:E9566. [PMID: 33334078 DOI: 10.3390/ijms21249566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 291 |
Di Bartolomeo M, Stark T, Maurel OM, Iannotti FA, Kuchar M, Ruda-Kucerova J, Piscitelli F, Laudani S, Pekarik V, Salomone S, Arosio B, Mechoulam R, Maccarrone M, Drago F, Wotjak CT, Di Marzo V, Vismara M, Dell'Osso B, D'Addario C, Micale V. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats. Pharmacol Res 2021;164:105357. [PMID: 33285233 DOI: 10.1016/j.phrs.2020.105357] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 292 |
Noel JM, Jackson CW. ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder. Am J Health Syst Pharm 2020;77:2114-32. [PMID: 32871013 DOI: 10.1093/ajhp/zxaa303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 293 |
Granger KT, Talwar A, Barnett JH. Latent inhibition and its potential as a biomarker for schizophrenia. Biomarkers in Neuropsychiatry 2020;3:100025. [DOI: 10.1016/j.bionps.2020.100025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 294 |
Sydnor VJ, Roalf DR. A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk. Schizophr Res 2020;226:61-9. [PMID: 32723493 DOI: 10.1016/j.schres.2020.06.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 295 |
Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, Yau Y, Abbasi N, Maatz A, Habermeyer B, Abivardi A, Avram M, Brandl F, Sorg C, Homan P, Riecher-Rössler A, Borgwardt S, Seifritz E, Dagher A, Kaiser S. Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum. Schizophr Bull 2021;47:849-63. [PMID: 33257954 DOI: 10.1093/schbul/sbaa169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 296 |
Samaei A, Moradi K, Bagheri S, Ashraf-Ganjouei A, Alikhani R, Mousavi SB, Rezaei F, Akhondzadeh S. Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial. Int J Neuropsychopharmacol 2020;23:775-82. [PMID: 33372679 DOI: 10.1093/ijnp/pyaa006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 297 |
Millman ZB, Gallagher K, Demro C, Schiffman J, Reeves GM, Gold JM, Rakhshan Rouhakhtar PJ, Fitzgerald J, Andorko ND, Redman S, Buchanan RW, Rowland LM, Waltz JA. Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms. Schizophr Res 2020;226:111-9. [PMID: 30995969 DOI: 10.1016/j.schres.2019.03.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 298 |
Szűcs E, Ducza E, Büki A, Kekesi G, Benyhe S, Horvath G. Characterization of dopamine D2 receptor binding, expression and signaling in different brain regions of control and schizophrenia-model Wisket rats. Brain Research 2020;1748:147074. [DOI: 10.1016/j.brainres.2020.147074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 299 |
Cao T, Li N, Cai H. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist? Schizophr Res 2020;226:95-110. [PMID: 30935700 DOI: 10.1016/j.schres.2019.03.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 300 |
Sonnenschein SF, Grace A. Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis. Expert Opin Ther Targets 2021;25:15-26. [PMID: 33170748 DOI: 10.1080/14728222.2021.1849144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 301 |
Jen YW, Hwang TJ, Chan HY, Hsieh MH, Liu CC, Liu CM, Hwu HG, Kuo CH, Lin YT, Chien YL, Chen WJ. Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? BMC Psychiatry 2020;20:552. [PMID: 33228575 DOI: 10.1186/s12888-020-02957-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 302 |
Rezaie R, Modaffar M, Jung P, Hindocha C, Bisby JA, Bloomfield MAP. The effects of developmental trauma on reinforcement learning and its relationship to psychotic experiences: a behavioural study.. [DOI: 10.1101/2020.11.18.20234112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 303 |
Bell V, Raihani N, Wilkinson S. Derationalizing Delusions. Clin Psychol Sci 2021;9:24-37. [PMID: 33552704 DOI: 10.1177/2167702620951553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 304 |
Dzikowski M, Juchnowicz D, Dzikowska I, Rog J, Próchnicki M, Kozioł M, Karakula-Juchnowicz H. The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia. J Clin Med 2020;9:E3707. [PMID: 33218214 DOI: 10.3390/jcm9113707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 305 |
Mackintosh AJ, de Bock R, Lim Z, Trulley VN, Schmidt A, Borgwardt S, Andreou C. Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: A systematic review. Neurosci Biobehav Rev 2021;120:354-71. [PMID: 33171145 DOI: 10.1016/j.neubiorev.2020.10.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 306 |
Torrisi SA, Laudani S, Contarini G, De Luca A, Geraci F, Managò F, Papaleo F, Salomone S, Drago F, Leggio GM. Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments. Pharmaceuticals (Basel) 2020;13:E365. [PMID: 33167370 DOI: 10.3390/ph13110365] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 307 |
Sun X, Liu J, Ma Q, Duan J, Wang X, Xu Y, Xu Z, Xu K, Wang F, Tang Y, He Y, Xia M. Disrupted Intersubject Variability Architecture in Functional Connectomes in Schizophrenia. Schizophr Bull 2021;47:837-48. [PMID: 33135075 DOI: 10.1093/schbul/sbaa155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 308 |
Baudin G, Réveillère C. Vers une psychologie janétienne des psychoses ? European Journal of Trauma & Dissociation 2020;4:100094. [DOI: 10.1016/j.ejtd.2018.12.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 309 |
Wei S, Wang D, Wei G, Wang J, Zhou H, Xu H, Xia L, Tian Y, Dai Q, Zhu R, Wang W, Chen D, Xiu M, Wang L, Zhang XY. Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia. Psychopharmacology (Berl) 2020;237:3409-16. [PMID: 32757027 DOI: 10.1007/s00213-020-05621-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 310 |
Hui CLM, Lam BST, Lee EHM, Chan SKW, Chang WC, Suen YN, Chen EYH. Perspective on medication decisions following remission from first-episode psychosis. Schizophr Res 2020;225:82-9. [PMID: 32115314 DOI: 10.1016/j.schres.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 311 |
Cha HY, Yang SJ. Anti-Inflammatory Diets and Schizophrenia.Clin Nutr Res. 2020;9:241-257. [PMID: 33204665 DOI: 10.7762/cnr.2020.9.4.241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 312 |
Zelli S, Brancato A, Mattioli F, Pepe M, Alleva E, Carbone C, Cannizzaro C, Adriani W. A new "sudden fright paradigm" to explore the role of (epi)genetic modulations of the DAT gene in fear-induced avoidance behavior. Genes Brain Behav 2021;20:e12709. [PMID: 33070435 DOI: 10.1111/gbb.12709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 313 |
Damme KSF, Schiffman J, Ellman LM, Mittal VA. Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation. Schizophr Bull 2021;47:332-43. [PMID: 33047134 DOI: 10.1093/schbul/sbaa138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 314 |
Herborg F, Jensen KL, Tolstoy S, Arends NV, Posselt LP, Shekar A, Aguilar J, Lund VK, Erreger K, Rickhag M, Lykas MD, Lonsdale MN, Rahbek-clemmensen T, Sørensen AT, Newman AH, Løkkegaard A, Kjærulff O, Werge T, Møller LB, Matthies HJ, Galli A, Hjermind LE, Gether U. A dominant-negative variant in the dopamine transporter PDZ-binding motif is linked to parkinsonism and neuropsychiatric disease.. [DOI: 10.1101/2020.10.12.336461] [Reference Citation Analysis]
|
| 315 |
Hussain MS, Siddiqui SA, Mondal S, Millat MS, Marzan S, Uddin MG, Aziz MA, Alam MF, Islam MS. Association of DRD2 gene polymorphisms with schizophrenia in the young Bangladeshi population: A pilot study. Heliyon 2020;6:e05125. [PMID: 33043160 DOI: 10.1016/j.heliyon.2020.e05125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 316 |
Leicht G, Andreou C, Nafe T, Nägele F, Rauh J, Curic S, Schauer P, Schöttle D, Steinmann S, Mulert C. Alterations of oscillatory neuronal activity during reward processing in schizophrenia. J Psychiatr Res 2020;129:80-7. [PMID: 32619750 DOI: 10.1016/j.jpsychires.2020.05.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 317 |
Punchaichira TJ, Kukshal P, Bhatia T, Deshpande SN, Thelma BK. The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects. Psychiatr Genet 2020;30:125-35. [PMID: 32931693 DOI: 10.1097/YPG.0000000000000258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 318 |
Bjarke J, Sinkeviciute I, Kroken RA, Løberg EM, Jørgensen HA, Johnsen E, Gjestad R. Different response patterns in hallucinations and delusions to antipsychotic treatment. Nord J Psychiatry 2020;74:497-504. [PMID: 32242498 DOI: 10.1080/08039488.2020.1745273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 319 |
Tryon VL, Garman HD, Loewy RL, Niendam TA. Links Between Human and Animal Models of Trauma and Psychosis: A Narrative Review. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:154-65. [PMID: 33309566 DOI: 10.1016/j.bpsc.2020.09.012] [Reference Citation Analysis]
|
| 320 |
Casanova MF, Sokhadze EM, Casanova EL, Li X. Transcranial Magnetic Stimulation in Autism Spectrum Disorders: Neuropathological Underpinnings and Clinical Correlations. Semin Pediatr Neurol 2020;35:100832. [PMID: 32892959 DOI: 10.1016/j.spen.2020.100832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 321 |
Meller T, Ettinger U, Grant P, Nenadić I. The association of striatal volume and positive schizotypy in healthy subjects: intelligence as a moderating factor. Psychol Med 2020;50:2355-63. [PMID: 31530329 DOI: 10.1017/S0033291719002459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 322 |
Gendron M, Mesquita B, Barrett LF. The Brain as a Cultural Artifact. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 323 |
Cascio MA. Neurodiversity as a Conceptual Lens and Topic of Cross-Cultural Study. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 324 |
Worthman CM. Being There. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 325 |
Kitayama S, Yu Q. Mutual Constitution of Culture and the Mind. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 326 |
Gold BP, Zatorre RJ. The Reward of Musical Emotions and Expectations. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.021] [Reference Citation Analysis]
|
| 327 |
Choudhury S, Berson J. Liminal Brains in Uncertain Futures. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 328 |
Moses O. Literary Analysis and Weak Theories. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.022] [Reference Citation Analysis]
|
| 329 |
Lemelson R, Tucker A. Capturing Context Is Not Enough. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 330 |
Kavanagh C, Jong J, Whitehouse H. Ritual and Religion as Social Technologies of Cooperation. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 331 |
Han S, Northoff G. Cultural Priming Effects and the Human Brain. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 332 |
Index. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.029] [Reference Citation Analysis]
|
| 333 |
Culture, Mind, and Brain. 2020. [DOI: 10.1017/9781108695374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 334 |
Stendel M, Ramstead MJD, Veissière SPL. Internet Sociality. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 335 |
The Co-emergence of Culture, Mind, and Brain. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.004] [Reference Citation Analysis]
|
| 336 |
Boddice R. The Cultural Brain as Historical Artifact. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.018] [Reference Citation Analysis]
|
| 337 |
Kirmayer LJ, Gómez-carrillo A, Langlois-thérien T, Ramstead MJD, Gold I. Culture, Self, and Agency. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 338 |
Hutto DD, Gallagher S, Ilundáin-agurruza J, Hipólito I. Culture in Mind – An Enactivist Account. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 339 |
Kirmayer LJ, Worthman CM, Kitayama S. Introduction. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 340 |
West GL, Bohbot VD. Experience-Dependent Plasticity in the Hippocampus. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.019] [Reference Citation Analysis]
|
| 341 |
Sayanvala F, Bornstein L, Choudhury S, Shah J, Weinstock D, Gold I. Cities, Psychosis, and Social Defeat. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.025] [Reference Citation Analysis]
|
| 342 |
The Situated Brain. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.008] [Reference Citation Analysis]
|
| 343 |
Applications. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.017] [Reference Citation Analysis]
|
| 344 |
Lende DH, Downey G. Neuroanthropological Perspectives on Culture, Mind, and Brain. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 345 |
How Social Coordination and Cooperation are Achieved. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.013] [Reference Citation Analysis]
|
| 346 |
Kohrt B. Social Neuroscience in Global Mental Health. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.024] [Reference Citation Analysis]
|
| 347 |
Kirmayer LJ, Worthman CM, Kitayama S. Epilogue. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 348 |
Stout D. Culture, Mind, and Brain in Human Evolution. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.005] [Reference Citation Analysis]
|
| 349 |
Preface. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.001] [Reference Citation Analysis]
|
| 350 |
Mu Y, Gelfand MJ. The Neural Mechanisms Underlying Social Norms. Culture, Mind, and Brain 2020. [DOI: 10.1017/9781108695374.015] [Reference Citation Analysis]
|
| 351 |
Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, Owens SJ, Rothmond DA, Shannon Weickert C. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia. Front Immunol 2020;11:2002. [PMID: 33133060 DOI: 10.3389/fimmu.2020.02002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 352 |
Wu X, Xu FL, Xia X, Wang BJ, Yao J. MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3'UTR -12 bp to + 154 bp. Artif Cells Nanomed Biotechnol 2020;48:276-87. [PMID: 31858826 DOI: 10.1080/21691401.2019.1703729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 353 |
Zamanpoor M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatr Genet 2020;30:1-9. [PMID: 31764709 DOI: 10.1097/YPG.0000000000000245] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 354 |
Świerczek A, Jankowska A, Chłoń-Rzepa G, Pawłowski M, Wyska E. Advances in the Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 2: Focus on Schizophrenia. Curr Drug Targets 2019;20:1652-69. [PMID: 31368871 DOI: 10.2174/1389450120666190801114210] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 355 |
Ramchandran K, Fiedorowicz J, Chen Z, Bu Y, Bechara A, Andreasen NC. Patients on the psychosis spectrum employ an alternate brain network to engage in complex decision-making. PLoS One 2020;15:e0238774. [PMID: 32915832 DOI: 10.1371/journal.pone.0238774] [Reference Citation Analysis]
|
| 356 |
Cofré R, Herzog R, Mediano PAM, Piccinini J, Rosas FE, Sanz Perl Y, Tagliazucchi E. Whole-Brain Models to Explore Altered States of Consciousness from the Bottom Up. Brain Sci 2020;10. [PMID: 32927678 DOI: 10.3390/brainsci10090626] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 357 |
Spronk M, Keane BP, Ito T, Kulkarni K, Ji JL, Anticevic A, Cole MW. A Whole-Brain and Cross-Diagnostic Perspective on Functional Brain Network Dysfunction. Cereb Cortex 2021;31:547-61. [PMID: 32909037 DOI: 10.1093/cercor/bhaa242] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 358 |
Thompson JL, Rosell DR, Slifstein M, Xu X, Rothstein EG, Modiano YA, Kegeles LS, Koenigsberg HW, New AS, Hazlett EA, McClure MM, Perez-Rodriguez MM, Siever LJ, Abi-Dargham A. Amphetamine-induced striatal dopamine release in schizotypal personality disorder. Psychopharmacology (Berl) 2020;237:2649-59. [PMID: 32572588 DOI: 10.1007/s00213-020-05561-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 359 |
Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT(3) modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 2020;40:1593-678. [PMID: 32115745 DOI: 10.1002/med.21666] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 360 |
Sabe M, Zhao N, Kaiser S. Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies. Neuroscience & Biobehavioral Reviews 2020;116:415-25. [DOI: 10.1016/j.neubiorev.2020.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 361 |
Morrison PD, Murray RM. Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
. Dialogues Clin Neurosci 2020;22:251-8. [PMID: 33162768 DOI: 10.31887/DCNS.2020.22.3/pmorrison] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 362 |
Donthamsetti P, Gallo EF, Buck DC, Stahl EL, Zhu Y, Lane JR, Bohn LM, Neve KA, Kellendonk C, Javitch JA. Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation. Mol Psychiatry 2020;25:2086-100. [PMID: 30120413 DOI: 10.1038/s41380-018-0212-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 363 |
Huang WC, Liu WS, Chen TT, Chen WH, Huang WL. Parasympathetic activity as a potential biomarker of negative symptoms in patients with schizophrenia. Asia Pac Psychiatry 2020;12:e12392. [PMID: 32452616 DOI: 10.1111/appy.12392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 364 |
Karalija N, Jonassson L, Johansson J, Papenberg G, Salami A, Andersson M, Riklund K, Nyberg L, Boraxbekk CJ. High long-term test-retest reliability for extrastriatal (11)C-raclopride binding in healthy older adults. J Cereb Blood Flow Metab 2020;40:1859-68. [PMID: 31506011 DOI: 10.1177/0271678X19874770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 365 |
Nair PC, McKinnon RA, Miners JO, Bastiampillai T. Binding of clozapine to the GABA(B) receptor: clinical and structural insights. Mol Psychiatry 2020;25:1910-9. [PMID: 32203158 DOI: 10.1038/s41380-020-0709-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 366 |
Singh S, Khanna D, Kalra S. Role of Neurochemicals in Schizophrenia. CPSP 2020;9:144-161. [DOI: 10.2174/2211556009666200401150756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 367 |
Weeks JJ, Rupprecht LE, Grace AA, Donny EC, Sved AF. Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia. Nicotine Tob Res 2020;22:204-12. [PMID: 30899959 DOI: 10.1093/ntr/ntz048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 368 |
Vinding RK, Rago D, Kelly RS, Gürdeniz G, Rasmussen MA, Stokholm J, Bønnelykke K, Litonjua AA, Weiss ST, Lasky-Su J, Bisgaard H, Chawes BL. Delayed Motor Milestones Achievement in Infancy Associates with Perturbations of Amino Acids and Lipid Metabolic Pathways. Metabolites 2020;10:E337. [PMID: 32824932 DOI: 10.3390/metabo10090337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 369 |
Huang LC, Lin SH, Tseng HH, Chen KC, Yang YK. The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant patients. Med Hypotheses 2020;143:110159. [PMID: 32795840 DOI: 10.1016/j.mehy.2020.110159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 370 |
Howes OD, Hird EJ, Adams RA, Corlett PR, McGuire P. Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis. Biol Psychiatry 2020;88:304-14. [PMID: 32430200 DOI: 10.1016/j.biopsych.2020.03.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 371 |
Yuan S, Yao H, Larsson SC. Associations of cigarette smoking with psychiatric disorders: evidence from a two-sample Mendelian randomization study. Sci Rep 2020;10:13807. [PMID: 32796876 DOI: 10.1038/s41598-020-70458-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 372 |
Olasupo SB, Uzairu A, Shallangwa GA, Uba S. Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents. Heliyon 2020;6:e04464. [PMID: 32760824 DOI: 10.1016/j.heliyon.2020.e04464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 373 |
Kirlioglu SS, Balcioglu YH. Chronobiology Revisited in Psychiatric Disorders: From a Translational Perspective. Psychiatry Investig 2020;17:725-43. [PMID: 32750762 DOI: 10.30773/pi.2020.0129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 374 |
Matheson GJ, Plavén-Sigray P, Louzolo A, Borg J, Farde L, Petrovic P, Cervenka S. Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness. Schizophr Res 2020;222:175-84. [PMID: 32616361 DOI: 10.1016/j.schres.2020.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 375 |
Karcher NR, Niendam TA, Barch DM. Adverse childhood experiences and psychotic-like experiences are associated above and beyond shared correlates: Findings from the adolescent brain cognitive development study. Schizophr Res 2020;222:235-42. [PMID: 32522466 DOI: 10.1016/j.schres.2020.05.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 376 |
Appiah-Kusi E, Wilson R, Colizzi M, Foglia E, Klamerus E, Caldwell A, Bossong MG, McGuire P, Bhattacharyya S. Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids. Psychol Med 2020;50:1862-71. [PMID: 31422779 DOI: 10.1017/S0033291719001946] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 377 |
Delfin C, Reckless GE, Bolstad I, Groote I, Andreassen OA, Jensen J. Exploring the Effects of an Acute Dose of Antipsychotic Medication on Motivation-mediated BOLD Activity Using fMRI and a Perceptual Decision-making Task. Neuroscience 2020;440:146-59. [PMID: 32473275 DOI: 10.1016/j.neuroscience.2020.05.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 378 |
Fisher E, Wood SJ, Elsworthy RJ, Upthegrove R, Aldred S. Exercise as a protective mechanism against the negative effects of oxidative stress in first-episode psychosis: a biomarker-led study. Transl Psychiatry 2020;10:254. [PMID: 32709912 DOI: 10.1038/s41398-020-00927-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 379 |
Zheng P, Su QP, Jin D, Yu Y, Huang XF. Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor Overactivation in Striatal Neurons. Front Neurosci 2020;14:642. [PMID: 32655360 DOI: 10.3389/fnins.2020.00642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 380 |
Damme KSF, Schiffman J, Ellman LM, Mittal VA. Motor and Activity Psychosis-Risk (MAP-R) Scale: An exploration of scale structure with replication and validation.. [DOI: 10.1101/2020.07.02.20145482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 381 |
Kozak R, Kiss T, Dlugolenski K, Johnson DE, Gorczyca RR, Kuszpit K, Harvey BD, Stolyar P, Sukoff Rizzo SJ, Hoffmann WE, Volfson D, Hajós M, Davoren JE, Abbott AL, Williams GV, Castner SA, Gray DL. Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Front Pharmacol 2020;11:1005. [PMID: 32733245 DOI: 10.3389/fphar.2020.01005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 382 |
Borgan F, Kokkinou M, Howes O. The Cannabinoid CB1 Receptor in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:646-59. [PMID: 33077399 DOI: 10.1016/j.bpsc.2020.06.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 383 |
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, Crespo-Facorro B, Pantelis C, Wood SJ, Zhuo C, Shinohara RT, Shou H, Fan Y, Gur RC, Gur RE, Satterthwaite TD, Koutsouleris N, Wolf DH, Davatzikos C. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain 2020;143:1027-38. [PMID: 32103250 DOI: 10.1093/brain/awaa025] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 28.3] [Reference Citation Analysis]
|
| 384 |
Barnby JM, Bell V, Deeley Q, Mehta MA. Dopamine manipulations modulate paranoid social inferences in healthy people. Transl Psychiatry 2020;10:214. [PMID: 32624569 DOI: 10.1038/s41398-020-00912-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 385 |
Chen J, Müller VI, Dukart J, Hoffstaedter F, Baker JT, Holmes AJ, Vatansever D, Nickl-jockschat T, Liu X, Derntl B, Kogler L, Jardri R, Gruber O, Aleman A, Sommer IE, Eickhoff SB, Patil KR. Connectivity patterns of task-specific brain networks allow individual prediction of cognitive symptom dimension of schizophrenia and link to molecular architecture.. [DOI: 10.1101/2020.07.02.185124] [Reference Citation Analysis]
|
| 386 |
Vostrikov VM. Neuromorphological Aspects of the GABAergic Hypothesis of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 2020;50:663-668. [DOI: 10.1007/s11055-020-00952-9] [Reference Citation Analysis]
|
| 387 |
Sanchez-Gistau V, Manzanares N, Cabezas A, Sole M, Algora M, Vilella E. Clinical and cognitive correlates of childhood attention-deficit/hyperactivity disorder in first-episode psychosis: A controlled study. Eur Neuropsychopharmacol 2020;36:90-9. [PMID: 32540207 DOI: 10.1016/j.euroneuro.2020.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 388 |
Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. CNS Spectr 2020;:1-25. [PMID: 32594935 DOI: 10.1017/S1092852920001546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 389 |
Makkar R, Behl T, Bungau S, Zengin G, Mehta V, Kumar A, Uddin MS, Ashraf GM, Abdel-Daim MM, Arora S, Oancea R. Nutraceuticals in Neurological Disorders. Int J Mol Sci 2020;21:E4424. [PMID: 32580329 DOI: 10.3390/ijms21124424] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 390 |
Haddad PM, Nutt DJ, Green AR. A Brief History of Psychopharmacology. Seminars in Clinical Psychopharmacology 2020. [DOI: 10.1017/9781911623465.003] [Reference Citation Analysis]
|
| 391 |
Collo G, Mucci A, Giordano GM, Merlo Pich E, Galderisi S. Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques. Front Neurosci 2020;14:632. [PMID: 32625059 DOI: 10.3389/fnins.2020.00632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 392 |
Smeland OB, Frei O, Dale AM, Andreassen OA. The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology. Nat Rev Neurol 2020;16:366-79. [DOI: 10.1038/s41582-020-0364-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 393 |
Nullmeier S, Elmers C, D'Hanis W, Sandhu KVK, Stork O, Yanagawa Y, Panther P, Schwegler H. Glutamic acid decarboxylase 67 haplodeficiency in mice: consequences of postweaning social isolation on behavior and changes in brain neurochemical systems. Brain Struct Funct 2020;225:1719-42. [PMID: 32514634 DOI: 10.1007/s00429-020-02087-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 394 |
O'Tuathaigh CMP, Dawes C, Bickerdike A, Duggan E, O'Neill C, Waddington JL, Moran PM. Does cannabis use predict psychometric schizotypy via aberrant salience? Schizophr Res 2020;220:194-200. [PMID: 32273148 DOI: 10.1016/j.schres.2020.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 395 |
Warlow SM, Naffziger EE, Berridge KC. The central amygdala recruits mesocorticolimbic circuitry for pursuit of reward or pain. Nat Commun 2020;11:2716. [PMID: 32483118 DOI: 10.1038/s41467-020-16407-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 396 |
Zhuo C, Wang C, Song X, Xu X, Li G, Lin X, Xu Y, Tian H, Jiang D, Wang W, Zhou C. A unified model of shared brain structural alterations in patients with different mental disorders who experience own-thought auditory verbal hallucinations-A pilot study. Brain Behav 2020;10:e01614. [PMID: 32304354 DOI: 10.1002/brb3.1614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 397 |
Mitelman SA, Buchsbaum MS, Christian BT, Merrill BM, Buchsbaum BR, Mukherjee J, Lehrer DS. Positive association between cerebral grey matter metabolism and dopamine D(2)/D(3) receptor availability in healthy and schizophrenia subjects: An (18)F-fluorodeoxyglucose and (18)F-fallypride positron emission tomography study. World J Biol Psychiatry 2020;21:368-82. [PMID: 31552783 DOI: 10.1080/15622975.2019.1671609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 398 |
Kumar D. Promoting insight into delusions: Issues and challenges in therapy. Int J Psychiatry Clin Pract 2020;24:208-13. [PMID: 31928095 DOI: 10.1080/13651501.2019.1711420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 399 |
Xenaki LA, Kollias CT, Stefanatou P, Ralli I, Soldatos RF, Dimitrakopoulos S, Hatzimanolis A, Triantafyllou TF, Kosteletos I, Vlachos II, Selakovic M, Foteli S, Mantonakis L, Ermiliou V, Voulgaraki M, Psarra E, Gülöksüz S, van Os J, Stefanis NC. Organization framework and preliminary findings from the Athens First-Episode Psychosis Research Study. Early Interv Psychiatry 2020;14:343-55. [PMID: 31402581 DOI: 10.1111/eip.12865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 400 |
Mabry SJ, McCollum LA, Farmer CB, Bloom ES, Roberts RC. Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia. World J Biol Psychiatry 2020;21:339-56. [PMID: 31062628 DOI: 10.1080/15622975.2019.1615638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 401 |
Baajour SJ, Chowdury A, Thomas P, Rajan U, Khatib D, Zajac-Benitez C, Falco D, Haddad L, Amirsadri A, Bressler S, Stanley JA, Diwadkar VA. Disordered directional brain network interactions during learning dynamics in schizophrenia revealed by multivariate autoregressive models. Hum Brain Mapp 2020;41:3594-607. [PMID: 32436639 DOI: 10.1002/hbm.25032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 402 |
Yuan T, Wang S, Le J, Li Y. Effects of Atypical Antipsychotics on Neuroactive Vitamins in Patients With Schizophrenia. J Clin Pharmacol 2020;60:1355-61. [PMID: 32428979 DOI: 10.1002/jcph.1625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 403 |
Andersen HG, Raghava JM, Svarer C, Wulff S, Johansen LB, Antonsen PK, Nielsen MØ, Rostrup E, Vernon AC, Jensen LT, Pinborg LH, Glenthøj BY, Ebdrup BH. Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients. Front Neurosci 2020;14:484. [PMID: 32508577 DOI: 10.3389/fnins.2020.00484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 404 |
Antonio-Tolentino K, Hopkins CR. Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia - a review. Expert Opin Investig Drugs 2020;29:603-10. [PMID: 32396418 DOI: 10.1080/13543784.2020.1764938] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 405 |
Osborne KJ, Walther S, Shankman SA, Mittal VA. Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development. Biomark Neuropsychiatry 2020;2:100016. [PMID: 33738459 DOI: 10.1016/j.bionps.2020.100016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 406 |
Reis-de-Oliveira G, Zuccoli GS, Fioramonte M, Schimitt A, Falkai P, Almeida V, Martins-de-Souza D. Digging deeper in the proteome of different regions from schizophrenia brains. J Proteomics 2020;223:103814. [PMID: 32389842 DOI: 10.1016/j.jprot.2020.103814] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 407 |
Thompson IA, de Vries EFJ, Sommer IEC. Dopamine D2 up-regulation in psychosis patients after antipsychotic drug treatment. Curr Opin Psychiatry 2020;33:200-5. [PMID: 32049767 DOI: 10.1097/YCO.0000000000000598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 408 |
Plitman E, Raihaan P, Chakravarty MM. Seeing the bigger picture: multimodal neuroimaging to investigate neuropsychiatric illnesses. J Psychiatry Neurosci 2020;45:147-9. [PMID: 32338856 DOI: 10.1503/jpn.200070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 409 |
Oh S, Kim M, Kim T, Lee TY, Kwon JS. Resting-state functional connectivity of the striatum predicts improvement in negative symptoms and general functioning in patients with first-episode psychosis: A 1-year naturalistic follow-up study. Aust N Z J Psychiatry 2020;54:509-18. [PMID: 31702384 DOI: 10.1177/0004867419885452] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 410 |
Baltzersen OB, Meltzer HY, Frokjaer VG, Raghava JM, Baandrup L, Fagerlund B, Larsson HBW, Fibiger HC, Glenthøj BY, Knudsen GM, Ebdrup BH. Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol. Front Pharmacol 2020;11:591. [PMID: 32425802 DOI: 10.3389/fphar.2020.00591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 411 |
Göder R, Bares S, Vogel C, Böttcher H, Drews HJ, Lechinger J, Jauch-Chara K, Weinhold S. Psychotic-like experiences in patients with insomnia or sleep apnea: associations with sleep parameters. Sleep Med 2021;77:367-73. [PMID: 32819820 DOI: 10.1016/j.sleep.2020.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 412 |
Pozhidaev IV, Boiko AS, Loonen AJM, Paderina DZ, Fedorenko OY, Tenin G, Kornetova EG, Semke AV, Bokhan NA, Wilffert B, Ivanova SA. Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia. Appl Clin Genet 2020;13:97-105. [PMID: 32368127 DOI: 10.2147/TACG.S247174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 413 |
Katthagen T, Kaminski J, Heinz A, Buchert R, Schlagenhauf F. Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients. Schizophr Bull 2020;46:1535-46. [PMID: 32318717 DOI: 10.1093/schbul/sbaa055] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 414 |
Li XN, Zheng JL, Wei XH, Wang BJ, Yao J. No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies. BMC Med Genet 2020;21:85. [PMID: 32316934 DOI: 10.1186/s12881-020-01018-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 415 |
Sami M, Worker A, Colizzi M, Annibale L, Das D, Kelbrick M, Eranti S, Collier T, Onyejiaka C, O'Neill A, Lythgoe D, McGuire P, Williams SCR, Kempton MJ, Bhattacharyya S; Collaborators. Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis. Transl Psychiatry 2020;10:111. [PMID: 32317625 DOI: 10.1038/s41398-020-0790-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 416 |
Areal LB, Blakely RD. Neurobehavioral changes arising from early life dopamine signaling perturbations. Neurochem Int 2020;137:104747. [PMID: 32325191 DOI: 10.1016/j.neuint.2020.104747] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 417 |
Tomasella E, Falasco G, Urrutia L, Bechelli L, Padilla L, Gelman DM. Impaired brain glucose metabolism and presynaptic dopaminergic functioning in a mouse model of schizophrenia. EJNMMI Res 2020;10:39. [PMID: 32303857 DOI: 10.1186/s13550-020-00629-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 418 |
Grant P, Gabriel F, Kuepper Y, Wielpuetz C, Hennig J. Psychosis-proneness correlates with expression levels of dopaminergic genes. Eur psychiatr 2014;29:304-6. [DOI: 10.1016/j.eurpsy.2013.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 419 |
Turconi G, Kopra J, Võikar V, Kulesskaya N, Vilenius C, Piepponen TP, Andressoo JO. Chronic 2-Fold Elevation of Endogenous GDNF Levels Is Safe and Enhances Motor and Dopaminergic Function in Aged Mice. Mol Ther Methods Clin Dev 2020;17:831-42. [PMID: 32368564 DOI: 10.1016/j.omtm.2020.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 420 |
Ioanas H, Saab BJ, Rudin M. Whole-Brain opto-fMRI Map of Mouse VTA Dopaminergic Activation Reflects Structural Projections with Small but Significant Deviations.. [DOI: 10.1101/2020.04.03.023648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 421 |
Prestori F, Montagna I, D'Angelo E, Mapelli L. The Optogenetic Revolution in Cerebellar Investigations. Int J Mol Sci 2020;21:E2494. [PMID: 32260234 DOI: 10.3390/ijms21072494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 422 |
Hu M, Xia Y, Zong X, Sweeney JA, Bishop JR, Liao Y, Giase G, Li B, Rubin LH, Wang Y, Li Z, He Y, Chen X, Liu C, Chen C, Tang J. Risperidone-induced changes in DNA methylation from peripheral blood in first-episode schizophrenia parallel neuroimaging and cognitive phenotype.. [DOI: 10.1101/2020.03.31.018283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 423 |
Duan X, Hu M, Huang X, Su C, Zong X, Dong X, He C, Xiao J, Li H, Tang J, Chen X, Chen H. Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia. Schizophr Bull 2020;46:650-60. [PMID: 31504959 DOI: 10.1093/schbul/sbz087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 424 |
Solmi F, Lewis G, Zammit S, Kirkbride JB. Neighborhood Characteristics at Birth and Positive and Negative Psychotic Symptoms in Adolescence: Findings From the ALSPAC Birth Cohort. Schizophr Bull 2020;46:581-91. [PMID: 31167032 DOI: 10.1093/schbul/sbz049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 425 |
Duan X, Hu M, Huang X, Dong X, Zong X, He C, Xiao J, Tang J, Chen X, Chen H. Effects of risperidone monotherapy on the default-mode network in antipsychotic-naïve first-episode schizophrenia: Posteromedial cortex heterogeneity and relationship with the symptom improvements. Schizophr Res 2020;218:201-8. [PMID: 31954611 DOI: 10.1016/j.schres.2020.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 426 |
Rössler J, Rössler W, Seifritz E, Unterrassner L, Wyss T, Haker H, Wotruba D. Dopamine-Induced Dysconnectivity Between Salience Network and Auditory Cortex in Subjects With Psychotic-like Experiences: A Randomized Double-Blind Placebo-Controlled Study. Schizophr Bull 2020;46:732-40. [PMID: 31751466 DOI: 10.1093/schbul/sbz110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 427 |
Magioncalda P, Martino M, Conio B, Lee HC, Ku HL, Chen CJ, Inglese M, Amore M, Lane TJ, Northoff G. Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: A preliminary study. Schizophr Res 2020;218:157-65. [PMID: 32029353 DOI: 10.1016/j.schres.2020.01.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 428 |
Henssler J, Brandt L, Müller M, Liu S, Montag C, Sterzer P, Heinz A. Migration and schizophrenia: meta-analysis and explanatory framework. Eur Arch Psychiatry Clin Neurosci 2020;270:325-35. [PMID: 31161262 DOI: 10.1007/s00406-019-01028-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 429 |
van Duin EDA, Ceccarini J, Booij J, Kasanova Z, Vingerhoets C, van Huijstee J, Heinzel A, Mohammadkhani-Shali S, Winz O, Mottaghy F, Myin-Germeys I, van Amelsvoort T. Lower [(18)F]fallypride binding to dopamine D(2/3) receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study. Psychol Med 2020;50:799-807. [PMID: 30935427 DOI: 10.1017/S003329171900062X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 430 |
Schwarz K, Moessnang C, Schweiger JI, Baumeister S, Plichta MM, Brandeis D, Banaschewski T, Wackerhagen C, Erk S, Walter H, Tost H, Meyer-Lindenberg A. Transdiagnostic Prediction of Affective, Cognitive, and Social Function Through Brain Reward Anticipation in Schizophrenia, Bipolar Disorder, Major Depression, and Autism Spectrum Diagnoses. Schizophr Bull 2020;46:592-602. [PMID: 31586408 DOI: 10.1093/schbul/sbz075] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 431 |
Li A, Zalesky A, Yue W, Howes O, Yan H, Liu Y, Fan L, Whitaker KJ, Xu K, Rao G, Li J, Liu S, Wang M, Sun Y, Song M, Li P, Chen J, Chen Y, Wang H, Liu W, Li Z, Yang Y, Guo H, Wan P, Lv L, Lu L, Yan J, Song Y, Wang H, Zhang H, Wu H, Ning Y, Du Y, Cheng Y, Xu J, Xu X, Zhang D, Wang X, Jiang T, Liu B. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med 2020;26:558-65. [DOI: 10.1038/s41591-020-0793-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 432 |
Chopra S, Fornito A, Francey SM, O’donoghue B, Cropley V, Nelson B, Graham J, Baldwin L, Tahtalian S, Yuen HP, Allott K, Alvarez-jimenez M, Harrigan S, Sabaroedin K, Pantelis C, Wood SJ, Mcgorry P. Differentiating the Effect of Medication and Illness on Brain Volume Reductions in First-Episode Psychosis: A Longitudinal, Randomized, Triple-blind, Placebo-controlled MRI Study.. [DOI: 10.1101/2020.03.18.20038471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 433 |
Frydecka D, Misiak B, Kotowicz K, Pionke R, Krężołek M, Cechnicki A, Gawęda Ł. The interplay between childhood trauma, cognitive biases, and cannabis use on the risk of psychosis in nonclinical young adults in Poland. Eur Psychiatry 2020;63:e35. [PMID: 32200775 DOI: 10.1192/j.eurpsy.2020.31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 434 |
Gawlik M, Savic V, Jovanovic M, Skibiński R. Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS. Molecules 2020;25:E1367. [PMID: 32192164 DOI: 10.3390/molecules25061367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 435 |
Avram M, Brandl F, Cabello J, Leucht C, Scherr M, Mustafa M, Leucht S, Ziegler S, Sorg C. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain 2019;142:1813-26. [PMID: 31135051 DOI: 10.1093/brain/awz093] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 436 |
Zhou C, Kong D, Zhu X, Wu W, Xue R, Li G, Xu Y, Liu S, Tian H, Zhuo C. Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model. Front Neurosci 2020;14:115. [PMID: 32218718 DOI: 10.3389/fnins.2020.00115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 437 |
Cole DM, Diaconescu AO, Pfeiffer UJ, Brodersen KH, Mathys CD, Julkowski D, Ruhrmann S, Schilbach L, Tittgemeyer M, Vogeley K, Stephan KE. Atypical processing of uncertainty in individuals at risk for psychosis. Neuroimage Clin 2020;26:102239. [PMID: 32182575 DOI: 10.1016/j.nicl.2020.102239] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 438 |
Lemvigh CK, Jepsen JRM, Fagerlund B, Pagsberg AK, Glenthøj BY, Rydkjær J, Oranje B. Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder. Neuropsychopharmacology 2020;45:649-55. [PMID: 31649298 DOI: 10.1038/s41386-019-0555-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 439 |
Rydkjaer J, Jepsen JRM, Pagsberg AK, Fagerlund B, Glenthoej BY, Oranje B. Do young adolescents with first-episode psychosis or ADHD show sensorimotor gating deficits? Psychol Med 2020;50:607-15. [PMID: 30873927 DOI: 10.1017/S0033291719000412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 440 |
Snyder MA, Gao WJ. NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms. Schizophr Res 2020;217:60-70. [PMID: 30979669 DOI: 10.1016/j.schres.2019.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 441 |
Howell KR, Law AJ. Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development. Schizophr Res 2020;217:95-104. [PMID: 31522868 DOI: 10.1016/j.schres.2019.08.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 442 |
Hong J, Bang M. Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing. Clin Psychopharmacol Neurosci 2020;18:10-24. [PMID: 31958901 DOI: 10.9758/cpn.2020.18.1.10] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 443 |
de Souza Lima ACM, de Alvarenga KAF, Codo BC, Sacramento EK, Rosa DVF, Souza RP, Romano-Silva MA, Souza BR. Impairment of motor but not anxiety-like behavior caused by the increase of dopamine during development is sustained in zebrafish larvae at later stages. Int J Dev Neurosci 2020;80:106-22. [PMID: 31990423 DOI: 10.1002/jdn.10009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 444 |
Limongi R, Mackinley M, Dempster K, Khan AR, Gati JS, Palaniyappan L. Understanding the Effect of Left Prefrontal Stimulation on Positive Symptoms of Schizophrenia: A Dynamic Causal Modeling Study of Ultra-high field (7-Tesla) Resting-state fMRI.. [DOI: 10.1101/2020.02.07.939470] [Reference Citation Analysis]
|
| 445 |
Servonnet A, Samaha A. Antipsychotic-evoked dopamine supersensitivity. Neuropharmacology 2020;163:107630. [DOI: 10.1016/j.neuropharm.2019.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 446 |
Ramírez-Bermúdez J, Perez-Neri I, Montes S, Nente F, Ramirez-Abascal M, Carrillo-Mezo R, Pérez-Esparza R, Soto-Hernandez JL, Espinola-Nadurille M, Bayliss L, De Jesus Flores Rivera J, Rios C. Dopaminergic Hyperactivity in Neurological Patients with Delirium. Arch Med Res 2019;50:477-83. [PMID: 32018069 DOI: 10.1016/j.arcmed.2019.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 447 |
Brugger SP, Angelescu I, Abi-Dargham A, Mizrahi R, Shahrezaei V, Howes OD. Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance. Biol Psychiatry 2020;87:215-24. [PMID: 31561858 DOI: 10.1016/j.biopsych.2019.07.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 448 |
Nagy L, Mangini P, Schroen C, Aziz R, Tobia A. Prolonged Hypercalcemia-Induced Psychosis. Case Rep Psychiatry 2020;2020:6954036. [PMID: 32099711 DOI: 10.1155/2020/6954036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 449 |
Shaw AD, Knight L, Freeman TCA, Williams GM, Moran RJ, Friston KJ, Walters JTR, Singh KD. Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in Schizophrenia. Schizophr Bull 2020;46:345-53. [PMID: 31219602 DOI: 10.1093/schbul/sbz066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 450 |
Torshin IY, Gromova OA, Zgoda VG, Tikhonova OV, Malyavskaya SI. [Cerebrolysin peptides as mood stabilizers]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:69-75. [PMID: 31994517 DOI: 10.17116/jnevro201911912169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 451 |
Hossain MR, Jamal M, Tanoue Y, Ojima D, Takahashi H, Kubota T, Ansary TM, Ito A, Tanaka N, Kinoshita H, Kishimoto Y, Yamamoto T. MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis. Neurosci Lett 2020;716:134677. [PMID: 31812551 DOI: 10.1016/j.neulet.2019.134677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 452 |
Haugg A, Sladky R, Skouras S, Mcdonald A, Craddock C, Kirschner M, Herdener M, Koush Y, Papoutsi M, Keynan JN, Hendler T, Kadosh KC, Zich C, Macinnes J, Adcock A, Dickerson K, Chen N, Young K, Bodurka J, Yao S, Becker B, Auer T, Schweizer R, Pamplona G, Emmert K, Haller S, Van De Ville D, Blefari M, Kim D, Lee J, Marins T, Fukuda M, Sorger B, Kamp T, Liew S, Veit R, Spetter M, Weiskopf N, Scharnowski F. Can we predict real-time fMRI neurofeedback learning success from pre-training brain activity?. [DOI: 10.1101/2020.01.15.906388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 453 |
Gifford G, Crossley N, Kempton MJ, Morgan S, Dazzan P, Young J, McGuire P. Resting state fMRI based multilayer network configuration in patients with schizophrenia. Neuroimage Clin 2020;25:102169. [PMID: 32032819 DOI: 10.1016/j.nicl.2020.102169] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 454 |
Engen K, Wortinger LA, Jørgensen KN, Lundberg M, Bohman H, Smelror RE, Myhre AM, Jacobson L, Vincent A, Agartz I. Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents with Early Onset Psychosis and Healthy Controls.. [DOI: 10.1101/2020.01.06.20016626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 455 |
Corripio I, Roldán A, Sarró S, McKenna PJ, Alonso-Solís A, Rabella M, Díaz A, Puigdemont D, Pérez-Solà V, Álvarez E, Arévalo A, Padilla PP, Ruiz-Idiago JM, Rodríguez R, Molet J, Pomarol-Clotet E, Portella MJ. Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial. EBioMedicine 2020;51:102568. [PMID: 31927311 DOI: 10.1016/j.ebiom.2019.11.029] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 456 |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D(2/3) receptor agonist radioligand study. Transl Psychiatry 2020;10:2. [PMID: 32066718 DOI: 10.1038/s41398-019-0681-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 457 |
Moon AL, Brydges NM, Wilkinson LS, Hall J, Thomas KL. Cacna1c Hemizygosity Results in Aberrant Fear Conditioning to Neutral Stimuli. Schizophr Bull 2020;46:1231-8. [PMID: 31910256 DOI: 10.1093/schbul/sbz127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 458 |
Schlagenhauf F, Sterzer P. Psychotische Erkrankungen („Schizophrenie“). Psychoneurowissenschaften 2020. [DOI: 10.1007/978-3-662-59038-6_11] [Reference Citation Analysis]
|
| 459 |
Conio B, Martino M, Magioncalda P, Escelsior A, Inglese M, Amore M, Northoff G. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatry 2020;25:82-93. [PMID: 30953003 DOI: 10.1038/s41380-019-0406-4] [Cited by in Crossref: 107] [Cited by in F6Publishing: 106] [Article Influence: 35.7] [Reference Citation Analysis]
|
| 460 |
Kent JS, Disner SG, Van Voorhis AC, Urošević S, Caligiuri MP, Sponheim SR. Exploring the Relationship of Transdiagnostic Mood and Psychosis Symptom Domains with Motor Dysfunction. Neuropsychobiology 2020;79:301-12. [PMID: 31851987 DOI: 10.1159/000503928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 461 |
Milne G, Fujimoto C, Bean T, Peters HJ, Hemmington M, Taylor C, Fowkes RC, Martineau HM, Hamilton CM, Walker M, Mitchell JA, Léger E, Priestnall SL, Webster JP. Infectious Causation of Abnormal Host Behavior: Toxoplasma gondii and Its Potential Association With Dopey Fox Syndrome. Front Psychiatry 2020;11:513536. [PMID: 33192643 DOI: 10.3389/fpsyt.2020.513536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 462 |
Engen K, Wortinger LA, Jørgensen KN, Lundberg M, Bohman H, Smelror RE, Myhre AM, Jacobson L, Vincent A, Agartz I. Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls. Front Psychiatry 2020;11:666. [PMID: 32765314 DOI: 10.3389/fpsyt.2020.00666] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 463 |
Bilgrami ZR, Kostek N, Kim IT, Kraut RA, Kim JK, Corcoran CM. Attenuated Psychosis Syndrome. Schizophrenia Treatment Outcomes 2020. [DOI: 10.1007/978-3-030-19847-3_14] [Reference Citation Analysis]
|
| 464 |
Nelson B, Lavoie S, Gawęda Ł, Li E, Sass L, Koren D, Mcgorry P, Jack B, Parnas J, Polari A, Allott K, Hartmann J, Whitford T. The neurophenomenology of early psychosis: An integrative empirical study. Consciousness and Cognition 2020;77:102845. [DOI: 10.1016/j.concog.2019.102845] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 465 |
Freudenreich O. Antipsychotics: Overview. Psychotic Disorders 2020. [DOI: 10.1007/978-3-030-29450-2_13] [Reference Citation Analysis]
|
| 466 |
Ouyang W, Sun G, Hsu M. Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application. Aggression and Violent Behavior 2020;50:101347. [DOI: 10.1016/j.avb.2019.101347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 467 |
Han S, Becker B, Duan X, Cui Q, Xin F, Zong X, Hu M, Yang M, Li R, Yu Y, Liao W, Chen X, Chen H. Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy. Schizophr Res 2020;215:89-96. [PMID: 31759811 DOI: 10.1016/j.schres.2019.11.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 468 |
Goldsmith DR, Rapaport MH. Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits. Front Psychiatry 2020;11:46. [PMID: 32153436 DOI: 10.3389/fpsyt.2020.00046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 469 |
Godlewska BR, Harmer CJ. How functional neuroimaging can be used for prediction and evaluation in psychiatry. Personalized Psychiatry 2020. [DOI: 10.1016/b978-0-12-813176-3.00040-7] [Reference Citation Analysis]
|
| 470 |
Morrow O, Gibson L, Bhamra M, David AS, Posporelis S. G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine. Ther Adv Psychopharmacol 2020;10:2045125320956414. [PMID: 32973999 DOI: 10.1177/2045125320956414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 471 |
Culej J, Nikolac Gabaj N, Štefanović M, Karlović D. Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case-control study. Indian J Psychiatry 2020;62:80-6. [PMID: 32001935 DOI: 10.4103/psychiatry.IndianJPsychiatry_54_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 472 |
Hanssen E, Krabbendam L, Robberegt S, Fett AK. Social and non-social reward learning reduced and related to a familial vulnerability in schizophrenia spectrum disorders. Schizophr Res 2020;215:256-62. [PMID: 31753593 DOI: 10.1016/j.schres.2019.10.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 473 |
de Barros JLVM, de Miranda AS, Teixeira AL. Toxoplasma gondii Infection as a Risk Factor for Major Psychiatric Disorders: Pre-clinical and Clinical Evidence. Progress in Inflammation Research 2020. [DOI: 10.1007/978-3-030-39335-9_7] [Reference Citation Analysis]
|
| 474 |
Driver DI, Thomas S, Gogtay N, Rapoport JL. Childhood-Onset Schizophrenia and Early-onset Schizophrenia Spectrum Disorders: An Update. Child Adolesc Psychiatr Clin N Am 2020;29:71-90. [PMID: 31708054 DOI: 10.1016/j.chc.2019.08.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 475 |
Sanders L, Gabler F, De Lucena D. A Critical Appraisal on the Epidemiological Evidence Linking Perinatal Inflammation and Risk of Psychosis. Progress in Inflammation Research 2020. [DOI: 10.1007/978-3-030-39335-9_8] [Reference Citation Analysis]
|
| 476 |
Frangou S, Kahn RS. Gray Matter Involvement in Schizophrenia: Evidence from Magnetic Resonance Imaging Studies. Neuroimaging in Schizophrenia 2020. [DOI: 10.1007/978-3-030-35206-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 477 |
Marinelli M(. Dopamine. Encyclopedia of Behavioral Medicine 2020. [DOI: 10.1007/978-3-030-39903-0_244] [Reference Citation Analysis]
|
| 478 |
Stefanou MI, Vittore D, Wolz I, Klingberg S, Wildgruber D. Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia. Front Psychiatry 2020;11:318. [PMID: 32425825 DOI: 10.3389/fpsyt.2020.00318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 479 |
Pearce BD, Massa N, Goldsmith DR, Gandhi ZH, Hankus A, Alrohaibani A, Goel N, Cuthbert B, Fargotstein M, Barr DB, Panuwet P, Brown VM, Duncan E. Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects. Front Psychiatry 2020;11:552743. [PMID: 33329089 DOI: 10.3389/fpsyt.2020.552743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 480 |
Gifford G, Mccutcheon R, Mcguire P. Neuroimaging studies in people at clinical high risk for psychosis. Risk Factors for Psychosis 2020. [DOI: 10.1016/b978-0-12-813201-2.00009-0] [Reference Citation Analysis]
|
| 481 |
Collins N. Low Prevalence Psychiatric Disorders in Rural and Remote Settings. Handbook of Rural, Remote, and very Remote Mental Health 2020. [DOI: 10.1007/978-981-10-5012-1_35-1] [Reference Citation Analysis]
|
| 482 |
Fry BR, Russell N, Gifford R, Robles CF, Manning CE, Sawa A, Niwa M, Johnson AW. Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli. Schizophr Bull 2020;46:54-67. [PMID: 31150554 DOI: 10.1093/schbul/sbz043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 483 |
Grimm O, Kopfer V, Küpper-Tetzel L, Deppert V, Kuhn M, de Greck M, Reif A. Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging. Hum Brain Mapp 2020;41:1806-18. [PMID: 31880365 DOI: 10.1002/hbm.24913] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 484 |
Zhou L, Bi Y, Liang M, Kong Y, Tu Y, Zhang X, Song Y, Du X, Tan S, Hu L. A modality-specific dysfunction of pain processing in schizophrenia. Hum Brain Mapp 2020;41:1738-53. [PMID: 31868305 DOI: 10.1002/hbm.24906] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 485 |
Lövdén M, Karalija N, Andersson M, Wåhlin A, Axelsson J, Köhncke Y, Jonasson LS, Rieckman A, Papenberg G, Garrett DD, Guitart-Masip M, Salami A, Riklund K, Bäckman L, Nyberg L, Lindenberger U. Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations. Cereb Cortex 2018;28:3894-907. [PMID: 29028935 DOI: 10.1093/cercor/bhx253] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 486 |
Zhu Y, Mészáros J, Walle R, Fan R, Sun Z, Dwork AJ, Trifilieff P, Javitch JA. Detecting G protein-coupled receptor complexes in postmortem human brain with proximity ligation assay and a Bayesian classifier. Biotechniques 2020;68:122-9. [PMID: 31859535 DOI: 10.2144/btn-2019-0083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 487 |
Barnby J, Bell V, Deeley Q, Mehta M. Dopamine manipulations modulate paranoid social inferences in healthy people.. [DOI: 10.1101/2019.12.18.874255] [Reference Citation Analysis]
|
| 488 |
Ben-Shachar D. The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia. J Neural Transm (Vienna). 2020;127:159-168. [PMID: 31848775 DOI: 10.1007/s00702-019-02120-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 489 |
Ortiz-Orendain J, Covarrubias-Castillo SA, Vazquez-Alvarez AO, Castiello-de Obeso S, Arias Quiñones GE, Seegers M, Colunga-Lozano LE. Modafinil for people with schizophrenia or related disorders. Cochrane Database Syst Rev 2019;12:CD008661. [PMID: 31828767 DOI: 10.1002/14651858.CD008661.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 490 |
Sekiguchi H, Pavey G, Dean B. Altered levels of dopamine transporter in the frontal pole and dorsal striatum in schizophrenia. NPJ Schizophr 2019;5:20. [PMID: 31792225 DOI: 10.1038/s41537-019-0087-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 491 |
Raffard S, Bortolon C, Yazbek H, Lançon C, Benoit M, Norton J, Capdevielle D. The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2019;269:911-20. [PMID: 29948250 DOI: 10.1007/s00406-018-0907-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 492 |
Albacete A, Makowski C, Mallar Chakravarty M, Joober R, Malla AK, Contreras F, Menchón JM, Lepage M. The effect of second-generation antipsychotics on basal ganglia and thalamus in first-episode psychosis patients. Eur Neuropsychopharmacol 2019;29:1408-18. [PMID: 31708330 DOI: 10.1016/j.euroneuro.2019.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 493 |
Swerdlow NR, Bhakta SG, Talledo J, Benster L, Kotz J, Lavadia M, Light GA. Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. Neuropsychopharmacology 2019;44:2277-84. [PMID: 31445502 DOI: 10.1038/s41386-019-0495-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 494 |
Kaufmann M, Lehmann P. Überfällige ärztliche Hilfen. NeuroTransmitter 2019;30:18-26. [DOI: 10.1007/s15016-019-6915-1] [Reference Citation Analysis]
|
| 495 |
Li XB, Wang LB, Xiong YB, Bo QJ, He F, Li F, Hou WP, Wen YJ, Wang XQ, Yang NB, Mao Z, Dong QH, Zhang FF, Yang R, Wang D, Xiang YT, Zhu YY, Tang YL, Yang Z, Wang CY. Altered resting-state functional connectivity of the insula in individuals with clinical high-risk and patients with first-episode schizophrenia. Psychiatry Res 2019;282:112608. [PMID: 31655405 DOI: 10.1016/j.psychres.2019.112608] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 496 |
Michielse S, Lange I, Bakker J, Goossens L, Verhagen S, Papalini S, Wichers M, Lieverse R, Schruers K, van Amelsvoort T, van Os J, Murray GK, Marcelis M. Reward anticipation in individuals with subclinical psychotic experiences: A functional MRI approach. Eur Neuropsychopharmacol 2019;29:1374-85. [PMID: 31685359 DOI: 10.1016/j.euroneuro.2019.10.002] [Reference Citation Analysis]
|
| 497 |
Ng B, Casazza W, Kim NH, Wang C, Farhadi F, Tasaki S, Bennett DA, De Jager PL, Gaiteri C, Mostafavi S. Cascading Epigenomic Analysis for Identifying Disease Genes from the Regulatory Landscape of GWAS Variants.. [DOI: 10.1101/859512] [Reference Citation Analysis]
|
| 498 |
Corsico P. Psychosis, vulnerability, and the moral significance of biomedical innovation in psychiatry. Why ethicists should join efforts. Med Health Care Philos 2020;23:269-79. [PMID: 31773383 DOI: 10.1007/s11019-019-09932-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 499 |
Østerbøg TB, On DM, Oliveras I, Río-álamos C, Sanchez-gonzalez A, Tapias-espinosa C, Tobeña A, González-maeso J, Fernández-teruel A, Aznar S. Metabotropic Glutamate Receptor 2 and Dopamine Receptor 2 Gene Expression Predict Sensorimotor Gating Response in the Genetically Heterogeneous NIH-HS Rat Strain. Mol Neurobiol 2020;57:1516-28. [DOI: 10.1007/s12035-019-01829-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 500 |
Khandaker GM. Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknowns. Int J Epidemiol 2019;48:1516-8. [PMID: 31563954 DOI: 10.1093/ije/dyz201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 501 |
Sarker G, Litwan K, Kastli R, Peleg-Raibstein D. Maternal overnutrition during critical developmental periods leads to different health adversities in the offspring: relevance of obesity, addiction and schizophrenia. Sci Rep 2019;9:17322. [PMID: 31754139 DOI: 10.1038/s41598-019-53652-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 502 |
Ruso-Julve F, Pombero A, Pilar-Cuéllar F, García-Díaz N, Garcia-Lopez R, Juncal-Ruiz M, Castro E, Díaz Á, Vazquez-Bourgón J, García-Blanco A, Garro-Martinez E, Pisonero H, Estirado A, Ayesa-Arriola R, López-Giménez J, Mayor F Jr, Valdizán E, Meana J, Gonzalez-Maeso J, Martínez S, Vaqué JP, Crespo-Facorro B. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics. Transl Psychiatry 2019;9:306. [PMID: 31740729 DOI: 10.1038/s41398-019-0647-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 503 |
Maes M, Vojdani A, Geffard M, Moreira EG, Barbosa DS, Michelin AP, Semeão LO, Sirivichayakul S, Kanchanatawan B. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways. Biomol Concepts 2019;10:209-25. [PMID: 31734647 DOI: 10.1515/bmc-2019-0023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 504 |
Bendala-Rodríguez P, Senín-Calderón C, Peluso-Crespi L, Rodríguez-Testal JF. Vulnerability to Psychosis, Ideas of Reference and Evaluation with an Implicit Test. J Clin Med 2019;8:E1956. [PMID: 31766179 DOI: 10.3390/jcm8111956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 505 |
Koo B, Bae HJ, Goo N, Kim J, Kim J, Cai M, Jung IH, Cho K, Jung SY, Chang SW, Jang DS, Ryu JH. A botanical drug composed of three herbal materials attenuates the sensorimotor gating deficit and cognitive impairment induced by MK-801 in mice. Journal of Pharmacy and Pharmacology 2020;72:149-60. [DOI: 10.1111/jphp.13199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 506 |
Dahoun T, Nour MM, McCutcheon RA, Adams RA, Bloomfield MAP, Howes OD. The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [(11)C]-(+)-PHNO PET study. Transl Psychiatry 2019;9:287. [PMID: 31712556 DOI: 10.1038/s41398-019-0627-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 507 |
Aponte EA, Schöbi D, Stephan KE, Heinzle J. Computational Dissociation of Dopaminergic and Cholinergic Effects on Action Selection and Inhibitory Control. Biol Psychiatry Cogn Neurosci Neuroimaging 2020;5:364-72. [PMID: 31952937 DOI: 10.1016/j.bpsc.2019.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 508 |
Moran SP, Maksymetz J, Conn PJ. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders. Trends Pharmacol Sci 2019;40:1006-20. [PMID: 31711626 DOI: 10.1016/j.tips.2019.10.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 509 |
Niyonambaza SD, Kumar P, Xing P, Mathault J, De Koninck P, Boisselier E, Boukadoum M, Miled A. A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research. Applied Sciences 2019;9:4719. [DOI: 10.3390/app9214719] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 510 |
Rakovska A, Javitt D, Petkova-kirova P, Balla A, Ang R, Kalfin R. Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats. Brain Research Bulletin 2019;153:39-46. [DOI: 10.1016/j.brainresbull.2019.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 511 |
Ryan AE, Mowry BJ, Kesby JP, Scott JG, Greer JM. Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia? Aust N Z J Psychiatry 2019;53:1059-69. [PMID: 31347380 DOI: 10.1177/0004867419864438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 512 |
Miyata J. Toward integrated understanding of salience in psychosis. Neurobiology of Disease 2019;131:104414. [DOI: 10.1016/j.nbd.2019.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 513 |
Palaniyappan L. Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis. J Psychiatry Neurosci 2019;44:367-83. [PMID: 31245961 DOI: 10.1503/jpn.180038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 514 |
Kowalczyk M, Kucia K, Owczarek A, Suchanek-Raif R, Merk W, Fila-Danilow A, Paul-Samojedny M, Choreza P, Kowalski J. Association of HSPA1B Polymorphisms with Paranoid Schizophrenia in a Polish Population. Neuromolecular Med 2020;22:159-69. [PMID: 31642026 DOI: 10.1007/s12017-019-08575-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 515 |
Vostrikov VM. [Neuromorphological aspect of the GABAergic hypothesis of the pathogenesis of schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:124-9. [PMID: 31626180 DOI: 10.17116/jnevro2019119081124] [Reference Citation Analysis]
|
| 516 |
Nakazawa K, Sapkota K. The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther 2020;205:107426. [PMID: 31629007 DOI: 10.1016/j.pharmthera.2019.107426] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 517 |
Cole DM, Diaconescu AO, Pfeiffer UJ, Brodersen KH, Mathys CD, Julkowski D, Ruhrmann S, Schilbach L, Tittgemeyer M, Vogeley K, Stephan KE. Atypical processing of uncertainty in individuals at risk for psychosis.. [DOI: 10.1101/796300] [Reference Citation Analysis]
|
| 518 |
Taylor SF, Grove TB, Ellingrod VL, Tso IF. The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis. Schizophr Bull 2019;45:1170-83. [PMID: 31150555 DOI: 10.1093/schbul/sbz046] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 519 |
Tong J, Huang J, Luo X, Chen S, Cui Y, An H, Xiu M, Tan S, Wang Z, Yuan Y, Zhang J, Yang F, Li CR, Hong LE, Tan Y. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia. Brain Behav Immun 2019;81:213-9. [PMID: 31201848 DOI: 10.1016/j.bbi.2019.06.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 520 |
Varun CN, Venkataswamy MM, Ravikumar R, Nagaraju R, Debnath M, Varambally S, Venkatasubramanian G, Ravi V. Th17 and MAIT cell mediated inflammation in antipsychotic free schizophrenia patients. Schizophr Res 2019;212:47-53. [PMID: 31439420 DOI: 10.1016/j.schres.2019.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 521 |
Morgan C, Knowles G, Hutchinson G. Migration, ethnicity and psychoses: evidence, models and future directions. World Psychiatry 2019;18:247-58. [PMID: 31496097 DOI: 10.1002/wps.20655] [Cited by in Crossref: 47] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 522 |
Owens SJ, Purves-Tyson TD, Webster MJ, Shannon Weickert C. Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder. Psychiatry Res 2019;280:112503. [PMID: 31446215 DOI: 10.1016/j.psychres.2019.112503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 523 |
Karcher NR, Hua JPY, Kerns JG. Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk. Neuropsychopharmacology 2019;44:1967-74. [PMID: 31272104 DOI: 10.1038/s41386-019-0455-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 524 |
Zong X, Hu M, Pantazatos SP, Mann JJ, Wang G, Liao Y, Liu ZC, Liao W, Yao T, Li Z, He Y, Lv L, Sang D, Tang J, Chen H, Zheng J, Chen X. A Dissociation in Effects of Risperidone Monotherapy on Functional and Anatomical Connectivity Within the Default Mode Network. Schizophr Bull 2019;45:1309-18. [PMID: 30508134 DOI: 10.1093/schbul/sby175] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 525 |
Adorjan K, Mekonnen Z, Tessema F, Ayana M, Degenhardt F, Hoffmann P, Fricker N, Widmann M, Riedke H, Toennes SW, Soboka M, Suleman S, Andlauer TFM, Tesfaye M, Rietschel M, Susser E, Odenwald M, Schulze TG, Mattheisen M. Genotype-phenotype feasibility studies on khat abuse, traumatic experiences and psychosis in Ethiopia. Psychiatr Genet 2020;30:34-8. [PMID: 31568069 DOI: 10.1097/YPG.0000000000000242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 526 |
D'Ambrosio E, Dahoun T, Pardiñas AF, Veronese M, Bloomfield MAP, Jauhar S, Bonoldi I, Rogdaki M, Froudist-Walsh S, Walters JTR, Howes OD. The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study. Psychiatry Res Neuroimaging 2019;291:34-41. [PMID: 31386983 DOI: 10.1016/j.pscychresns.2019.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 527 |
Mätlik K, Olfat S, Garton DR, Montaño-rodriguez A, Turconi G, Porokuokka LL, Panhelainen A, Schweizer N, Kopra J, Cowlishaw MC, Piepponen TP, Zhang F, Sipilä P, Jakobsson J, Andressoo J. Gene Knock Up via 3’UTR editing to study gene functionin vivo.. [DOI: 10.1101/775031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 528 |
Alizadeh F, Davoodian N, Kazemi H, Ghasemi-Kasman M, Shaerzadeh F. Prenatal zinc supplementation attenuates lipopolysaccharide-induced behavioral impairments in maternal immune activation model. Behav Brain Res 2020;377:112247. [PMID: 31545978 DOI: 10.1016/j.bbr.2019.112247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 529 |
Shen WW. Anticraving therapy for alcohol use disorder: A clinical review. Neuropsychopharmacol Rep 2018;38:105-16. [PMID: 30175522 DOI: 10.1002/npr2.12028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 530 |
Genetik. Nicht 1 % Schizophrene 2019. [DOI: 10.14220/9783737010269.13] [Reference Citation Analysis]
|
| 531 |
Deegan AM, Steinhauer RB, Feinn RS, Moeller MC, Pylypiw HM Jr, Nabel M, Kovelowski CJ, Kaplan LAE. Modulation of brain serotonin by benzyl butyl phthalate in Fundulus heteroclitus (mummichog). Ecotoxicology 2019;28:1038-45. [PMID: 31489593 DOI: 10.1007/s10646-019-02101-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 532 |
Gao X, Grendel J, Muhia M, Castro-Gomez S, Süsens U, Isbrandt D, Kneussel M, Kuhl D, Ohana O. Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in Arc/Arg3.1 Deficient Mice. J Neurosci 2019;39:8149-63. [PMID: 31488612 DOI: 10.1523/JNEUROSCI.0623-19.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 533 |
Chan NK, Kim J, Shah P, Brown EE, Plitman E, Carravaggio F, Iwata Y, Gerretsen P, Graff-Guerrero A. Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review. Schizophr Res 2019;211:10-20. [PMID: 31331784 DOI: 10.1016/j.schres.2019.07.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 534 |
Schmidt SNL, Fenske SC, Kirsch P, Mier D. Nucleus accumbens activation is linked to salience in social decision making. Eur Arch Psychiatry Clin Neurosci 2019;269:701-12. [PMID: 30361926 DOI: 10.1007/s00406-018-0947-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 535 |
Domenici MR, Ferrante A, Martire A, Chiodi V, Pepponi R, Tebano MT, Popoli P. Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders. Pharmacological Research 2019;147:104338. [DOI: 10.1016/j.phrs.2019.104338] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 536 |
Berkhout SG, Zaheer J, Remington G. Identity, Subjectivity, and Disorders of Self in Psychosis. Cult Med Psychiatry 2019;43:442-67. [PMID: 30980233 DOI: 10.1007/s11013-019-09631-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 537 |
Churchward MA, Michaud ER, Todd KG. Supporting microglial niches for therapeutic benefit in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2019;94:109648. [PMID: 31078613 DOI: 10.1016/j.pnpbp.2019.109648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 538 |
Aquino-Miranda G, Rivera-Ramírez N, Márquez-Gómez R, Escamilla-Sánchez J, González-Pantoja R, Ramos-Languren LE, Perez-Neri I, Bueno-Nava A, Ríos C, Arias-Montaño JA. Histamine H(3) receptor activation reduces the impairment in prepulse inhibition (PPI) of the acoustic startle response and Akt phosphorylation induced by MK-801 (dizocilpine), antagonist at N-Methyl-d-Aspartate (NMDA) receptors. Prog Neuropsychopharmacol Biol Psychiatry 2019;94:109653. [PMID: 31108178 DOI: 10.1016/j.pnpbp.2019.109653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 539 |
Tullo S, Patel R, Devenyi GA, Salaciak A, Bedford SA, Farzin S, Wlodarski N, Tardif CL, Breitner JCS, Chakravarty MM; PREVENT-AD Research Group. MR-based age-related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan. Hum Brain Mapp 2019;40:5269-88. [PMID: 31452289 DOI: 10.1002/hbm.24771] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 540 |
Xu FL, Ding M, Wu X, Liu YP, Xia X, Yao J, Wang BJ. A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia. J Mol Neurosci 2020;70:155-66. [PMID: 31440993 DOI: 10.1007/s12031-019-01399-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 541 |
Anglin DM, Espinosa A, Barada B, Tarazi R, Feng A, Tayler R, Allicock NM, Pandit S. Comparing the Role of Aberrant Salience and Dissociation in the Relation between Cumulative Traumatic Life Events and Psychotic-Like Experiences in a Multi-Ethnic Sample. J Clin Med 2019;8:E1223. [PMID: 31443188 DOI: 10.3390/jcm8081223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 542 |
Garip B, Kayir H. Alteration in NMDAR-related amino acids in first episode psychosis. Synapse 2019;73:e22127. [PMID: 31403728 DOI: 10.1002/syn.22127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 543 |
Mallet J, Gorwood P, Le Strat Y, Dubertret C. Major Depressive Disorder (MDD) and Schizophrenia- Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review. Int J Neuropsychopharmacol 2019;22:651-64. [PMID: 31406978 DOI: 10.1093/ijnp/pyz043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 544 |
Krajcovic B, Fajnerova I, Horacek J, Kelemen E, Kubik S, Svoboda J, Stuchlik A. Neural and neuronal discoordination in schizophrenia: From ensembles through networks to symptoms. Acta Physiol (Oxf) 2019;226:e13282. [PMID: 31002202 DOI: 10.1111/apha.13282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 545 |
Plitman E, Guma E, Lepage M, Near J, Chakravarty MM. Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review. Schizophr Res 2019;210:13-20. [PMID: 31272905 DOI: 10.1016/j.schres.2019.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 546 |
Maurus I, Hasan A, Röh A, Takahashi S, Rauchmann B, Keeser D, Malchow B, Schmitt A, Falkai P. Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2019;269:499-515. [PMID: 31115660 DOI: 10.1007/s00406-019-01025-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 547 |
Liu C, Cao B, Yu R, Sim K. Basal ganglia volumetric changes in psychotic spectrum disorders. J Affect Disord 2019;255:150-7. [PMID: 31153051 DOI: 10.1016/j.jad.2019.05.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 548 |
Hayakawa E, Ohgidani M, Fujimura Y, Kanba S, Miura D, Kato TA. Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus. Schizophr Res 2019;210:326-8. [PMID: 31296416 DOI: 10.1016/j.schres.2019.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 549 |
Carta I, Chen CH, Schott AL, Dorizan S, Khodakhah K. Cerebellar modulation of the reward circuitry and social behavior. Science 2019;363:eaav0581. [PMID: 30655412 DOI: 10.1126/science.aav0581] [Cited by in Crossref: 259] [Cited by in F6Publishing: 264] [Article Influence: 64.8] [Reference Citation Analysis]
|
| 550 |
Teal LB, Gould RW, Felts AS, Jones CK. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders. Adv Pharmacol 2019;86:153-96. [PMID: 31378251 DOI: 10.1016/bs.apha.2019.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 551 |
Shah UH, González-Maeso J. Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models. ACS Chem Neurosci 2019;10:3068-77. [PMID: 30807107 DOI: 10.1021/acschemneuro.9b00044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 552 |
Jerzemowska G, Plucińska K, Piwka A, Ptaszek K, Podlacha M, Orzeł-Gryglewska J. NMDA receptor modulation of the pedunculopontine tegmental nucleus underlies the motivational drive for feeding induced by midbrain dopaminergic neurons. Brain Res 2019;1715:134-47. [PMID: 30914249 DOI: 10.1016/j.brainres.2019.03.028] [Reference Citation Analysis]
|
| 553 |
Ney LJ, Matthews A, Bruno R, Felmingham KL. Cannabinoid interventions for PTSD: Where to next? Prog Neuropsychopharmacol Biol Psychiatry 2019;93:124-40. [PMID: 30946942 DOI: 10.1016/j.pnpbp.2019.03.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 554 |
Li H, Guo W, Liu F, Chen J, Su Q, Zhang Z, Fan X, Zhao J. Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples. EBioMedicine 2019;46:248-55. [PMID: 31307956 DOI: 10.1016/j.ebiom.2019.07.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 555 |
Imburgio MJ, Ballard HK, Cornwall AC, Worthy DA, Bernard JA, Orr JM. Effects of prefrontal tDCS on dopamine-mediated behavior and psychophysiology.. [DOI: 10.1101/697466] [Reference Citation Analysis]
|
| 556 |
Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704. [PMID: 31299229 DOI: 10.1016/j.neuropharm.2019.107704] [Cited by in Crossref: 95] [Cited by in F6Publishing: 105] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 557 |
Bradshaw NJ, Korth C. Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness. Mol Psychiatry 2019;24:936-51. [PMID: 30089789 DOI: 10.1038/s41380-018-0133-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 558 |
Komatsu H, Fukuchi M, Habata Y. Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders. Int J Mol Sci 2019;20:E3207. [PMID: 31261897 DOI: 10.3390/ijms20133207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 559 |
Reininghaus U, Oorschot M, Moritz S, Gayer-Anderson C, Kempton MJ, Valmaggia L, McGuire P, Murray R, Garety P, Wykes T, Morgan C, Myin-Germeys I. Liberal Acceptance Bias, Momentary Aberrant Salience, and Psychosis: An Experimental Experience Sampling Study. Schizophr Bull 2019;45:871-82. [PMID: 30189093 DOI: 10.1093/schbul/sby116] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 560 |
Franklin RJM, Bullmore ET. Do Not Adjust Your Mind: The Fault Is in Your Glia. Cell Stem Cell 2017;21:155-6. [PMID: 28777939 DOI: 10.1016/j.stem.2017.07.005] [Reference Citation Analysis]
|
| 561 |
Karcher NR, Rogers BP, Woodward ND. Functional Connectivity of the Striatum in Schizophrenia and Psychotic Bipolar Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2019;4:956-65. [PMID: 31399394 DOI: 10.1016/j.bpsc.2019.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 562 |
Xu P, Klaasen NG, Opmeer EM, Pijnenborg GHM, van Tol MJ, Liemburg EJ, Aleman A. Intrinsic mesocorticolimbic connectivity is negatively associated with social amotivation in people with schizophrenia. Schizophr Res 2019;208:353-9. [PMID: 30711314 DOI: 10.1016/j.schres.2019.01.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 563 |
Bhavsar V, Boydell J, McGuire P, Harris V, Hotopf M, Hatch SL, MacCabe JH, Morgan C. Childhood abuse and psychotic experiences - evidence for mediation by adulthood adverse life events. Epidemiol Psychiatr Sci 2019;28:300-9. [PMID: 28988558 DOI: 10.1017/S2045796017000518] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 564 |
Meller T, Schmitt S, Stein F, Brosch K, Mosebach J, Yüksel D, Zaremba D, Grotegerd D, Dohm K, Meinert S, Förster K, Redlich R, Opel N, Repple J, Hahn T, Jansen A, Andlauer TFM, Forstner AJ, Heilmann-Heimbach S, Streit F, Witt SH, Rietschel M, Müller-Myhsok B, Nöthen MM, Dannlowski U, Krug A, Kircher T, Nenadić I. Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects. Schizophr Res 2019;208:67-75. [PMID: 31076262 DOI: 10.1016/j.schres.2019.04.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 565 |
Allebone J, Kanaan R, Maller J, O'Brien T, Mullen SA, Cook M, Adams SJ, Vogrin S, Vaughan DN, Connelly A, Kwan P, Berkovic SF, D'Souza WJ, Jackson G, Velakoulis D, Wilson SJ. Bilateral volume reduction in posterior hippocampus in psychosis of epilepsy. J Neurol Neurosurg Psychiatry 2019;90:688-94. [PMID: 30796132 DOI: 10.1136/jnnp-2018-319396] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 566 |
Aponte EA, Schöbi D, Stephan KE, Heinzle J. Computational dissociation of dopaminergic and cholinergic effects on action selection and inhibitory control.. [DOI: 10.1101/645093] [Reference Citation Analysis]
|
| 567 |
Kozlovskiy VI, Kosterin DN, Popov MY. The role of agonistic/antagonistic activity in the development of psychotropic effects of antipsychotics. V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 2019. [DOI: 10.31363/2313-7053-2019-1-3-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 568 |
Roberts M. Psychiatric drugs: reconsidering their mode of action and the implications for service user involvement. MHRJ 2019;24:1-10. [DOI: 10.1108/mhrj-08-2018-0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 569 |
Behan JA, Grajkowski F, Jayasundara DR, Vilella-arribas L, García-melchor M, Colavita PE. Influence of carbon nanostructure and oxygen moieties on dopamine adsorption and charge transfer kinetics at glassy carbon surfaces. Electrochimica Acta 2019;304:221-30. [DOI: 10.1016/j.electacta.2019.02.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 570 |
Voss P, Thomas ME, Guercio GD, de Villers-Sidani E. Dysregulation of auditory neuroplasticity in schizophrenia. Schizophr Res 2019;207:3-11. [PMID: 29703662 DOI: 10.1016/j.schres.2018.04.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 571 |
Weissleder C, North HF, Shannon Weickert C. Important unanswered questions about adult neurogenesis in schizophrenia. Curr Opin Psychiatry 2019;32:170-8. [PMID: 30762701 DOI: 10.1097/YCO.0000000000000501] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 572 |
Ye J, Ji F, Jiang D, Lin X, Chen G, Zhang W, Shan P, Zhang L, Zhuo C. Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment. Front Neurosci 2019;13:355. [PMID: 31057354 DOI: 10.3389/fnins.2019.00355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 573 |
Bauman MD, Lesh TA, Rowland DJ, Schumann CM, Smucny J, Kukis DL, Cherry SR, McAllister AK, Carter CS. Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation. Transl Psychiatry 2019;9:135. [PMID: 30979867 DOI: 10.1038/s41398-019-0449-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 574 |
Stenkrona P, Matheson GJ, Halldin C, Cervenka S, Farde L. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients. Int J Neuropsychopharmacol 2019;22:415-25. [PMID: 30958880 DOI: 10.1093/ijnp/pyz017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 575 |
Sun F, Zeng J, Jing M, Zhou J, Feng J, Owen SF, Luo Y, Li F, Wang H, Yamaguchi T, Yong Z, Gao Y, Peng W, Wang L, Zhang S, Du J, Lin D, Xu M, Kreitzer AC, Cui G, Li Y. A Genetically Encoded Fluorescent Sensor Enables Rapid and Specific Detection of Dopamine in Flies, Fish, and Mice. Cell 2018;174:481-496.e19. [PMID: 30007419 DOI: 10.1016/j.cell.2018.06.042] [Cited by in Crossref: 396] [Cited by in F6Publishing: 280] [Article Influence: 99.0] [Reference Citation Analysis]
|
| 576 |
Hayes JF, Picot S, Osborn DPJ, Lewis G, Dalman C, Lundin A. Visual Acuity in Late Adolescence and Future Psychosis Risk in a Cohort of 1 Million Men. Schizophr Bull 2019;45:571-8. [PMID: 29901774 DOI: 10.1093/schbul/sby084] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 577 |
Rössler J, Unterassner L, Wyss T, Haker H, Brugger P, Rössler W, Wotruba D. Schizotypal Traits are Linked to Dopamine-Induced Striato-Cortical Decoupling: A Randomized Double-Blind Placebo-Controlled Study. Schizophr Bull 2019;45:680-8. [PMID: 29878280 DOI: 10.1093/schbul/sby079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 578 |
Fiorillo A. The complexity of vulnerability to psychosis. Epidemiol Psychiatr Sci 2019;28:138-9. [PMID: 30486916 DOI: 10.1017/S2045796018000690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 579 |
Brandl F, Avram M, Weise B, Shang J, Simões B, Bertram T, Hoffmann Ayala D, Penzel N, Gürsel DA, Bäuml J, Wohlschläger AM, Vukadinovic Z, Koutsouleris N, Leucht S, Sorg C. Specific Substantial Dysconnectivity in Schizophrenia: A Transdiagnostic Multimodal Meta-analysis of Resting-State Functional and Structural Magnetic Resonance Imaging Studies. Biol Psychiatry 2019;85:573-83. [PMID: 30691673 DOI: 10.1016/j.biopsych.2018.12.003] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 580 |
Yan C, Lui SSY, Zou LQ, Wang CY, Zhou FC, Cheung EFC, Shum DHK, Chan RCK. Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits. Schizophr Res 2019;206:118-26. [PMID: 30545761 DOI: 10.1016/j.schres.2018.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 581 |
Garip B, Kayir H, Uzun O. l-Arginine metabolism before and after 10 weeks of antipsychotic treatment in first-episode psychotic patients. Schizophr Res 2019;206:58-66. [PMID: 30587428 DOI: 10.1016/j.schres.2018.12.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 582 |
Postolache TT, Del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. Am J Med Genet B Neuropsychiatr Genet 2019;180:186-203. [PMID: 30729689 DOI: 10.1002/ajmg.b.32712] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 583 |
Huang P, Zheng-Dao D, Sun BM, Pan YX, Zhang J, Wang T, Liu W, Jin HY, Zhan SK. Bilateral anterior capsulotomy enhances medication compliance in patients with epilepsy and psychiatric comorbidities. CNS Neurosci Ther 2019;25:824-31. [PMID: 30868752 DOI: 10.1111/cns.13118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 584 |
Zou M, Li D, Li L, Wu L, Sun C. Role of the endocannabinoid system in neurological disorders. Int J Dev Neurosci 2019;76:95-102. [PMID: 30858029 DOI: 10.1016/j.ijdevneu.2019.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 585 |
Ben-Azu B, Aderibigbe AO, Ajayi AM, Eneni AO, Omogbiya IA, Owoeye O, Umukoro S, Iwalewa EO. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia. Int Immunopharmacol 2019;70:338-53. [PMID: 30852289 DOI: 10.1016/j.intimp.2019.02.052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 586 |
Cao B, Jin M, Brietzke E, McIntyre RS, Wang D, Rosenblat JD, Ragguett RM, Zhang C, Sun X, Rong C, Wang J. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design. Psychiatry Clin Neurosci 2019;73:100-8. [PMID: 30156046 DOI: 10.1111/pcn.12779] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 587 |
Schneider K, Michels L, Hartmann-Riemer MN, Burrer A, Tobler PN, Stämpfli P, Kirschner M, Seifritz E, Kaiser S. Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia. J Psychiatry Neurosci 2019;44:102-10. [PMID: 30246686 DOI: 10.1503/jpn.170150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 588 |
Trakadis YJ, Sardaar S, Chen A, Fulginiti V, Krishnan A. Machine learning in schizophrenia genomics, a case-control study using 5,090 exomes. Am J Med Genet B Neuropsychiatr Genet 2019;180:103-12. [PMID: 29704323 DOI: 10.1002/ajmg.b.32638] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 589 |
Osimo EF, Goujon MJ, Perez J, Murray GK. Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia? BMJ Case Rep 2019;12:e228573. [DOI: 10.1136/bcr-2018-228573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 590 |
Haarsma J, Fletcher P, Griffin J, Taverne H, Ziauddeen H, Spencer T, Goodyer I, Diederen K, Murray G. Precision-weighting of superior frontal cortex unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.. [DOI: 10.1101/558478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 591 |
Veronese M, Moro L, Arcolin M, Dipasquale O, Rizzo G, Expert P, Khan W, Fisher PM, Svarer C, Bertoldo A, Howes O, Turkheimer FE. Covariance statistics and network analysis of brain PET imaging studies. Sci Rep 2019;9:2496. [PMID: 30792460 DOI: 10.1038/s41598-019-39005-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 592 |
Wu C, Ding Y, Chen B, Gao Y, Wang Q, Wu Z, Lu L, Luo L, Zhang C, Bao X, Yang P, Fan L, Lei M, Li L. Both Val158Met Polymorphism of Catechol-O-Methyltransferase Gene and Menstrual Cycle Affect Prepulse Inhibition but Not Attentional Modulation of Prepulse Inhibition in Younger-Adult Females. Neuroscience 2019;404:396-406. [PMID: 30742958 DOI: 10.1016/j.neuroscience.2019.02.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 593 |
Bandura J, Feng ZP. Current Understanding of the Role of Neuronal Calcium Sensor 1 in Neurological Disorders. Mol Neurobiol 2019;56:6080-94. [PMID: 30719643 DOI: 10.1007/s12035-019-1497-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 594 |
Gilmour G, Porcelli S, Bertaina-anglade V, Arce E, Dukart J, Hayen A, Lobo A, Lopez-anton R, Merlo Pich E, Pemberton DJ, Havenith MN, Glennon JC, Harel BT, Dawson G, Marston H, Kozak R, Serretti A. Relating constructs of attention and working memory to social withdrawal in Alzheimer’s disease and schizophrenia: issues regarding paradigm selection. Neuroscience & Biobehavioral Reviews 2019;97:47-69. [DOI: 10.1016/j.neubiorev.2018.09.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 595 |
Raballo A, Cicero DC, Kerns JG, Sanna S, Pintus M, Agartz I, Pintus E, Corrias I, Lai V, Petretto DR, Carta MG, Preti A. Tracking salience in young people: A psychometric field test of the Aberrant Salience Inventory (ASI). Early Interv Psychiatry 2019;13:64-72. [PMID: 28719056 DOI: 10.1111/eip.12449] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 596 |
Kent JS, Caligiuri MP, Skorheim MK, Lano TJ, Mittal VA, Sponheim SR. Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder. Psychiatry Res 2019;272:135-40. [PMID: 30580137 DOI: 10.1016/j.psychres.2018.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 597 |
Niarchou M, Chawner SJRA, Fiksinski A, Vorstman JAS, Maeder J, Schneider M, Eliez S, Armando M, Pontillo M, Vicari S, McDonald-McGinn DM, Emanuel BS, Zackai EH, Bearden CE, Shashi V, Hooper SR, Owen MJ, Gur RE, Wray NR, van den Bree MBM, Thapar A; International 22q11.2 Deletion Syndrome Brain and Behavior Consortium. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. Schizophr Res 2019;204:320-5. [PMID: 30093352 DOI: 10.1016/j.schres.2018.07.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 598 |
Zhang XC, Ding M, Adnan A, Liu Y, Liu YP, Xing JX, Xuan JF, Xia X, Yao J, Wang BJ. No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study. Brain Behav 2019;9:e01193. [PMID: 30657260 DOI: 10.1002/brb3.1193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 599 |
Karalija N, Papenberg G, Wåhlin A, Johansson J, Andersson M, Axelsson J, Riklund K, Lövdén M, Lindenberger U, Bäckman L, Nyberg L. C957T -mediated Variation in Ligand Affinity Affects the Association between 11 C-raclopride Binding Potential and Cognition. Journal of Cognitive Neuroscience 2019;31:314-25. [DOI: 10.1162/jocn_a_01354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 600 |
Pehlivan S, Aydin PC, Uysal MA, Ciftci HS, Sever U, Yavuz FK, Aydin N, Nursal AF. Effect of monoamine oxidase B A644G variant on nicotine dependence and/or schizophrenia risk. Arch Clin Psychiatry (São Paulo) 2019;46:21-4. [DOI: 10.1590/0101-60830000000186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 601 |
Ott T, Nieder A. Dopamine and Cognitive Control in Prefrontal Cortex. Trends Cogn Sci 2019;23:213-34. [PMID: 30711326 DOI: 10.1016/j.tics.2018.12.006] [Cited by in Crossref: 170] [Cited by in F6Publishing: 183] [Article Influence: 42.5] [Reference Citation Analysis]
|
| 602 |
Tavitian A, Song W, Schipper HM. Dentate Gyrus Immaturity in Schizophrenia. Neuroscientist 2019;25:528-47. [DOI: 10.1177/1073858418824072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 603 |
Kim P, Scott MR, Meador-Woodruff JH. Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia. Transl Psychiatry 2019;9:6. [PMID: 30664618 DOI: 10.1038/s41398-018-0359-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 604 |
Graham K, Zhang J, Qiao H, Wu Y, Zhou Y. Region-specific inhibition of 14-3-3 proteins induces psychomotor behaviors in mice. NPJ Schizophr 2019;5:1. [PMID: 30643138 DOI: 10.1038/s41537-018-0069-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 605 |
Shin SW, Lee JS, Abdi S, Lee SJ, Kim KH. Antipsychotics for patients with pain. Korean J Pain 2019;32:3-11. [PMID: 30671198 DOI: 10.3344/kjp.2019.32.1.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 606 |
Paul J. Experimental Medicine Approaches in CNS Drug Development. Translational Medicine in CNS Drug Development 2019. [DOI: 10.1016/b978-0-12-803161-2.00005-9] [Reference Citation Analysis]
|
| 607 |
Monville F. Délire, Self et Neuroleptique. Approche phénoménologique de l’effet des neuroleptiques. L'Évolution Psychiatrique 2019;84:33-47. [DOI: 10.1016/j.evopsy.2018.05.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 608 |
Guerin AA, Bonomo Y, Lawrence AJ, Baune BT, Nestler EJ, Rossell SL, Kim JH. Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research. Front Psychiatry 2019;10:880. [PMID: 31920743 DOI: 10.3389/fpsyt.2019.00880] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 609 |
Wu R, Ou Y, Liu F, Chen J, Li H, Zhao J, Guo W, Fan X. Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia. Front Psychiatry 2019;10:741. [PMID: 31649567 DOI: 10.3389/fpsyt.2019.00741] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 610 |
Croft J, Heron J, Teufel C, Cannon M, Wolke D, Thompson A, Houtepen L, Zammit S. Association of Trauma Type, Age of Exposure, and Frequency in Childhood and Adolescence With Psychotic Experiences in Early Adulthood. JAMA Psychiatry 2019;76:79-86. [PMID: 30477014 DOI: 10.1001/jamapsychiatry.2018.3155] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 29.3] [Reference Citation Analysis]
|
| 611 |
Gogos A, Skokou M, Ferentinou E, Gourzis P. Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature. Neuropsychiatr Dis Treat 2019;15:2943-58. [PMID: 31802874 DOI: 10.2147/NDT.S210199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 612 |
Mäki-Marttunen T, Kaufmann T, Elvsåshagen T, Devor A, Djurovic S, Westlye LT, Linne ML, Rietschel M, Schubert D, Borgwardt S, Efrim-Budisteanu M, Bettella F, Halnes G, Hagen E, Næss S, Ness TV, Moberget T, Metzner C, Edwards AG, Fyhn M, Dale AM, Einevoll GT, Andreassen OA. Biophysical Psychiatry-How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders. Front Psychiatry 2019;10:534. [PMID: 31440172 DOI: 10.3389/fpsyt.2019.00534] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 613 |
Gray A, Tattoli R, Dunn A, Hodgson D, Michie P, Harms L. Maternal immune activation in mid-late gestation alters amphetamine sensitivity and object recognition, but not other schizophrenia-related behaviours in adult rats. Behavioural Brain Research 2019;356:358-64. [DOI: 10.1016/j.bbr.2018.08.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 614 |
Jinks T. The How and Why of Psychedelics. Psychological Perspectives on Reality, Consciousness and Paranormal Experience 2019. [DOI: 10.1007/978-3-030-28902-7_18] [Reference Citation Analysis]
|
| 615 |
Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review. J Psychiatr Res 2019;108:57-83. [PMID: 30055853 DOI: 10.1016/j.jpsychires.2018.07.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 616 |
Polner B, Pengue A, Kéri S, Moustafa AA. Cognitive and social cognitive deficits in paranoia. Social Cognition in Psychosis 2019. [DOI: 10.1016/b978-0-12-815315-4.00002-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 617 |
Diaconescu AO, Hauke DJ, Borgwardt S. Models of persecutory delusions: a mechanistic insight into the early stages of psychosis. Mol Psychiatry 2019;24:1258-67. [PMID: 31076646 DOI: 10.1038/s41380-019-0427-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 618 |
Fountoulakis KN, Nimatoudis I, Stahl SM. Biological Psychiatry and Psychopharmacology. Psychobiology of Behaviour 2019. [DOI: 10.1007/978-3-030-18323-3_13] [Reference Citation Analysis]
|
| 619 |
Fu S, Czajkowski N, Torgalsbøen AK. Cognitive, Work and Social Outcomes in Fully Recovered First-Episode Schizophrenia: On and Off Antipsychotic Medication. Psychiatry 2019;82:42-56. [PMID: 30608217 DOI: 10.1080/00332747.2018.1550735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 620 |
Orsolini L, Chiappini S, Papanti D, De Berardis D, Corkery JM, Schifano F. The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Front Psychiatry 2019;10:851. [PMID: 31849723 DOI: 10.3389/fpsyt.2019.00851] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 621 |
Klaus K, Pennington K. Dopamine and Working Memory: Genetic Variation, Stress and Implications for Mental Health. Processes of Visuospatial Attention and Working Memory 2019. [DOI: 10.1007/7854_2019_113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 622 |
Gaebel W, Hasan A, Falkai P. Pharmakotherapie und andere somatische Behandlungsverfahren (Modul 4a). S3-Leitlinie Schizophrenie 2019. [DOI: 10.1007/978-3-662-59380-6_5] [Reference Citation Analysis]
|
| 623 |
Monville F. Delusion, self, and antipsychotics. A phenomenological approach to antipsychotics’ effect. L'Évolution Psychiatrique 2019;84:e1-e15. [DOI: 10.1016/j.evopsy.2018.11.002] [Reference Citation Analysis]
|
| 624 |
Pollak TA, Rogers JP, Nagele RG, Peakman M, Stone JM, David AS, McGuire P. Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. Schizophr Bull 2019;45:233-46. [PMID: 29474698 DOI: 10.1093/schbul/sby021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 625 |
Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Natesan S, Turkheimer F, Stone J, Egerton A, McGuire P, Kapur S, Howes OD. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study. Biol Psychiatry 2019;85:79-87. [PMID: 30122287 DOI: 10.1016/j.biopsych.2018.07.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 626 |
Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Ng CH, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo JP, Walder K, Sarris J, Berk M. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Front Psychiatry 2019;10:115. [PMID: 30918489 DOI: 10.3389/fpsyt.2019.00115] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 627 |
Grace AA, Gomes FV. The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention. Schizophr Bull 2019;45:148-57. [PMID: 29385549 DOI: 10.1093/schbul/sbx199] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 628 |
Chalkiadaki K, Velli A, Kyriazidis E, Stavroulaki V, Vouvoutsis V, Chatzaki E, Aivaliotis M, Sidiropoulou K. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function. Neuropharmacology 2019;144:193-207. [DOI: 10.1016/j.neuropharm.2018.10.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 629 |
Nakao K, Jeevakumar V, Jiang SZ, Fujita Y, Diaz NB, Pretell Annan CA, Eskow Jaunarajs KL, Hashimoto K, Belforte JE, Nakazawa K. Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction. Schizophr Bull 2019;45:138-47. [PMID: 29394409 DOI: 10.1093/schbul/sby003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 630 |
Barch DM, Pagliaccio D, Luking K, Moran EK, Culbreth AJ. Pathways to Motivational Impairments in Psychopathology: Common Versus Unique Elements Across Domains. Nebraska Symposium on Motivation 2019. [DOI: 10.1007/978-3-030-27473-3_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 631 |
Scutt E, Borgwardt S, Fusar-poli P. Research Perspectives for Neuroimaging of Schizophrenia Spectrum Disorders. Neuroimaging of Schizophrenia and Other Primary Psychotic Disorders 2019. [DOI: 10.1007/978-3-319-97307-4_8] [Reference Citation Analysis]
|
| 632 |
Knytl P, Voráčková V, Dorazilová A, Rodriguez M, Cvrčková A, Kofroňová E, Kuchař M, Kratochvílová Z, Šustová P, Čerešňáková S, Mohr P. Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings. Front Psychiatry 2019;10:390. [PMID: 31275177 DOI: 10.3389/fpsyt.2019.00390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 633 |
van der Gaag M. Cognitieve therapie bij auditief verbale hallucinaties en wanen. Cognitieve therapie 2019. [DOI: 10.1007/978-90-368-2021-9_14] [Reference Citation Analysis]
|
| 634 |
Upthegrove R, Khandaker GM. Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia. Curr Top Behav Neurosci 2020;44:49-66. [PMID: 31115797 DOI: 10.1007/7854_2018_88] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 635 |
Ordieres MGL. Schizophrenia: A Complex Mental Illness. Psychiatry and Neuroscience Update 2019. [DOI: 10.1007/978-3-319-95360-1_33] [Reference Citation Analysis]
|
| 636 |
Quigley H, MacCabe JH. The relationship between nicotine and psychosis. Ther Adv Psychopharmacol 2019;9:2045125319859969. [PMID: 31308936 DOI: 10.1177/2045125319859969] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 637 |
Zhang B, Lin P, Wang X, Öngür D, Ji X, Situ W, Yao S, Wang X. Altered Functional Connectivity of Striatum Based on the Integrated Connectivity Model in First-Episode Schizophrenia. Front Psychiatry 2019;10:756. [PMID: 31681050 DOI: 10.3389/fpsyt.2019.00756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 638 |
Loch AA. Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited. Front Psychiatry 2019;10:328. [PMID: 31133901 DOI: 10.3389/fpsyt.2019.00328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 639 |
Barth B, Portella AK, Dubé L, Meaney MJ, Silveira PP. The Interplay Between Dopamine and Environment as the Biological Basis for the Early Origins of Mental Health. Healthy Ageing and Longevity 2019. [DOI: 10.1007/978-3-030-24958-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 640 |
Penadés R, Franck N, González-Vallespí L, Dekerle M. Neuroimaging Studies of Cognitive Function in Schizophrenia. Adv Exp Med Biol 2019;1118:117-34. [PMID: 30747420 DOI: 10.1007/978-3-030-05542-4_6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 641 |
Endophenotype Potential of Nucleus Accumbens Functional Connectivity: Effects of Polygenic Risk for Schizophrenia Interacting with Childhood Adversity. J Psychiatry Brain Sci 2019. [DOI: 10.20900/jpbs.20190011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 642 |
Koreki A, Maeda T, Okimura T, Terasawa Y, Kikuchi T, Umeda S, Nishikata S, Yagihashi T, Kasahara M, Nagai C, Moriyama Y, Den R, Watanabe T, Kikumoto H, Kato M, Mimura M. Dysconnectivity of the Agency Network in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Front Psychiatry 2019;10:171. [PMID: 31001152 DOI: 10.3389/fpsyt.2019.00171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 643 |
Towlson EK, Vértes PE, Müller-Sedgwick U, Ahnert SE. Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls. Front Psychiatry 2019;10:611. [PMID: 31572229 DOI: 10.3389/fpsyt.2019.00611] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 644 |
Raij TT, Riekki TJJ, Rikandi E, Mäntylä T, Kieseppä T, Suvisaari J. Activation of the motivation-related ventral striatum during delusional experience. Transl Psychiatry 2018;8:283. [PMID: 30563960 DOI: 10.1038/s41398-018-0347-8] [Reference Citation Analysis]
|
| 645 |
Railo H, Olkoniemi H, Eeronheimo E, Pääkkönen O, Joutsa J, Kaasinen V. Dopamine and eye movement control in Parkinson's disease: deficits in corollary discharge signals? PeerJ 2018;6:e6038. [PMID: 30568856 DOI: 10.7717/peerj.6038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 646 |
Cunningham Owens D, Johnstone EC. The development of antipsychotic drugs. Brain Neurosci Adv 2018;2:2398212818817498. [PMID: 32166169 DOI: 10.1177/2398212818817498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 647 |
Benrimoh D, Parr T, Vincent P, Adams RA, Friston K. Active Inference and Auditory Hallucinations. Comput Psychiatr 2018;2:183-204. [PMID: 30627670 DOI: 10.1162/cpsy_a_00022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 648 |
Weele CMV, Siciliano CA, Tye KM. Dopamine tunes prefrontal outputs to orchestrate aversive processing. Brain Res 2019;1713:16-31. [PMID: 30513287 DOI: 10.1016/j.brainres.2018.11.044] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 649 |
Riecher-Rössler A, Butler S, Kulkarni J. Sex and gender differences in schizophrenic psychoses-a critical review. Arch Womens Ment Health 2018;21:627-48. [PMID: 29766281 DOI: 10.1007/s00737-018-0847-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 650 |
Mansur RB, Fries GR, Subramaniapillai M, Frangou S, De Felice FG, Rasgon N, McEwen B, Brietzke E, McIntyre RS. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes. J Psychiatr Res 2018;107:128-35. [PMID: 30391805 DOI: 10.1016/j.jpsychires.2018.10.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 651 |
Antonucci LA, Taurisano P, Coppola G, Cassibba R. Attachment style: The neurobiological substrate, interaction with genetics and role in neurodevelopmental disorders risk pathways. Neuroscience & Biobehavioral Reviews 2018;95:515-27. [DOI: 10.1016/j.neubiorev.2018.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 652 |
Hoffmann C, Van Rheenen TE, Mancuso SG, Zalesky A, Bruggemann J, Lenroot RK, Sundram S, Weickert CS, Weickert TW, Pantelis C, Cropley V, Bousman CA. Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders. Psychiatry Res Neuroimaging 2018;281:61-8. [PMID: 30253269 DOI: 10.1016/j.pscychresns.2018.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 653 |
Leishman E, Murphy MN, Murphy MI, Mackie K, Bradshaw HB. Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains. Front Mol Neurosci 2018;11:436. [PMID: 30542263 DOI: 10.3389/fnmol.2018.00436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 654 |
Kim S, Webster MJ. The Stanley Neuropathology Consortium Integrative Database (SNCID) for Psychiatric Disorders. Neurosci Bull 2019;35:277-82. [PMID: 30484114 DOI: 10.1007/s12264-018-0314-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 655 |
Simon N, Azorin JM. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact]. Encephale 2018;44:558-64. [PMID: 30466778 DOI: 10.1016/j.encep.2018.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 656 |
Dias KCF, de Almeida JC, Vasconcelos LC, Patrocínio MLV, Barbosa TM, Ximenes NC, Leitão APA, Louchard BO, Pimenta ATÁ, Pinto FDCL, Leal LKAM, Honório Junior JER, Vasconcelos SMM. Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-Like behaviours and oxidative parameters in experimental animal models. J Pharm Pharmacol 2019;71:379-89. [PMID: 30456833 DOI: 10.1111/jphp.13039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 657 |
Szczypiński JJ, Gola M. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia? Rev Neurosci 2018;29:727-44. [PMID: 29573379 DOI: 10.1515/revneuro-2017-0091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 658 |
Price C, Dalman C, Zammit S, Kirkbride JB. Association of Residential Mobility Over the Life Course With Nonaffective Psychosis in 1.4 Million Young People in Sweden. JAMA Psychiatry 2018;75:1128-36. [PMID: 30140915 DOI: 10.1001/jamapsychiatry.2018.2233] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 659 |
Deng X, Guo J. Parvalbumin阳性中间神经元缺陷在精神分裂症病理机制中的作用. Adv Psychol Sci 2018;26:1992-2002. [DOI: 10.3724/sp.j.1042.2018.01992] [Reference Citation Analysis]
|
| 660 |
Cratsley K. The Ethical and Empirical Status of Dimensional Diagnosis: Implications for Public Mental Health? Neuroethics 2019;12:183-99. [DOI: 10.1007/s12152-018-9390-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 661 |
Deakin IH, Godlewska BR, Walker MA, Huang GJ, Schwab MH, Nave KA, Law AJ, Harrison PJ. Altered hippocampal gene expression and structure in transgenic mice overexpressing neuregulin 1 (Nrg1) type I. Transl Psychiatry 2018;8:229. [PMID: 30348978 DOI: 10.1038/s41398-018-0288-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 662 |
Manvich DF, Petko AK, Branco RC, Foster SL, Porter-stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D. Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.. [DOI: 10.1101/439398] [Reference Citation Analysis]
|
| 663 |
Owens DC. Tardive dyskinesia update: treatment and management. BJPsych advances 2019;25:78-89. [DOI: 10.1192/bja.2018.46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 664 |
Feroz FS, Leicht G, Rauh J, Mulert C. The Time Course of Dorsal and Rostral-Ventral Anterior Cingulate Cortex Activity in the Emotional Stroop Experiment Reveals Valence and Arousal Aberrant Modulation in Patients with Schizophrenia. Brain Topogr 2019;32:161-77. [PMID: 30288663 DOI: 10.1007/s10548-018-0677-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 665 |
Zsilla G, Hegyi DE, Baranyi M, Vizi ES. 3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake. European Journal of Pharmacology 2018;837:72-80. [DOI: 10.1016/j.ejphar.2018.08.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 666 |
Xie DJ, Shi HS, Lui SSY, Shi C, Li Y, Ho KKY, Hung KSY, Li WX, Yi ZH, Cheung EFC, Kring AM, Chan RCK. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective. Schizophr Bull 2018;44:S547-55. [PMID: 29471331 DOI: 10.1093/schbul/sby013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 667 |
de Almeida V, Martins-de-Souza D. Cannabinoids and glial cells: possible mechanism to understand schizophrenia. Eur Arch Psychiatry Clin Neurosci 2018;268:727-37. [PMID: 29392440 DOI: 10.1007/s00406-018-0874-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 668 |
Jauhar S, McCutcheon R, Borgan F, Veronese M, Nour M, Pepper F, Rogdaki M, Stone J, Egerton A, Turkheimer F, McGuire P, Howes OD. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study. Lancet Psychiatry 2018;5:816-23. [PMID: 30236864 DOI: 10.1016/S2215-0366(18)30268-2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 669 |
Grant P, Green MJ, Mason OJ. Models of Schizotypy: The Importance of Conceptual Clarity. Schizophr Bull 2018;44:S556-63. [PMID: 29474661 DOI: 10.1093/schbul/sby012] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 19.2] [Reference Citation Analysis]
|
| 670 |
Papanastasiou E, Mouchlianitis E, Joyce DW, McGuire P, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Quinlan EB, Desrivières S, Flor H, Frouin V, Garavan H, Spechler P, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Papadopoulos Orfanos D, Poustka L, Millenet S, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Shergill S; IMAGEN Consortium. Examination of the Neural Basis of Psychoticlike Experiences in Adolescence During Reward Processing. JAMA Psychiatry 2018;75:1043-51. [PMID: 30073329 DOI: 10.1001/jamapsychiatry.2018.1973] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 671 |
Vaessen T, Kasanova Z, Hernaus D, Lataster J, Collip D, van Nierop M, Myin-Germeys I. Overall cortisol, diurnal slope, and stress reactivity in psychosis: An experience sampling approach. Psychoneuroendocrinology 2018;96:61-8. [PMID: 29906787 DOI: 10.1016/j.psyneuen.2018.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 672 |
McCutcheon R, Beck K, Jauhar S, Howes OD. Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. Schizophr Bull 2018;44:1301-11. [PMID: 29301039 DOI: 10.1093/schbul/sbx180] [Cited by in Crossref: 144] [Cited by in F6Publishing: 146] [Article Influence: 28.8] [Reference Citation Analysis]
|
| 673 |
Nelson B, Hartmann JA. Prediction in mental health research and its limits (or why life can only be understood backwards but must be lived forwards). Early Interv Psychiatry 2018;12:767-70. [PMID: 29278296 DOI: 10.1111/eip.12530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 674 |
Hook PW, Mccallion AS. Leveraging mouse chromatin data for heritability enrichment informs common disease architecture and reveals cortical layer contributions to schizophrenia.. [DOI: 10.1101/427484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 675 |
Berridge KC. Evolving Concepts of Emotion and Motivation. Front Psychol 2018;9:1647. [PMID: 30245654 DOI: 10.3389/fpsyg.2018.01647] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 22.4] [Reference Citation Analysis]
|
| 676 |
Köhler S, Wagner G, Bär KJ. Activation of brainstem and midbrain nuclei during cognitive control in medicated patients with schizophrenia. Hum Brain Mapp 2019;40:202-13. [PMID: 30184301 DOI: 10.1002/hbm.24365] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 677 |
Oezgen M, Grant P. Odd and disorganized-Comparing the factor structure of the three major schizotypy inventories. Psychiatry Res 2018;267:289-95. [PMID: 29945071 DOI: 10.1016/j.psychres.2018.06.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 678 |
Baldwin S, Hall C, Blaskovits B, Bennell C, Lawrence C, Semple T. Excited delirium syndrome (ExDS): Situational factors and risks to officer safety in non-fatal use of force encounters. Int J Law Psychiatry 2018;60:26-34. [PMID: 30217327 DOI: 10.1016/j.ijlp.2018.06.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 679 |
Paula-pérez I. Convergencias y divergencias genéticas, neurobiológicas y ambientales entre el autismo y el espectro de la esquizofrenia. Anuario de Psicología 2018;48:105-12. [DOI: 10.1016/j.anpsic.2018.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 680 |
Tollens F, Gass N, Becker R, Schwarz AJ, Risterucci C, Künnecke B, Lebhardt P, Reinwald J, Sack M, Weber-Fahr W, Meyer-Lindenberg A, Sartorius A. The affinity of antipsychotic drugs to dopamine and serotonin 5-HT(2) receptors determines their effects on prefrontal-striatal functional connectivity. Eur Neuropsychopharmacol 2018;28:1035-46. [PMID: 30006253 DOI: 10.1016/j.euroneuro.2018.05.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 681 |
Grant P, Munk AJL, Hennig J. A positive-psychological intervention reduces acute psychosis-proneness. Schizophr Res 2018;199:414-9. [PMID: 29661523 DOI: 10.1016/j.schres.2018.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 682 |
So SH, Chau AKC, Peters ER, Swendsen J, Garety PA, Kapur S. Moment-to-moment associations between negative affect, aberrant salience, and paranoia. Cogn Neuropsychiatry 2018;23:299-306. [PMID: 30047842 DOI: 10.1080/13546805.2018.1503080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 683 |
Issy AC, Dos-Santos-Pereira M, Pedrazzi JFC, Kubrusly RCC, Del-Bel E. The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds. Prog Neuropsychopharmacol Biol Psychiatry 2018;86:353-62. [PMID: 29555252 DOI: 10.1016/j.pnpbp.2018.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 684 |
Kim J, Cumming P, Son Y, Kim H, Joo Y, Kim J. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [ 18 F]fallypride PET and functional MRI study: Kim et al. Synapse 2018;72:e22064. [DOI: 10.1002/syn.22064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 685 |
Sumner PJ, Bell IH, Rossell SL. A systematic review of task-based functional neuroimaging studies investigating language, semantic and executive processes in thought disorder. Neurosci Biobehav Rev 2018;94:59-75. [PMID: 30142368 DOI: 10.1016/j.neubiorev.2018.08.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 686 |
Stępnicki P, Kondej M, Kaczor AA. Current Concepts and Treatments of Schizophrenia. Molecules 2018;23:E2087. [PMID: 30127324 DOI: 10.3390/molecules23082087] [Cited by in Crossref: 160] [Cited by in F6Publishing: 169] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 687 |
Stefanowicz J, Słowiński T, Wróbel MZ, Ślifirski G, Dawidowski M, Stefanowicz Z, Jastrzębska-Więsek M, Partyka A, Wesołowska A, Turło J. Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile. Med Chem Res 2018;27:1906-28. [PMID: 30100693 DOI: 10.1007/s00044-018-2203-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 688 |
Cookson J. Rapid tranquillisation: the science and advice. BJPsych advances 2018;24:346-58. [DOI: 10.1192/bja.2018.25] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 689 |
Pinares-Garcia P, Stratikopoulos M, Zagato A, Loke H, Lee J. Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders. Brain Sci 2018;8:E154. [PMID: 30104506 DOI: 10.3390/brainsci8080154] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 690 |
Mätlik K, Võikar V, Vilenius C, Kulesskaya N, Andressoo JO. Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects. Sci Rep 2018;8:11861. [PMID: 30089897 DOI: 10.1038/s41598-018-29988-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 691 |
Hüfner K, Brugger H, Kuster E, Dünsser F, Stawinoga AE, Turner R, Tomazin I, Sperner-Unterweger B. Isolated psychosis during exposure to very high and extreme altitude - characterisation of a new medical entity. Psychol Med 2018;48:1872-9. [PMID: 29202898 DOI: 10.1017/S0033291717003397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 692 |
Wiers CE, Towb PC, Hodgkinson CA, Shen PH, Freeman C, Miller G, Lindgren E, Shokri-Kojori E, Demiral ŞB, Kim SW, Tomasi D, Sun H, Wang GJ, Goldman D, Volkow ND. Association of genetic ancestry with striatal dopamine D2/D3 receptor availability. Mol Psychiatry 2018;23:1711-6. [PMID: 29112197 DOI: 10.1038/mp.2017.208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 693 |
Sami MB, Bhattacharyya S. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. J Psychopharmacol 2018;32:825-49. [PMID: 29591635 DOI: 10.1177/0269881118760662] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 694 |
Parr T, Friston KJ. Uncertainty, epistemics and active inference. J R Soc Interface 2017;14:20170376. [PMID: 29167370 DOI: 10.1098/rsif.2017.0376] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 20.4] [Reference Citation Analysis]
|
| 695 |
Khlghatyan J, Beaulieu JM. Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses? Front Synaptic Neurosci 2018;10:22. [PMID: 30087606 DOI: 10.3389/fnsyn.2018.00022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 696 |
Clissold M, Crowe SF. Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach. J Clin Exp Neuropsychol 2019;41:26-42. [PMID: 30025491 DOI: 10.1080/13803395.2018.1488952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 697 |
Arioka Y, Shishido E, Kubo H, Kushima I, Yoshimi A, Kimura H, Ishizuka K, Aleksic B, Maeda T, Ishikawa M, Kuzumaki N, Okano H, Mori D, Ozaki N. Single-cell trajectory analysis of human homogenous neurons carrying a rare RELN variant. Transl Psychiatry 2018;8:129. [PMID: 30022058 DOI: 10.1038/s41398-018-0177-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 698 |
Duvarci S, Simpson EH, Schneider G, Kandel ER, Roeper J, Sigurdsson T. Impaired recruitment of dopamine neurons during working memory in mice with striatal D2 receptor overexpression. Nat Commun 2018;9:2822. [PMID: 30026489 DOI: 10.1038/s41467-018-05214-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 699 |
Tuplin EW, Holahan MR. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Curr Neuropharmacol 2017;15:1192-207. [PMID: 28412910 DOI: 10.2174/1570159X15666170413115754] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 700 |
Andreou C, Steinmann S, Leicht G, Kolbeck K, Moritz S, Mulert C. fMRI correlates of jumping-to-conclusions in patients with delusions: Connectivity patterns and effects of metacognitive training. Neuroimage Clin 2018;20:119-27. [PMID: 30094162 DOI: 10.1016/j.nicl.2018.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 701 |
Stephenson J. I, Me, You & Us: can a psychodynamic model provide a relational perspective on psychosis? Psychoanalytic Psychotherapy 2018;32:267-281. [DOI: 10.1080/02668734.2018.1487464] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 702 |
Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res 2018;265:25-38. [PMID: 29680514 DOI: 10.1016/j.psychres.2018.04.036] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 703 |
Kroll J, Froudist-Walsh S, Brittain PJ, Tseng CJ, Karolis V, Murray RM, Nosarti C. A dimensional approach to assessing psychiatric risk in adults born very preterm. Psychol Med 2018;48:1738-44. [PMID: 29350124 DOI: 10.1017/S0033291717003804] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 704 |
Kim P, Scott MR, Meador-Woodruff JH. Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 2018;197:484-91. [PMID: 29496332 DOI: 10.1016/j.schres.2018.02.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 705 |
Grimm O, Löffler M, Kamping S, Hartmann A, Rohleder C, Leweke M, Flor H. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity. Eur Neuropsychopharmacol 2018;28:841-9. [PMID: 29887287 DOI: 10.1016/j.euroneuro.2018.04.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 706 |
Tullo S, Devenyi GA, Patel R, Park MTM, Collins DL, Chakravarty MM. Warping an atlas derived from serial histology to 5 high-resolution MRIs. Sci Data 2018;5:180107. [PMID: 29917012 DOI: 10.1038/sdata.2018.107] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 707 |
McGarrity S, Mason R, Fone KC, Pezze M, Bast T. Hippocampal Neural Disinhibition Causes Attentional and Memory Deficits. Cereb Cortex 2017;27:4447-62. [PMID: 27550864 DOI: 10.1093/cercor/bhw247] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 708 |
Niarchou M, Calkins ME, Moore TM, Tang SX, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome. Schizophr Bull 2018;44:824-33. [PMID: 29040797 DOI: 10.1093/schbul/sbx113] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 709 |
Quarto T, Paparella I, De Tullio D, Viscanti G, Fazio L, Taurisano P, Romano R, Rampino A, Masellis R, Popolizio T, Selvaggi P, Pergola G, Bertolino A, Blasi G. Familial Risk and a Genome-Wide Supported DRD2 Variant for Schizophrenia Predict Lateral Prefrontal-Amygdala Effective Connectivity During Emotion Processing. Schizophr Bull 2018;44:834-43. [PMID: 28981847 DOI: 10.1093/schbul/sbx128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 710 |
van Duin EDA, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MCH, Booij J, Myin-Germeys I, van Amelsvoort T. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome. Eur Neuropsychopharmacol 2018;28:732-42. [PMID: 29703646 DOI: 10.1016/j.euroneuro.2018.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 711 |
Nelson B, Amminger GP, Yuen HP, Wallis N, J Kerr M, Dixon L, Carter C, Loewy R, Niendam TA, Shumway M, Morris S, Blasioli J, McGorry PD. Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. Early Interv Psychiatry 2018;12:292-306. [PMID: 28719151 DOI: 10.1111/eip.12459] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 712 |
Dean DJ, Walther S, Bernard JA, Mittal VA. Motor clusters reveal differences in risk for psychosis, cognitive functioning, and thalamocortical connectivity: evidence for vulnerability subtypes. Clin Psychol Sci 2018;6:721-34. [PMID: 30319928 DOI: 10.1177/2167702618773759] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 713 |
Sun F, Zeng J, Jing M, Zhou J, Feng J, Owen SF, Luo Y, Li F, Yamaguchi T, Yong Z, Gao Y, Peng W, Wang L, Zhang S, Du J, Lin D, Xu M, Kreitzer AC, Cui G, Li Y. A genetically-encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice.. [DOI: 10.1101/332528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 714 |
Cao B, Wang D, Brietzke E, McIntyre RS, Pan Z, Cha D, Rosenblat JD, Zuckerman H, Liu Y, Xie Q, Wang J. Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case-control study. Amino Acids 2018;50:1013-23. [PMID: 29796929 DOI: 10.1007/s00726-018-2579-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 715 |
Matheson GJ, Plavén-sigray P, Louzolo A, Borg J, Farde L, Petrovic P, Cervenka S. Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness.. [DOI: 10.1101/321646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 716 |
Lammer E, Klingelhöfer D, Bendels MH, Ohlendorf D, Groneberg DA, Spallek MM. Schizophrenie. Zbl Arbeitsmed 2018;68:177-186. [DOI: 10.1007/s40664-018-0274-9] [Reference Citation Analysis]
|
| 717 |
Adams SA, Nasrallah HA. Multiple retinal anomalies in schizophrenia. Schizophr Res 2018;195:3-12. [PMID: 28755877 DOI: 10.1016/j.schres.2017.07.018] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 718 |
Li Z, Yan C, Lv QY, Yi ZH, Zhang JY, Wang JH, Lui SSY, Xu YF, Cheung EFC, Gur RE, Gur RC, Chan RCK. Striatal dysfunction in patients with schizophrenia and their unaffected first-degree relatives. Schizophr Res 2018;195:215-21. [PMID: 28867519 DOI: 10.1016/j.schres.2017.08.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 719 |
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM, Giros B. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage 2018;176:226-38. [PMID: 29704613 DOI: 10.1016/j.neuroimage.2018.04.054] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 720 |
Liu Z, Zhang J, Zhang K, Zhang J, Li X, Cheng W, Li M, Zhao L, Deng W, Guo W, Ma X, Wang Q, Matthews PM, Feng J, Li T. Distinguishable brain networks relate disease susceptibility to symptom expression in schizophrenia. Hum Brain Mapp 2018;39:3503-15. [PMID: 29691943 DOI: 10.1002/hbm.24190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 721 |
Lambert C, Da Silva S, Ceniti AK, Rizvi SJ, Foussias G, Kennedy SH. Anhedonia in depression and schizophrenia: A transdiagnostic challenge. CNS Neurosci Ther 2018;24:615-23. [PMID: 29687627 DOI: 10.1111/cns.12854] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 722 |
Weïwer M, Xu Q, Gale JP, Lewis M, Campbell AJ, Schroeder FA, Van de Bittner GC, Walk M, Amaya A, Su P, D Ordevic L, Sacher JR, Skepner A, Fei D, Dennehy K, Nguyen S, Faloon PW, Perez J, Cottrell JR, Liu F, Palmer M, Pan JQ, Hooker JM, Zhang YL, Scolnick E, Wagner FF, Holson EB. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. ACS Chem Biol 2018;13:1038-47. [PMID: 29485852 DOI: 10.1021/acschembio.8b00168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 723 |
Giannopoulou I, Pagida MA, Briana DD, Panayotacopoulou MT. Perinatal hypoxia as a risk factor for psychopathology later in life: the role of dopamine and neurotrophins. Hormones (Athens) 2018;17:25-32. [PMID: 29858855 DOI: 10.1007/s42000-018-0007-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 724 |
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain. CNS Neurosci Ther 2018;24:624-32. [PMID: 29656549 DOI: 10.1111/cns.12852] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 725 |
Wang H, Jing M, Li Y. Lighting up the brain: genetically encoded fluorescent sensors for imaging neurotransmitters and neuromodulators. Curr Opin Neurobiol 2018;50:171-8. [PMID: 29627516 DOI: 10.1016/j.conb.2018.03.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 726 |
Chalkiadaki K, Velli A, Kyriazidis E, Stavroulaki V, Vouvoutsis V, Chatzaki E, Aivaliotis M, Sidiropoulou K. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.. [DOI: 10.1101/295741] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 727 |
Rasouli O, Vasseljen O, Fors EA, Lorås HW, Stensdotter AK. Lower regulatory frequency for postural control in patients with fibromyalgia and chronic fatigue syndrome. PLoS One 2018;13:e0195111. [PMID: 29617424 DOI: 10.1371/journal.pone.0195111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 728 |
Goldsmith DR, Crooks CL, Walker EF, Cotes RO. An Update on Promising Biomarkers in Schizophrenia. Focus (Am Psychiatr Publ) 2018;16:153-63. [PMID: 31975910 DOI: 10.1176/appi.focus.20170046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 729 |
Joseph E, Reddi S, Rinwa V, Balwani G, Saha R. DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model. International Journal of Pharmaceutics 2018;541:198-205. [DOI: 10.1016/j.ijpharm.2018.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 730 |
Makowski C, Béland S, Kostopoulos P, Bhagwat N, Devenyi GA, Malla AK, Joober R, Lepage M, Chakravarty MM. Evaluating accuracy of striatal, pallidal, and thalamic segmentation methods: Comparing automated approaches to manual delineation. NeuroImage 2018;170:182-98. [DOI: 10.1016/j.neuroimage.2017.02.069] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 731 |
Tseng HH, Watts JJ, Kiang M, Suridjan I, Wilson AA, Houle S, Rusjan PM, Mizrahi R. Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia. Schizophr Bull 2018;44:542-51. [PMID: 29036383 DOI: 10.1093/schbul/sbx042] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 732 |
van den Noort M, Yeo S, Lim S, Lee SH, Staudte H, Bosch P. Acupuncture as Add-On Treatment of the Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Systematic Review. Medicines (Basel) 2018;5:E29. [PMID: 29601477 DOI: 10.3390/medicines5020029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 733 |
Janetsian-Fritz SS, Timme NM, Timm MM, McCane AM, Baucum Ii AJ, O'Donnell BF, Lapish CC. Maternal deprivation induces alterations in cognitive and cortical function in adulthood. Transl Psychiatry 2018;8:71. [PMID: 29581432 DOI: 10.1038/s41398-018-0119-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 734 |
Haarsma J, Fletcher P, Ziauddeen H, Spencer T, Diederen K, Murray G. Precision weighting of cortical unsigned prediction errors is mediated by dopamine and benefits learning.. [DOI: 10.1101/288936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 735 |
Qi C, Ji X, Zhang G, Kang Y, Huang Y, Cui R, Li S, Cui H, Shi G. Haloperidol ameliorates androgen-induced behavioral deficits in developing male rats. J Endocrinol 2018;237:193-205. [PMID: 29563235 DOI: 10.1530/JOE-17-0642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 736 |
Norwood J. “There and Back Again”: A Tale of a Discipline’s Departure and Triumphant Return. Journal of Humanistic Psychology 2018. [DOI: 10.1177/0022167818766122] [Reference Citation Analysis]
|
| 737 |
Herborg F, Andreassen TF, Berlin F, Loland CJ, Gether U. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 2018;293:7250-62. [PMID: 29559554 DOI: 10.1074/jbc.RA118.001753] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 738 |
Azmanova M, Pitto-Barry A, Barry NPE. Schizophrenia: synthetic strategies and recent advances in drug design. Medchemcomm 2018;9:759-82. [PMID: 30108966 DOI: 10.1039/c7md00448f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 739 |
Gupta I, Young AMJ. Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices. Brain Res 2018;1687:155-61. [PMID: 29524437 DOI: 10.1016/j.brainres.2018.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 740 |
Tadmor H, Golani I, Doron R, Kremer I, Shamir A. ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers. Prog Neuropsychopharmacol Biol Psychiatry 2018;82:322-31. [PMID: 28818421 DOI: 10.1016/j.pnpbp.2017.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 741 |
Delvecchio G, Pigoni A, Perlini C, Barillari M, Versace A, Ruggeri M, Altamura AC, Bellani M, Brambilla P. A diffusion weighted imaging study of basal ganglia in schizophrenia. Int J Psychiatry Clin Pract 2018;22:6-12. [PMID: 28643537 DOI: 10.1080/13651501.2017.1340650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 742 |
Vingerhoets C, Bloemen OJN, Boot E, Bakker G, de Koning MB, da Silva Alves F, Booij J, van Amelsvoort TAMJ. Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis. Psychiatry Res Neuroimaging 2018;272:65-70. [PMID: 29174435 DOI: 10.1016/j.pscychresns.2017.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 743 |
Banaj N, Piras F, Piras F, Ciullo V, Iorio M, Battaglia C, Pantoli D, Ducci G, Spalletta G. Cognitive and psychopathology correlates of brain white/grey matter structure in severely psychotic schizophrenic inpatients. Schizophr Res Cogn 2018;12:29-36. [PMID: 29527507 DOI: 10.1016/j.scog.2018.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 744 |
Owens SJ, Murphy CE, Purves-tyson TD, Weickert TW, Shannon Weickert C. Considering the role of adolescent sex steroids in schizophrenia. J Neuroendocrinol 2018;30:e12538. [DOI: 10.1111/jne.12538] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 745 |
Martino M, Magioncalda P, Yu H, Li X, Wang Q, Meng Y, Deng W, Li Y, Li M, Ma X, Lane T, Duncan NW, Northoff G, Li T. Abnormal Resting-State Connectivity in a Substantia Nigra-Related Striato-Thalamo-Cortical Network in a Large Sample of First-Episode Drug-Naïve Patients With Schizophrenia. Schizophr Bull 2018;44:419-31. [PMID: 28605528 DOI: 10.1093/schbul/sbx067] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 746 |
Loonen AJM, Ivanova SA. Circuits regulating pleasure and happiness: evolution and role in mental disorders. Acta Neuropsychiatr 2018;30:29-42. [PMID: 28473012 DOI: 10.1017/neu.2017.8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 747 |
Teufel C. Sensory Neuroscience: Linking Dopamine, Expectation, and Hallucinations. Current Biology 2018;28:R158-60. [DOI: 10.1016/j.cub.2018.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 748 |
Martinelli C, Rigoli F, Averbeck B, Shergill SS. The value of novelty in schizophrenia. Schizophr Res 2018;192:287-93. [PMID: 28495493 DOI: 10.1016/j.schres.2017.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 749 |
Lansing AE, Plante WY, Fennema-Notestine C, Golshan S, Beck AN. Psychotic-spectrum symptoms, cumulative adversity exposure and substance use among high-risk girls. Early Interv Psychiatry 2018;12:74-86. [PMID: 29282872 DOI: 10.1111/eip.12533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 750 |
Hickling LM, Perez-Iglesias R, Ortiz-García de la Foz V, Balanzá-Martínez V, McGuire P, Crespo-Facorro B, Ayesa-Arriola R. Tobacco smoking and its association with cognition in first episode psychosis patients. Schizophr Res 2018;192:269-73. [PMID: 28412088 DOI: 10.1016/j.schres.2017.04.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 751 |
Souza BOF, Abou Rjeili M, Quintana C, Beaulieu JM, Casanova C. Spatial Frequency Selectivity Is Impaired in Dopamine D2 Receptor Knockout Mice. Front Integr Neurosci 2017;11:41. [PMID: 29379422 DOI: 10.3389/fnint.2017.00041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 752 |
Olney JJ, Warlow SM, Naffziger EE, Berridge KC. Current perspectives on incentive salience and applications to clinical disorders. Curr Opin Behav Sci 2018;22:59-69. [PMID: 29503841 DOI: 10.1016/j.cobeha.2018.01.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 93] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 753 |
Forrest AD, Bang J, Featherstone RE, Bloom JH, Luminais MS, Zhang RV, Gajewski CR, Mcmullen MF, Liang Y, Siegel SJ. Pyramidal cell-selective GluN1 knockout causes impairments in salience attribution and related EEG activity. Exp Brain Res 2018;236:837-46. [DOI: 10.1007/s00221-017-5152-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 754 |
Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EV, Niello M, Espinoza S, Sotnikova TD, Hoener MC, Laviola G, Fumagalli F, Adriani W, Gainetdinov RR. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats. J Neurosci 2018;38:1959-72. [PMID: 29348190 DOI: 10.1523/JNEUROSCI.1931-17.2018] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 20.8] [Reference Citation Analysis]
|
| 755 |
Klarer M, Krieger JP, Richetto J, Weber-Stadlbauer U, Günther L, Winter C, Arnold M, Langhans W, Meyer U. Abdominal Vagal Afferents Modulate the Brain Transcriptome and Behaviors Relevant to Schizophrenia. J Neurosci 2018;38:1634-47. [PMID: 29326171 DOI: 10.1523/JNEUROSCI.0813-17.2017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 756 |
Rutigliano G, Accorroni A, Zucchi R. The Case for TAAR1 as a Modulator of Central Nervous System Function. Front Pharmacol 2017;8:987. [PMID: 29375386 DOI: 10.3389/fphar.2017.00987] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 757 |
Railo H, Olkoniemi H, Eeronheimo E, Pääkkonen O, Joutsa J, Kaasinen V. Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?. [DOI: 10.1101/245381] [Reference Citation Analysis]
|
| 758 |
Smith JS, Lefkowitz RJ, Rajagopal S. Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov. 2018;17:243-260. [PMID: 29302067 DOI: 10.1038/nrd.2017.229] [Cited by in Crossref: 381] [Cited by in F6Publishing: 391] [Article Influence: 76.2] [Reference Citation Analysis]
|
| 759 |
Upthegrove R, Barnes NM. The immune system and schizophrenia: an update for clinicians. Adv psychiatr treat 2014;20:83-91. [DOI: 10.1192/apt.bp.113.011452] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 760 |
Moustafa AA, Garami JK, Mahlberg J, Golembieski J, Keri S, Misiak B, Frydecka D. Cognitive function in schizophrenia: conflicting findings and future directions. Rev Neurosci 2016;27:435-48. [PMID: 26756090 DOI: 10.1515/revneuro-2015-0060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 761 |
Hunter R. Developing tomorrow's antipsychotics: the need for a more personalised approach. Adv psychiatr treat 2014;20:3-12. [DOI: 10.1192/apt.bp.110.008235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 762 |
Hefter D, Marti HH, Gass P, Inta D. Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia. Front Psychiatry 2018;9:106. [PMID: 29651259 DOI: 10.3389/fpsyt.2018.00106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [ |
